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Abstract  
Meiotic prophase I (MPI) is a unique phase of the cell cycle, specific to germ cells and 
defining of sexual reproduction. MPI is a period of extensive and specialized homologous 
chromosome interactions and genetic exchange. Proper progression of MPI requires elaborate 
epigenetic control, deficiencies in which often lead to infertility. Changes in DNA methylation 
during MPI can endanger genome integrity by activating transposable elements (TEs) that when 
mobilized induce DNA breaks and mutations. Therefore, MPI was thought to be under strict 
surveillance by DNA methylation, whose levels were assumed to be high and stable throughout 
MPI. Interestingly, expression of LINE retrotransposons, specifically LINE-1 (L1)-encoded 
protein ORF1p has been observed in MPI germ cells of wild-type male mice. Since tight 
epigenetic regulation is associated with transposon silencing, we hypothesized that L1 expression 
in MPI may indicate relaxation of epigenetic silencing in meiotic germ cells. Thus, we 
investigated the dynamics of CpG DNA methylation during MPI. We enriched and isolated 
individual MPI stages by Fluorescence Activated Cell Sorting (FACS) and profiled individual 
MPI germ cells using whole-genome bisulfite sequencing, and RNA-sequencing. Using this 
approach we uncovered transient and stage-specific changes in DNA methylation dynamics. In 
contrast to the prevailing view, we show that male germ cells undergo genome-wide transient 
relaxation of DNA methylation (TRDM) during early MPI. Specifically, we find that a transition 
from pre-meiotic spermatogonia to meiotic onset in preleptotene spermatocytes is accompanied 
by genome-wide hypomethylation. Gradual, but uneven remethylation of the genome creates 
hypomethylated domains throughout meiotic prophase, with pre-meiotic levels of DNA 
methylation achieved only by late MPI. Our data are most consistent with a DNA replication-
coupled mechanism of DNA demethylation in pre-meiotic S-phase. Intriguingly, a TRDM-
independent set of hypomethylated domains emerges in mid to late MPI and is enriched in 
transcriptionally upregulated spermatogenic genes. Using Mael -/- mice defective in piRNA 
pathway, we show that early MPI offers an opportunity for TE expression and reactivation. We 
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demonstrate that if germ cells enter MPI with insufficient levels of DNA methylation at L1 
elements, then during TRDM, meiotic onset can be hijacked to reactivate potentially active L1s. 
Cumulatively, we demonstrate that early MPI is epigenetically relaxed, exhibits dynamic DNA 
methylation pattern in MPI and that transient genome-wide DNA hypomethylation at meiotic 
onset might have implications in gamete quality control. 
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1.1 An overview 
Germ cells give rise to gametes – sperm in males and eggs in females. Successful 
fertilization of an egg by a sperm results in the formation of a single cell called zygote, which 
gives rise to an entire organism. The story of an organism, then, is as much a story of existence, 
as it is a story of the survival of the fittest germ cell. Indeed, germ cells are unique cells with 
special properties. Meiosis, the playfield for my thesis research, is perhaps the most distinctive 
germ-cell specific property of all. Meiosis is a specialized cell cycle that ensures the production 
of haploid gametes from diploid progenitor germ cells.  
While genetic complexity of a cell provides a blueprint for development, epigenetic 
complexity provides a blueprint for developmental regulation. The word epigenetic, the literal 
meaning of which is “above genetics”, can thus generate complexity “above” and beyond that 
generated by the genetic code. The epigenetic complexity of a cell is set by a finite range of 
epigenetic marks, which are defined as covalent modifications of the DNA or post-translational 
modifications of the histone proteins that package DNA tightly into chromatin. DNA methylation 
is a key epigenetic DNA modification in mammals and involves the addition of a methyl group 
on the carbon-5 position of the cytosine ring of DNA, predominantly in the context of CpG 
dinucleotides in mammals [1]. The dynamics of cytosine methylation and demethylation are well 
known to influence the course of the developing germ cells, in terms of gene expression, 
chromatin compaction and other aspects of cell biology and development [2]. Consequently, 
improper DNA methylation patterns in germ cells are associated with genomic instability and 
infertility [3, 4]. In my work, I identify, describe and begin to explore the significance of changes 
in DNA methylation in meiosis, specifically meiotic prophase I (MPI) of mouse male germ cells. 
 
Section 1.2 The rise of male germ cells 
In mice, epiblast cells give rise to primordial germ cells (PGCs), the precursors of 
oocytes and spermatozoa (Spz). PGCs initially form a cluster of 30-50 cells in the extra-
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embryonic mesoderm on embryonic day 7.25 (E7.25) [5] (Fig 1-1A). These PGCs start to 
proliferate and migrate into the developing gonadal region (the genital ridge). Upon approaching 
the genital ridge, migrating PGCs become connected by cytoplasmic bridges [6] and at E10.5, a 
batch of ~1000 PGCs reach the developing gonads. Within the genital ridges, PGCs continue to 
proliferate, reaching about 26,000 cells by E13.5 [5]. Once PGCs fully colonize the gonads by 
E13.5, PGCs undergo sex differentiation and male primary testes and female ovaries can be 
distinguished from each other morphologically [7, 8]. 
At E13.5, male germ cells undergo cell cycle arrest at G1/G0 and do not enter meiosis 
during the embryonic stages of development, as female germ cells do [5]. At birth, mitotically 
arrested mouse male germ cells resume proliferation by postnatal days 1-2 (P1-P2) [9]. During 
the subsequent month, the first wave of postnatal spermatogenesis, which starts with 
spermatogonia (Spg), occurs in a juvenile mouse, resulting in a first batch of mature sperm in 31-
33 days [10] (Fig 1-1B). Subsequently, each new spermatogenic wave in the adult mouse testis, 
results in a continuous production of sperm. Spermatogenesis is divided into three main parts, (1) 
the mitotic proliferation of Spg, (2) meiosis of spermatocytes and (3) spermiogenesis, or 
differentiation and maturation of round spermatids into mature sperm (Fig 1-1B). This entire 
process occurs within the seminiferous tubule of testis, where Spg are found at the basement 
membrane, but spermatocytes and spermatids are found progressively further from Spg and 
towards the lumen, where mature sperm will be released (Fig 1C) [11]. During Spg proliferation, 
a self-renewing pool of spermatogonial stem cells, single cells located at the basement membrane 
of the seminiferous tubule, divide to renew themselves and to give rise to the more advanced Spg 
(Fig 1-1B). The first several rounds of mitotic divisions give rise to undifferentiated Type A Spg 
and include a renewed A single (As) and more advanced A paired (Apr) and A aligned (Aal) (Fig 
1-1B) [12]. Ultimately, each of these Aal cells undergo more mitotic cell divisions to produce 
differentiating Spg, including types A1, A2, A3 and A4, intermediate Spg (In) and type B Spg 
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(Fig 1-1B). Type B Spg divide to produce two preleptotene (PL) spermatocytes. Thus, about ten 
generations of Spg are necessary to form PL spermatocytes from one precursor stem cell. PL 
spermatocytes are cells that represent the beginning of meiotic prophase I (MPI), and are often 
considered as cells in meiotic onset. PL cells are primary spermatocytes that replicate and enter 
prophase of meiosis. The MPI is followed by two successive rounds of chromosome segregation 
resulting in the production of four haploid spermatids. The spermatids undergo a long process of 
spermiogenesis, during which a dramatic morphogenesis transforms them into mature Spz (Fig 1-
1B,C). In principle, differentiation of one spermatogonial type As stem cell could lead to the 
production of up to 4096 Spz (Fig 1-1B).   
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Fig 1-1. Diagram summary of gametogenesis and spermatogenesis. A) Gametogenesis 
overview. A zygote, which is a single cell that results from fertilization of an egg by a sperm, is 
made up of a maternal (red) and paternal (blue) pronuclei, but will give rise to an entire organism. 
After cleavage cell divisions, developmental milestones include the formation of the ICM, which 
will give rise to the embryo proper and to a more developmentally restricted epiblast. At around 
E7.5-8.5 (or 7.5-8.5 days post coitum, DPC), PGCs (green) arise from the epiblast, and eventually 
give rise to mature sperm and egg. B) Spermatogenesis overview, in males occurs starting 1-2 
days after birth. In theory, one spermatogonial stem cell (As Spg) having undergone 
differentiation can give rise to 4096 spermatozoa. On the left of the diagram is the duration of 
spermatogensis in days, where it takes 5-7 days to undergo Spermatogonial mitotic divisions, and 
26-28 days to undergo meiosis plus spermiogenesis. On the right of the diagram are values 
corresponding to the number of specific germ cell types. C) Diagram of testis cross-section. All 
spermatogonia are found at the basement membrane of seminiferous tubules. Spermatocytes, 
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round and elongated spermatids, are seen at successively higher levels within the seminiferous 
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Section 1.3 Germ cell development in the context of the mouse testis 
 
Unambiguous identification of the exact stage of male germ cell development throughout 
spermatogenesis is a challenge, and an art. Classical criteria used for “staging” involves tissue 
fixation and PAS-hematoxylin staining, followed by identification of a particular stage (Fig 1-2A. 
e.g stage IV) of the seminiferous epithelium cycle, which is composed of the 12 stages (Clermont 
and Leblond, 1953; Oakberg, 1956; Russel et al 1990) (Fig 1-2B). Each of the twelve stages is 
characterized by the presence of specific cellular associations. For example, stage VI (Fig 1-2A) 
necessarily contains A and B Spg (or A and B-to-PL cells), plus P spermatocyte, plus “step 6” 
round spermatid and also, a more differentiated “step 15” elongated spermatid. Thus, any given 
stage will contain a unique combination of pre-meiotic Spg, meiotic spermatocyte(s) and post-
meiotic spermatid(s) (Fig 1-2B). Recognition of stages depends on recognition of these cell types. 
It is, for example, extremely difficult to differentiate mid-P spermatocyte at stage VIII, from late-
P at stage X. Much easier, is to recognize that a cross-section at stage VIII contains two types of 
spermatids (a round one at step 8 and an elongating one at step 16 of development), while a 
section at stage X, contains no round spermatids, but only an early elongating spermatid of step 
10 (Fig 1-2B). Indeed, a sure way to differentiate stages is to differentiate the stages or steps of 
spermatid development. The development of an acrosome is a primary means to do so 
histologically (Russell et al, Hist and Histopath Evaluation of the Testis), where the development 
of the acrosome is accompanied by the dynamic changes in acrosome shape (Fig 1-2C).  
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Fig 1-2. Spermatogenesis and the cycle of seminiferous epithelium. Spermatogenesis is a long 
process during which spermatogonial cells transform into spermatozoa. A) Identification of a 
particular stage of spermatogenesis, e.g. stage IV, is contingent on an ability to identify germ cell 
associations in any one testicular cross-section. Specific cell associations make up the cycle of the 
seminiferous epithelium. B) This cycle of spermatogenesis is subdivided into 12 morphologically 
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distinct stages in the mouse. Any given testicular cross-section is associated with one or more of 
the proliferative Spg cells, meiotic spermatogonia and post-meiotic spermatids. C) The early, 
middle and late development of the acrosome is the primary criterion for identifying stages of 
spermatogenesis. It is accompanied by the dynamic changes in the shape of the acrosome, from 
early proacrosomal granule, to flattening and spreading of the developing acrosome. In the 
earliest step 1 spermatid, no discrete acrosomal granules are typically observed. 
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Section 1.4 Meiosis 
 
Meiosis, unique to sexually reproducing organisms, is a specialized cell cycle during 
which a single round of DNA replication is followed by two rounds of chromosome segregation 
and whose goal it is to reduce the chromosome number by half, from diploid to haploid. Thus, in 
sexually reproducing organisms, two parents will contribute one genome (one complement, or 
1C) each to an offspring, so that the latter ends up with a 2C genome, containing two copies of 
the genome, the maternal and the paternal one. In mice, the very first meiosis commences at 
around 8-10 days after birth, with a new wave of meiosis starting every ~8.6 days throughout the 
animal’s life [10, 13]. Prior to meiosis, type B spermatocytes, which are highly differentiated Spg 
committed to meiotic program, divide to produce PL spermatocytes, which undergo pre-meiotic 
DNA synthesis, resulting in the duplication of the parental genetic material, and beginning of 
meiotic prophase.  
The soul of meiosis lies within the MPI during which, unique pairing of homologous 
chromosomes and recombination take place. MPI is exceptionally long, lasting about 3 weeks, 
during which time the chromosomes undergo dramatic changes in their organization (Fig 1-3A). 
MPI is subdivided into leptotene (L), zygotene (Z), pachytene (P), and diplotene (D) stages, based 
on their unique nuclear and chromatin morphology [11] (e.g., Fig 1-3A). Even though MPI is 
subdivided into distinct stages, a change from one stage to another involves rather gradual 
morphological transitions [11] that are poorly defined molecularly.  
It is beyond the scope of this thesis to describe in detail all the events that make MPI 
unique, however, a reader is encouraged to visit the contents of in-depth literature on meiosis [14, 
15] and other chapters of this dissertation. Below, several important meiosis-specific phenomena 
are reviewed with focus on meiotic entry, homologous chromosome pairing, recombination and 
stage transitions.  
Meiotic S phase (or pre-meiotic S phase, used interchangeably) is much longer than 
mitotic S-phase in the same organism [16-18]. The difference in duration between mitotic and 
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meiotic S phases was found to be not due to the difference in replication fork movement rates, 
fork lengths or Okazaki fragment sizes [19]. Instead, it has been shown that considerably longer 
meiotic S phase is in part due to the reduced number of replication initiation sites [17, 20]. While 
the basis of the difference in meiotic S phase length is unclear, it is presumed to depend on the 
packaging of chromatin and is thought to be important for the unique events of meiotic prophase I 
[17, 18, 21].  Such events may be those required for or coordinated with the establishment of 
meiosis-specific chromosome features, like specialized sister-chromatid cohesion [18, 19]. It is 
well known that DNA topology and chromatin modifications exert influence on the replication 
timing, for example, inactive heterochromatin replicates late during S phase [22]. Thus, it is likely 
that meiotic and mitotic DNA topologies differ during S-phase and this difference may contribute 
to differential replication timing.  Yet, another potential difference in replication timing, could be 
due to the difference in accuracy of DNA replication, under the hypothetical premise that more 
accurate replication requires more time [23]. Since meiotic cells have the responsibility of 
contributing their genomes to the next generation, it is conceivable, that DNA replication in 
meiosis is more accurate than that in mitosis. Intriguingly, more types of DNA polymerases are 
found in meiosis than mitosis, with different DNA polymerases sporting differential accuracy and 
speed of replication [24]. 
After chromosome duplication in PL, the homologous chromosomes start to pair along 
their lengths, based on homology. Meiotic pairing is a truly unique and dynamic process, in the 
context of which key meiotic events occur. One way to demonstrate the main aspects of homolog 
pairing and the temporally parallel meiotic events is to follow the assembly of a meiosis-specific, 
structure, the Synaptonemal Complex (SC) (Fig 1-3A). SC marks and mediates stable and 
progressive interactions of the homologs, eventually bringing the homologs in close juxtaposition 
[25].  
The SC assembly starts early in MPI. In L stage, SC proteins, including SCP3 and SCP2 
begin to assemble on chromosomes, indicating early stages of pairing. At this time, these proteins 
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microscopically appear as short, thin stretches called Axial Elements (AEs) along which, sister 
chromatids of individual homologs organize in loops attached at the AE core (Figs 1-3A,B). The 
initiation of homolog pairing is very poorly understood, but is thought to take place in L stage, 
with initiation of programmed meiotic double-strand breaks (DSBs) by SPO11, an evolutionally 
conserved type II topoisomerase-like protein [26]. However, it is likely that in mouse 
spermatocytes, and in some other organisms, homologous pairing initiation occurs prior to DSB 
formation, during pre-meiotic S phase in PL stage [27]. Indeed, the occurrence of SC, a marker of 
homologous pairing, is observed during pre-meiotic S phase in mice, and is not unique to mouse 
model [28, 29]. 
Homologous chromosomes become paired in Z, forming the SC at points of association. 
Thus, in Z, homologous chromosomes become closely associated by synapsis at various points 
along their lengths, with AEs, appearing as long thin stretches along the length of the 
chromosome (Fig 1-3A). In Z, AEs start to zip up via the laying down of the Central Element 
(CE) made up of proteins including SCP1 (Fig 1-3B). As chromosomes become paired along 
their lengths, they undergo meiotic recombination, which is an essential source of genetic 
diversity. Meiotic recombination (a physical exchange of chromosome segments) is initiated with 
the formation of programmed DSBs, but stable homologous recombination occurs in the context 
of the SC, starting at Z. Much of meiosis is dedicated to repairing DSBs, and meiotic homologous 
recombination is one form of repair. The L-to-Z (LZ) transition is truly unique, and is defined as 
the period when homologs, already extensively paired, come close together forming the bouquet, 
a meiotic chromosome configuration where chromosome ends cluster and “integrate” into the 
nuclear envelope in a polarized fashion, creating an organization reminiscent of a bouquet of 
flowers held at the stems (although in the case of the meiotic bouquet, both ends of the 
chromosomes cluster). LZ transition is marked by extensive chromosome movements, both 
passive and active. The Z-to-P transition (ZP) is marked by the completion of meiotic synapsis 
and recombination. In P, AEs, now called Lateral Elements (LEs), are fully zipped up by CEs, 
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marking the end of the SC formation, and indicating homologous chromosome synapsis. In P, but 
initiated at Z-to-P transition, meiotic sex chromosome inactivation (MSCI) and meiotic silencing 
of unsynapsed chromatin (MSUC) occur in male germ cells [30]. MSCI is a process of XY 
inactivation via transcriptional silencing and compartmentalization into a nuclear subdomain 
called the sex-or XY-body, that persists through diplonema. MSUC silences autosomes that fail 
to properly pair with their homologs. Pachynema, is an extremely busy stage of MPI, exhibiting a 
dramatic increase in overall RNA and protein synthesis in preparation for the next phase of 
spermatogenesis. At Diplonema, SC disassembles and homologous chromosomes de-synapse. By 
the end of the diplotene stage, the homologs remain connected only at chiasma, the physical 
remnants of homologous recombination.   
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Fig 1-3. Key features of Meiotic Prophase I (MPI). A) Timing of MPI. Morphology of the 
nuclei of different stages of male meiosis by immunofluorescence analysis. Spg - differentiated 
spermatogonia; preL - preleptotene spermatocytes; L-leptotene spermatocytes; Z-zygotene 
spermatocytes; P - pachytene spermatocytes; D - diplotene spermatocytes. Spread nuclei were 
double labeled with γH2AX (green) and SYCP3 (red) and counterstained with DAPI (blue). 
Staging was deduced from changing, stage-specific labeling patterns of these markers. Bar - 10 
µm. B) Diagram of SC assembly in MPI and summary of key MPI events. 
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Section 1.5 Epigenetic dynamics in gametogenesis and meiosis 
 Epigenetic changes are those that can influence the phenotype without changing 
the genotype, yet have an ability to be inherited. Key epigenetic modifications include DNA 
methylation and histone modifications. Changes in these modifications can lead to changes in 
transcriptional program of the cell, chromatin remodeling, perpetuation of a particular chromatin 
structure through generations and more. Germ cell development is accompanied by extensive 
epigenetic transitions. In the following paragraphs, several epigenetic changes that are critical for 
proper germ cell development are highlighted, with focus on meiosis, a hub of epigenetic 
plasticity and diversity.  
Changes in Histone Modifications. Histones package and order genomic DNA into a 
structural complex called the nucleosome. Histone modifications affect nucleosome structure and 
stability and therefore chromatin organization. There are a large number of histone 
posttranslational modifications (PTMs), including histone methylation (primarily of lysines and 
arginines), histone acetylation (of lysines) and others. Histone PTMs play an important role in 
male germ cell development. While it is beyond the scope of this introduction to review histone 
PMTs, it is important to mention their significance in germ cell development. Major changes in 
histone PTMs occur in meiotic and post-meiotic germ cells. Below, several illustrative examples 
are provided.  
Post-meiotic chromatin remodeling involves the removal of canonical nucleosomal 
histone proteins (upon histone H4 hyperacetylation) and their replacement with histone variants; 
first with the transition nuclear proteins and later, with basic proteins called protamines [31]. The 
histone-to-protamine exchange is essential for the extreme condensation of the genome in mature 
sperm.  
Large-scale histone exchange is also important for meiotic spermatocytes. For example, 
MSCI is associated with chromosome-wide replacement of H3.1/H3.2 with H3.3 [32]. Similarly, 
shortly after MSUC induction in late Z/early P spermatocytes, H3.1/H3.2 nucleosomes are 
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evicted, and H3.3 incorporated into unsynapsed autosomal chromatin [32]. This loss of 
H3.1/H3.2 coincides with loss of most histone PTMs, with a few exceptions. Functionally, the 
progressive gain in H3.3 from late P-to-D spermatocytes is concomitant with increasing levels of 
autosomal transcription [33], because H3.3 attracts activating histone modifications conducive for 
transcription in euchromatin [34]. 
Dynamic mono-, di- or tri-methylated H3K4 (H3K4me1,2,3) and H3K9me2 
modifications have been observed in MPI [32, 35]. The functional importance of these changes is 
in infancy of elucidation, but the progress is exciting. In MPI germ cells, H3K9me1,2 is widely 
localized to euchromatin of  early L through late Z spermatocytes, disappearing in pachynema 
[35] and reappearing in heterochromatic foci of late P and D cells [32]. H3K9me1,2 
modifications are known to contribute to transcriptional silencing. Mutant mice in which an 
H3K9me1,2 histone methyl transferase (HMTs), G9a, is mutated, exhibit an overexpression of 
inappropriate genes in meiosis, disrupting the gene silencing crucial for MPI progression [35]. In 
another study, transient acquisition of H3K9me2 at pericentric heterochromatin of spermatocytes 
was found crucial for facilitating homologous chromosome interactions via maintenance of their 
centromeres in close proximity [36]. In general, loss of H3K9 HMTs negatively affects pairing of 
the homologous chromosomes in mouse MPI, and is associated with delayed synapsis and 
impaired post-meiotic development [37].  
Histone methylation also plays a very significant role in meiotic recombination. In 
mammals, crossing-over involves repair of meiotic DSBs, which map to preferred chromosomal 
locations called hotspots. Recently, it was demonstrated that meiosis-specific HMT that mediates 
H3K4me3, PRDM9 (also called MEISETZ), binds to the hotspot motifs [38]. Meiotic 
recombination is thus thought to be initiated when PRDM9 deposits H3K4me3 and triggers 
SPO11 mediated DSBs.  
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Changes in DNA methylation. An essential form of epigenetic change is the methylation of 
cytosine at its 5’ position (5meC). 5meC in DNA of mammalian cells is found almost entirely 
within CpG dinucleotides [39]. A great deal of attention has been focused on the endogenous 
patterns of CpG DNA methylation. This is because this epigenetic mark has significant regulatory 
and structural roles in a variety of fundamental developmental processes, such as genomic 
imprinting, where DNA methylation is essential for regulation of parent-specific gene expression 
[40, 41]. One critical function of DNA methylation is transcriptional regulation, although the 
relationship between DNA methylation and gene transcription is complex. At CpG-rich gene 
promoters, DNA methylation promotes and directs gene silencing [42, 43]. Transcriptional 
repression, associated with low promoter DNA methylation, is in part, mediated by the methyl 
CpG binding proteins (MeCP) and methyl domain binding proteins (MBD) [44]. The reverse 
relationship, that of gene expression and undermethylation is not as straightforward, since CpG-
rich regions (called CpG Islands, or CGIs) within the promoters of many genes are typically 
unmethylated regardless of the transcriptional status of the genes [44]. However, there are many 
exceptions, one, being the CpG-rich promoters of transposable elements (TEs) that are normally 
methylated, and whose DNA demethylation is associated with their transcriptional activation [4, 
45]. The role of DNA methylation in TE regulation is discussed later in the chapter.  
Mammalian development is characterized by bimodal DNA methylation reprogramming 
that occurs first during pre-implantation (with the lowest levels, of < 20% methylation genome-
wide, in the inner cell mass at ~E3.5) and then during embryonic germ cell development 
(reaching lowest DNA methylation levels, of < 20% genome-wide, at E12.5-E13.5) (Fig 1-4) [46-
48]. The former DNA methylation reprogramming begins in the zygote, when, upon fertilization, 
rapid demethylation of the paternal genome (male pronucleus) is observed [49]. Additionally, in 
the first few zygotic cleavage divisions, DNA methylation of both maternal and paternal genomes 
gets diluted in a replication-dependent manner, reaching its lowest levels in the ICM of the pre-
implantation embryo. DNA methylation is immediately regained post-implantation [50, 51] (Fig 
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1-4). In the event of PGC DNA methylation reprogramming, prior to reaching the genital ridges, 
PGCs exhibit parent-of-origin-specific imprinting methylation marks (called genomic 
imprinting), which enforce the mono-allelic expression of many imprinted genes. Most parental 
methylation imprints on paternal and maternal alleles are erased between E11.5 and E13.5 [52] 
and this genome-wide erasure of parental DNA methylation marks is associated with acquisition 
of totipotency. The global DNA demethylation is followed by the de novo methylation that 
involves germ-cell specific resetting of DNA methylation marks, which occurs only after sex 
determination, depending on sex of the developing embryo (Fig 1-4). De novo methylation takes 
several days, but is largely completed by birth in the male [53].  
DNA Methyltransferase enzymes (DNMTs) are responsible for creating and propagating 
all DNA methylation patterns. DNMTs catalyze either de novo methylation (DNMT3a, 
DNMT3b) or maintenance methylation (DNMT1) of hemi-methylated DNA following DNA 
replication [54, 55]. Dnmt3L, while lacking DNMT enzymatic activity, is critical for stimulating 
the activity of other DNMTs, like DNMT3a [55, 56]. These enzymes play a critical role in the 
genome-wide DNA methylation events that take place throughout germ cell development and 
their loss is detrimental to germ cell survival [3]. Different DNMTs are dynamically expressed 
throughout male germ cell development (Fig 1-5). The Dmnt3a and Dnmt3l peak during 
embryonic DNA methylation reprogramming, but their expression is heavily downregulated prior 
to meiosis [56]. While relatively lowly expressed during embryogenesis, Dnmt3b and Dnmt1 
mRNA exhibit a modest, transient increase after birth, but are down-regulated in meiosis. The 
highest DNMT1 protein levels in postnatal testes were found in proliferating mitotic Spg, with 
gradual decline in meiosis.  
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Fig 1-4. DNA methylation changes during embryogenesis and gametogenesis. Proliferating 
and migrating germ cells undergo epigenetic reprogramming, whereby DNA methylation is 
globally erased. E12.5-E13.5 marks the lowest point of methylation in an embryo. After sexual 
differentiation, mitotically arrested prospermatogonia regain methylation, and by birth, progenitor 
germ cells are highly methylated. After sexual differentiation, females take a different route and 
enter meiosis, whereby their levels of DNA methylation remain low. Post-fertilization, another 
DNA demethylation event takes place and is distinct on parental genomes. DNA demethylation at 
male pronucleus is fast and slower in female. Preimplantation embryo has very low levels of 
DNA methylation. Concomitant with implantation, the blastocyst undergoes remethylation. New 
methylation patterns are established according to the cell type and cell differentiation program. 
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Figure 1-5. Diagram of DNA methyltransferase (Dnmt) dynamics in gametogenesis. Relative 
mRNA levels of Dnmt1, Dnmt3a, Dnmt3b and Dnmt3l are shown. The data is based on the real-
time RT-qPCR from testis corresponding to embryonic stages (E13.5, E15.5 and E18.5) or 
postnatal stages (P6, P10, P16, P22 and P70). These ages correspond to embryonic DNAme 
reprogramming and after birth, starting with P6, to first wave of spermatogenesis. Approximately, 
the postnatal testis are enriched in mitotic Spg at P6, PL and L at P10, Z, P and D at P16, round 
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Section 1.6 Transposable element silencing in the germline: DNA methylation and piRNA 
pathway 
First discovered in maize by Barbara McClintock in the 1940s, transposable elements 
(TEs) are genomic DNA sequences that have the ability to become mobile and move from place 
to place in the genome. Due to their mobile nature, McClintock, who described TEs as 
“controlling elements”, showed they can cause chromosomal breaks and mutations [57]. It is now 
a common knowledge that TEs make up the majority of the mammalian genome [58, 59]. We 
also know, that only a small subset of TEs is potentially mobile or active, with the majority of 
TEs mutated and thus benign in terms of their capacity to autonomously mobilize.  Hence, the 
TEs in the genome can be divided into inactive and potentially active elements and 
correspondingly, into old and evolutionarily young ones [60]. 
There are many different types of TEs, and they are extremely diverse in sequence and 
structure. TEs can be categorized into two well-defined classes according to their structure and 
movement strategies. Class II elements, which only make up about 3% of the mouse genome, are 
made up of DNA transposons that are mobilized by a ‘cut and paste’ mechanism [61]. Class I 
elements, which account for almost half of the genome in mammals, mobilize by a ‘copy and 
paste’ mechanism involving an RNA intermediate [62]. A majority of these retrotransposons are 
truncated and mutated, but some active elements are capable of mobilization.  
TEs are highly interspersed throughout the genome, and have played a major role in 
shaping the mammalian genome structure, gene expression and epigenetic topology of chromatin. 
Indeed, besides contributing large amounts of DNA to the mammalian genomes (including at 
least 40% of human and mouse genomes), TEs have significantly contributed to the repertoire of 
gene expression, providing new genes [63], exons [64, 65], and regulatory motifs [66]. Indeed, 
new TE insertions continue to impact and diversify gene expression [67]. 
Several families of retrotransposons co-exist in the genome.  Retrotransposons are classified into 
long interspersed nuclear elements (LINEs), short interspersed nuclear elements (SINEs) and long 
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terminal repeats (LTRs). Long INterspersed Element-1 (LINE-1 or L1) is the major category of 
TEs in placental mammals, including mice, and contributes to over 20% of genome size, with 
~500,000-600,000 copies of L1 in humand and mouse genomes [62, 68]. Most retrotransposons 
are mutated “fossils” of previously active TEs, but L1 superfamily hosts a fraction of active 
elements, with at least 3,000 potentially active elements [69]. Given the activity of LINEs in 
mouse genome, L1-dependent SINE activity is also observed in the mouse, with, for example, 
more than 300,000 SINE element insertions estimated since mouse and rat diverged [70]. LTRs 
also contain active copies in the mouse (and human) genome, with most mutagenic insertions 
from the intracisternal A particle (IAP) and MusD/ETn elements. Currently, there are multiple 
potentially active L1 families, distinguished primarily, but not exclusively, by the type of 
promoter they have [60]. LINEs are strongly biased towards AT-rich regions, whereas a major 
inactive category of retrotransposons, short interspersed nuclear element (SINE) is biased towards 
GC-rich regions, preferences that are also evident in the human genome.  
Although a rich source of evolutionary variation, L1 activity can be detrimental to the 
fitness of the host, either by inserting into the genome, deleting and rearranging DNA or 
otherwise modifying the genome. Indeed, the role of TEs in human diseases is widely 
appreciated, from early discovery that hemophilia A resulted from a de novo insertion of L1 [71] 
to a growing list of diseases caused by TE-mediated mutagenesis. Most recently, TE expression 
has been associated with sporadic cancers or exacerbation of cancer phenotypes [72, 73]. Much of 
the TE activity, in both humans and mice, is due to active L1 retrotransposons.  
To ensure their propagation, TEs have to mobilize within germ cells, the cells destined 
for the next generation. Indeed, during epigenetic reprogramming of the embryonic germline, 
when relaxation of epigenetic control is observed, TE expression is also observed and constitutes 
a dangerous window in which TEs can potentially escape from host restraint, mobilize and 
expand [74]. However, embryonic germ cells are equipped to combat TE expression. As 
mentioned earlier, DNA methylation is critical for transposon control, and DNMTs play essential 
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roles in the establishment and maintenance of retroviral methylation in embryogenesis (Fig 5). 
Since the damaging effects of TEs could jeopardize germ cell genome integrity and germ line 
propagation, in addition to DNA methylation, germ cells possess other defense systems. An 
essential line of defense includes the post-transcriptional RNAi-like control provided by the 
piRNA pathway [3, 75] (Fig 1-6). DNA methylation and the piRNA pathway are intimately 
linked at the level of TE control. Essentially, in collaboration between DNA methylation and the 
piRNA pathway, in what is referred to as the piRNA-directed DNA methylation pathway, TE 
silencing is ensured until the end of spermatogenesis [76, 77].  
In addition to DNA methylation and piRNA pathway, various repressive histone 
modifications lock L1 and other TEs in the heterochromatic state [3, 75]. Indeed, there are a 
number of key repressors of TE activity in the male germ line whose inactivity leads to de-
repression of TEs and germ line demise [3]. Key among these known repressors are components 
of DNA methylation machinery DNMT1, DNMT3a, DNMT3L, H3K9 methylatranserases ESET 
(also known as Setdb1 or KMT1E) and Suv39h1 (also known as KMT1A), and piRNA pathway 
components MILI, MIWI2 and MAEL [3].  
  






Fig 1-6. TE silencing in male germline. Genome-wide loss of DNA methylation during 
embryonic reprogramming is immediately followed by gain in DNA remethylation executed by 
DNMTs DNMT3a and DNMT3L. TE control also involves degradation of transposon RNA to 
transposon piRNAs by piRNA pathway, which includes MIWI2, TDRD9, MILI, TDRD2 and 
MAEL proteins. DNA methylation during meiosis is thought to be stable and maintained by 
DNMT1, with DNMT3A also available.  Meiotic germ cells express some of the piRNA 
components, with early meiotic germ cells having seemingly low piRNA protein abundance.   
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Abstract  
Meiotic prophase I (MPI), is an initial stage of meiosis characterized by intricate homologous 
chromosome interactions, synapsis and DNA recombination. These processes depend on the 
complex, but poorly understood early MPI events of homologous chromosome search, alignment 
and pairing. Detailed molecular investigation of these early events requires isolation of individual 
MPI substages. Enrichment for Pachytene (P) and Diplotene (D) substages of late MPI was 
previously accomplished using flow cytometry. However, separation of early MPI spermatocytes, 
specifically, of Leptotene (L) and Zygotene (Z) substages, has been a challenge due to these cells’ 
similar characteristics. In this report, we describe an optimized Hoechst-33342 (Hoechst)-based 
flow cytometry approach for isolating individual MPI populations from adult murine testis. We 
get significant enrichment for individual L and Z spermatocytes, previously inseparable from 
each other, and optimize the isolation of other MPI substages. Our flow cytometry approach is a 
combination of three optimized strategies. The first is optimization of testis dissociation protocol 
that yields more consistent and reproducible testicular single cell suspension. The second 
involves optimization of flow cytometric gating protocol where a critical addition to the standard 
protocol for cell discrimination based on Hoechst fluorescence, involves a back-gating technique 
based on light scattering parameters. This step specifies selection of individual MPI substages. 
The third, is an addition of DNA content restriction to the gating protocol to minimize 
contamination from non-meiotic cells. Finally, we confirm significant enrichment of high-purity 
Preleptotene (PreL), L, Z, P and D MPI spermatocytes using stage-specific marker distribution. 
The technique will facilitate understanding of the molecular events underlying meiotic prophase I.  
 
Introduction  
Spermatogenesis, a multistage process by which spermatogonial stem cells differentiate into 
spermatozoa, occurs in the seminiferous tubules of the adult testis. As a result of asynchronous 
initiation of spermatogonial stem cell differentiation, the testis contains germ cells at all phases of 
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spermatogenesis. These include the proliferative phase, responsible for the mitotic expansion of 
diploid spermatogonia, the meiotic phase, which generates haploid cells from diploid progenitors 
by way of specialized two cell divisions preceded by one round of DNA replication, and 
spermiogenic phase, marked by the differentiation and maturation of haploid cells.  
The cellular heterogeneity of the testis necessitates developing methods for germ cell 
enrichment and isolation. The study of individual stages of spermatogenesis has become more 
accessible with Hoechst-based flow cytometry approaches. Indeed, flow cytometry is commonly 
used to enrich for murine spermatogonial stem cells [78-80] and more recently, for late MPI 
spermatocytes [81-83]. On the other hand, enrichment for high-purity early MPI populations has 
remained difficult, thus, these cell types have largely escaped comprehensive molecular analysis. 
One challenge is that testicular cell heterogeneity is not proportional with respect to the percent of 
each cell type present. Due to the logarithmic nature of spermatogenesis, early cell types are 
proportionately underrepresented. A spermatogonial stem cell can give rise to up to 1024 primary 
spermatocytes and four times as many haploid spermatids, and the maturation of spermatid into a 
mature spermatozoon is one of the lengthiest phases of spermatogenesis. As a result, post-meiotic 
cells occupy the majority of the total testicular volume [11]. This makes it difficult to enrich for 
and study the less abundant and more transient early MPI populations. In fact, the purification of 
individual L and Z substages has not yet been accomplished to date. A major goal of this study 
was to achieve separation of individual L and Z spermatocytes.  
Early MPI is critical for proper meiotic progression. Originally characterized in terms of 
changes in the chromosomal morphology [84], L and Z substages differ in a number of cellular 
processes. Leptonema, which follows Preleptonema where pre-meiotic S-phase occurs, involves 
extensive chromatin reorganization, telomere-led chromosome movement and telomere 
attachment to nuclear envelope. These are thought to facilitate homologous chromosome 
(homologue) interactions, alignment and pairing [84, 85]. At this time, meiotic “programmed” 
double stranded breaks (DSBs) form and Axial Elements (AEs) start to assemble along the paired 
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sister chromatids. During L to Z transition, a widely conserved telomere configuration known as 
meiotic bouquet can be observed, and is marked by telomere clustering at the nuclear periphery 
[86, 87]. In Zygonema, homologues begin to synapse as AEs assemble into synaptonemal 
complex (SC), a proteinateous structure that will eventually juxtapose the homologs along their 
entire lengths in Pachynema of MPI. The events observed in early MPI, including wide-range 
chromosomal movements, visible changes in the distribution of heterochromatin and assembly of 
SC, imply extensive changes in chromatin organization. Some molecular details of these early 
meiotic processes have been described in C. elegans [88, 89], S. cerevisiae [90], S. [91, 92] and 
other non- mammalian organisms. However, detailed molecular understanding of early meiotic 
events in mammals is still lacking. Clearly, detailed molecular and mechanistic studies, and the 
subsequent generation of appropriate mutants, are necessary to understand the scope of regulation 
and coordination of these events, necessary for proper meiosis. Thus, the isolation of homogenous 
populations of early meiocytes is essential for definitive molecular and biochemical studies of 
MPI.  
Recently, refined Hoechst dye staining protocols and flow cytometric analyses, have 
allowed for an enrichment of several mouse MPI populations [79, 81]. These efforts have led to 
the much needed molecular and/or genetic analyses including examination of pre-meiotic, pre-
DSB homolog pairing in PreL spermatocytes [27], nucleosome profiling at recombination 
hotspots in spermatogonia, PreL or mixtures of L/Z and P/D cells [83] and other studies [93]. 
However, questions that require the separation of L from Z remain unanswered, and even 
isolation of high-purity individual P and D populations remains a challenge, with publications 
resorting to analyzing mixtures of L/Z and P/D spermatocytes [83, 94]. This and a number of 
concerns prompted us to re-examine and optimize all major steps of the published Hoechst-based 
flow cytometry protocols, from cell dissociation to flow cytometric analysis. One concern was the 
preparation of a reliable testicular single cell suspension. There are a number of published 
protocols available for testis dissociation and Hoechst dye staining of adult murine testicular cells 
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[78-80, 82, 94-96]. While all these protocols provide an excellent foundation for preparation of 
testicular single cell suspension, a challenge, still, is to obtain suspensions of consistently high 
quality between the experiments. In addition, since the available protocols vary from one another 
in a number of aspects, including the medium and the duration of testicular tissue dissociation, 
the duration and concentration of Hoechst staining and other parameters, the resulting Hoechst-
labeled testicular suspension profiles differ between the laboratories. Another concern is cell 
purity. Published literature largely fails to document the purity of sorted cells, and/or note the 
criteria for purity determination. Consequently, practical information such as the number of cells 
examined, the markers used for evaluation, and the type of contaminants observed is largely 
unavailable. There is also an ambiguity associated with cell sorting and collection parameters, 
with often incomplete reporting on important parameters, including the rate of sorting and the 
number of populations sorted at a given time.  
Previous studies often used juvenile testes as the means of reducing cellular heterogeneity 
of the starting material and/or maximizing the yield of early MPI spermatocytes. Our method is 
optimized for the adult murine testis, which provides an enriched source of all MPI substages. An 
additional important reason for using adult versus juvenile testis in our analysis, is that the first 
round of spermatogenesis is thought to substantially differ from all subsequent rounds, and has 
been linked to differences in undifferentiated spermatogonia (Spg) [97] as well as associated with 
increased apoptosis [98, 99]. As the differences in the first wave of spermatogenesis may suggest 
differences in the first meiotic wave, this raises a question of whether first meiocytes are distinct 
from the subsequent ones. Furthermore, our approach should allow sorting from adult testes of 
mutant mouse lines deficient in various aspects of male germ cell differentiation.  
In this report we present an optimized flow cytometric analysis of Hoechst testicular 
single-cell suspension that greatly improves the purity and reproducibility of the sorted 
spermatogenic cell populations from adult murine testis.  
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Materials and Methods 
Materials, reagents and solutions for testicular cell suspension preparation  
Materials: 15 ml conical tubes (BD Falcon, #352097); Shaking Water Bath (VWT, #89032); 
Disposable transfer pipet (VWR); 100 µm nylon cell strainer (BD Falcon, #352360); 40 µm nylon 
cell strainer (BD Falcon, #352340); 12×75mm tube with 35-µm cell strainer cap (BD Falcon, 
#352235). Reagents: Collagenase Type I (Worthington Biochemical, #LS004196) DNAse I 
(Sigma, #DN25-10MG); Gey’s Balanced Salt Solution (GBSS) (Sigma-Aldrich); 2.5% Trypsin 
(10X) (Gibco, #15090-046); Hoechst 33342 (10 mg/ml solution in water) (Life Technologies, 
#H3570); Newborn Calf Serum (NCS) (Life Technologies); Propidium Iodide (PI) (1 mg/ml) 
(Sigma-Aldrich, #P4864). Stock solutions: DNAse I (1mg/ml solution in 50% glycerol was made 
from 552 Kunitz units/mg powder and stored at −20°C); Freshly prepared solutions: “Collagenase 
I/Dnase I” (Collagenase type I [200 U/ml] and DNAse I [5 µg/ml] in GBSS); “Collagenase 
I/Dnase I/Trypsin” (Collagenase type I [200 U/ml], DNAse I [5 µg/ml], and Trypsin (0.025%) in 
GBSS).  
 
Testicular single-cell suspensions and Hoechst-33342 (Hoechst) staining  
For protocol details, see Section 2.2 of this chapter. Testis dissociation was based on a recently 
described method [82] with modifications. Our final protocol was conducted based on six 
consecutive steps described below.  
1. Testis digestion: After the removal of tunica albuginea, each testis was placed in a 15 ml 
conical tube on ice with 6 ml “Collagenase I/Dnase I” solution. The tube was sealed with 
parafilm, shaken in horizontal position at 150 rpm for 10 min at 35°C. The temperature and 
agitation speed were the same for all subsequent incubation steps. Halfway into the 10 min 
incubation, the testis were gently pipetted, up and down twice to help tubule dispersion. This 
and all other pipetting steps were done using disposable transfer pipets. By the end of this 
step, tubules appeared thin and dispersed.   
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2. Somatic cell removal: Tubules were allowed to settle for 2 min at room temperature (RT) by 
standing the tube vertically. The supernatant, enriched in interstitial testicular cells was 
removed, leaving just enough liquid to cover the settled tubules.  
3. Seminiferous tubule digestion: 6 ml of pre-heated “Collagenase I/Dnase I/Trypsin” solution 
was added to the tube and the tubules were gently pipetted up and down 10 times. Halfway 
into the 25 min digestion period, 60 µl of 2.5% Trypsin was added, and the tubules were 
pipetted again 10 times. At the end of the incubation time, pipetting was repeated 10 times. 
The tubules appeared fragmented and solution dense with cells. The resulting suspension was 
passed through a 100 µm nylon cell strainer. At this point, a 100 µl aliquot was removed to be 
processed for cell  counting and viability estimation (see Materials and Methods below) while 
the rest of filtered cell suspension was pre-stained with Hoechst dye (during step 4 below).  
4. Pre-staining with 100 µg Hoechst dye: To the resulting filtered cell suspension, 10 µl of 
DNAse I (1 mg/ml) and 10 µl of Hoechst dye (10 mg/ml) were added. The suspension was 
pipetted up and down 10 times and incubated for 20 min. Halfway into the 20 min period, the 
suspension was pipetted again. At the end of incubation, 600 µl of NCS was added to 
inactivate trypsin and the suspension was pipetted up and down 5 times.  
5. Staining with Hoechst: After determining the cell number, the suspension was spiked with 10 
µl of DNAse I (1 mg/ml), and stained with Hoechst dye for the final 6 µg Hoechst/million 
cells. The suspension was pipetted up and down 10 times and incubated for 25 min. Halfway 
into the incubation period, the solution was pipetted again, and then once more at the end of 
the incubation. Finally, the suspension was passed through a 40 µm nylon cell strainer. The 
suspension was kept on ice until sorting, which usually proceeded within 30 min to one hour 
after the completion of step 5.  
6. Staining with PI: Immediately prior to sorting, 2 ml cell suspension was removed into a 5 ml 
polypropylene culture tube, the cells were stained with 10 µl of PI at room temperature and 
filtered into a tube with 35 µm cell strainer cap.  
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Cell Counting and Viability Estimation  
Prior to Hoechst staining, viability and total yield of testicular single cells were 
determined. For trypan blue exclusion test of cell viability, 100 µl of the cell suspension was 
combined with 200 µl GBSS and 300 µl 0.4% trypan blue and analyzed using hemocytometer. 
Cell viability was found to be more than 95% in all cases. The total number of alive cells per 
testis (50 to 90 million cells depending on age) was calculated based on the total viable cells per 
ml. Note, that these counts underestimate the total number of cells per testis, since the counts 
were performed after filtration through 100 µl nylon cell strainer, a procedure that eliminates an 
uncertain number of elongated spermatozoa. Additionally, small size and the mobility of sperm 
cells introduce some difficulty to accurate sperm quantification, potentially further 
underestimating cell counts.  
Prior to cell sorting, cell viability of the ready-to-sort samples was examined based on 
staining of cells with PI described above. The total cell viability, based on the number of PI- 
positive cells, ranged between 86 and 94 percent (Supplementary Fig 2-1).  
 
Flow Cytometric Analysis and Fluorescence Activated Cell Sorting  
For details, see Section 2.2 of this chapter. Data analysis was done using BD FACSDiva 
software. Hoechst was excited using 375 nm laser, and the dye’s wide emission spectrum 
detected in two distinct channels: the “Ho Blue” (450/40 nm band-pass filter) and the “Ho Red” 
(670 nm long pass filter). The latter was also used to detect PI. A dichroic mirror (610 nm long 
pass filter) was used to split these emission wavelengths. Forward Scatter (FSC-A) and Side 
Scatter (SSC-A) were detected using 488 nm laser. Two-way sorting was performed using a 
seventy-micron nozzle size. Sorting Flow rate was adjusted to 2000–3500 events/second. A 
minimum of 500,000 events, were pre-recorded before setting of the gates. Cells were sorted into 
5 ml polypropylene round-bottom tubes coated with (by pipetting) and containing 1 ml of 5% 
NCS in GBSS.  
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Meiotic spreads and Immunostaining  
To estimate percent purity of individual sorted populations, an aliquot of each was 
processed for immunofluorescence staining. Nuclear spreads were prepared as described [100], 
with minor modifications. See Chapter 4 of this thesis (Methods and Procedures) for details. 
 
Results and Discussion  
Preparation of adult murine testicular cell suspension, Hoechst dye staining and flow 
cytometric analysis  
A crucial first step towards successful flow sorting is preparation of a reliable testicular 
single cell suspension. Guided by the available published protocols, and predominantly by the 
one developed by Getun and colleagues [82], here, we optimize and present an improved testis 
dissociation and Hoechst dye staining protocol of adult murine testicular cells (detailed in the 
Materials and Methods section). The protocol has been optimized to produce a well-defined and 
consistent profile of MPI populations. We have incorporated a number of points in the testis 
dissociation and Hoechst dye staining procedures that facilitate the reproducibility of subsequent 
sorting results. For example, to minimize variability in cell dissociation efficiency, we performed 
all steps in a larger reaction volume and we have optimized the concentration of Collagenase I, 
DNAse I and Trypsin used. To avoid cell and DNA clumping, we periodically mix cells 
throughout the cell dissociation step and spike the testicular suspension with Trypsin and DNAse 
I. Perhaps the most critical optimized aspect of our protocol involves adjusting Hoechst 
concentration per total cell number counted per testis. We use 6 µg Hoechst dye per million cells, 
and depending on total cells counted, a different amount of Hoechst dye will be added to a 
particular testicular cell suspension. This is in contrast to, for example, adding a fixed amount of 
Hoechst dye per testis. Indeed, variability in Hoechst staining protocol easily leads to 
discrepancies in testicular Hoechst profile between the experiments. Although this protocol, like 
any other that involves Hoechst dye staining, exhibits sensitivity to variations that may influences 
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Hoechst equilibration and subsequent Hoechst-stained cellular profile [101], our protocol 
represents an improvement towards consistency and reproducibility between experiments. This 
point is illustrated by similar Hoechst profiles of different testicular digests (Supplementary Fig 
2-2.)  
Subsequently, Hoechst- and PI- dye stained testicular cell suspension is processed for 
flow cytometric analysis. It is essential to minimize noise from the unwanted sources such as 
debris. This is done on the basis of the cells’ light scattering parameters, namely, the Forward 
Scatter (FSC) and the Side Scatter (SSC), proportional to the cell size and cell granularity, 
respectively. Since most debris particles are typically of small size, the debris is excluded by 
setting a gate that excludes signals with low FSC intensity (Fig 2-1A). Due to the very small size 
of elongated spermatozoa, exclusion based on low FSC also eliminates much of their contribution 
from the analysis and sorting.  
Subsequent visualization of the selected cells simultaneously in Hoechst blue and red 
channels reveals a complex fluorescence profile (Fig 2-1B) that is consistent with published 
literature (1, 2, 17, 19). Major populations that can be identified include those expected to be 
enriched in spermatogonia (Spg), Pre-leptotene spermatocytes (PreL), Leptotene/Zygotene (L/Z) 
spermatocytes, Pachytene/Diplotene (P/D) spermatocytes, meiosis II spermatocytes (MII) and 
post-meiotic haploid round spermatids (RS) (Fig 2-1B, outlined in red). Importantly, our 
experimental and cytometric analysis setups yield “tight” demarcation of these spermatogenic 
populations. This is evident from the formation of distinct L/Z, P/D, MII and RS populations, 
when viewed using contour plot of one million cells (Fig 2-1B, red circles).  
To the debris-excluded cells, dead cell exclusion is applied based on PI fluorescence (Fig 
2-1C). Next, we can additionally exclude unwanted cells based on DNA-content (C-value) by 
setting boundaries on the Hoechst Blue gate (Fig 2-1D). Routinely, we exclude haploid cells with 
1C DNA content from our analysis (Fig 2-1D). Notably, the prominent delineation between L/Z 
and P/D in our analysis is marked by the presence of the bimodal 4C DNA content peak on the 
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Hoechst Blue histogram (Fig 2-1E), where left peak corresponds to the L/Z and right peak to the 
P/D population. Recently, a similar bimodal peak has been documented in guinea pig 
spermatocytes, whose testis exhibit a higher proportion of L/Z cells, as compared to mouse and 
rat [102]. Our analysis suggests that despite the underrepresentation of early meiocytes in adult 
murine testis, consistent dissociation and Hoechst staining conditions, followed by careful 
discrimination of debris, and noise like elongated spermatozoa, can significantly improve the 
resolution of the testicular single cell Hoechst profile.  
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Fig 2-1. Flow cytometric analysis of adult murine testicular cells based on Hoechst and PI 
fluorescence and light scattering parameters. Numbers on plots represent percent of parent 
population, the latter identified within a figure legend below. Gate name is found above the 
number. Both, the number and the gate name are encased by black box. A) Debris exclusion 
based on low light scattering parameters. Cells are distinguished from debris based on the FSC 
and SSC, proportional to the cell size and cell granularity, respectively. A dot plot shows debris 
exclusion gate (“Cell” gate, black outline) that includes the cells (black dots) and excludes the 
debris (grey dots), which exhibit low FSC intensity. The excluded region also contains some 
elongated spermatozoa, whose small size is a major contributor to the low FSC signal. The parent 
of the “Cell” gate includes all the cells.  B) Hoechst profile of testicular cells. Cells selected in 
Fig 2-2-1A are visualized in a “Hoechst Blue”/“Hoechst Red” contour plot, in which the density 
of the cells is displayed as contour lines that form circular contours upon high cell density. The 
main subpopulations visualized are contained within the white densities outlined in red. Spg, 
spermatogonia; PreL, preleptotene spermatocytes; L/Z, leptotene/zygotene spermatocytes; P/D, 
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pachytene/ diplotene spermatocytes; MII, meiosis II spermatocytes; RS, round spermatids.  C) 
Dead cell exclusion based on PI fluorescence. Alive, PI-negative cells are found within an “Alive 
cells” gate to the left of the red line and include over 94% of all cells (most are pushed off the x-
axis). Cells positive for PI (to the right of the red gate) are excluded from the analysis. The parent 
of the “Alive cells” gate is the “Cell” gate from Figs 2-1A and 2-1B. D) DNA content exclusion 
based on “Hoechst Blue” fluorescence. Populations that fall within the red gate called “DNA 
Content” are included in the analysis (2C and 4C DNA contents are labeled). Haploid cells with 
1C DNA content are outside of the gate and are excluded from the analysis. The parent of the 
“DNA Content” gate is the “Alive cells” gate from Fig 2-1C. In this example, the “DNA Content” 
gate represents 43.3 percent of all cells. E) Bimodal distribution of cells with 4C DNA content 
shows L/Z and P/D populations. The left and right peaks encompassed by the red gate (a 
restricted “DNA Content” gate) correspond to L/Z and P/D populations, respectively. The parent 
of the “DNA Content” gate is the “Alive cells” gate from Fig 2-1C. In this example, the restricted 
“DNA Content” gate represents 5.4 percent of all cells.  
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Gating and back-gating strategies for isolating high-purity MPI populations  
Previously published sorting approaches of murine MPI populations were based on gates 
specified on Hoechst dye fluorescence, similar to the gating approach in Fig 2-1A–C. This 
selection alone, however, does not discriminate sufficiently to obtain high-purity L, Z, P or D 
cells, and, in our experience, these cell populations were found contaminated with each other and 
with other spermiogenic cell types like haploid spermatozoa. To specify each MPI population 
more accurately, we wanted to better define the flow cytometric selection gates to minimize 
contamination. To this end, we have developed an analysis workflow of Hoechst dye-labeled 
testicular cell suspension that utilizes a back-gating approach to enrich for high-purity MPI 
substages. The back-gating approach involves setting a gate around the cells with certain 
fluorescence characteristics, and then asking what are the physical characteristics of these 
selected cells, based on their FSC and SSC criteria [103]. Ultimately, this approach allows to 
define a particular cell population of interest not only in terms of two Hoechst fluorescence 
parameters (Hoechst Blue and Hoechst Red), but also, in terms of the light scattering parameters 
(FSC and SSC), allowing a more precise definition of that population.  
In our standard workflow, we begin by setting the gates on Hoechst dye fluorescence 
profile (Fig 2-2A). Information on gate statistics for Fig 2-2 can be found in Supplementary Fig 
2-3. Within a large MPI gate, we assign PreL, L, Z, P and D gates based on previously published 
and empirical observations. We also gate on non-meiotic populations, including pre-meiotic 
diploid spermatogonia (gate Spg), diploid spermatocytes II (gate MII), and haploid, post-meiotic 
spermatids (gate RS) (Fig 2-2A). Sorting based on the debris and dead cell exclusion, and on 
Hoechst dye fluorescence, led to an extensive compromise in purity. Extensive cross-
contamination from P was observed in most fractions examined, with Z and D fractions often 
containing more than 30% of P spermatocytes. Additionally, Spg, PreL and L fractions were 
found heavily cross-contaminated. Furthermore, most fractions contained some elongated 
spermatozoa. The overall contamination is largely explained by the proximity and overlap of the 
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contaminating populations based on FSC and SSC parameters, or the overlap in cell size and 
granularity. To best illustrate this point, we can examine L and Z populations (Fig 2-2B). When L 
cells from Hoechst dye profile (Fig 2-2A, gate L, green) are viewed on the light scatter plot (Fig 
2-2B, panel i, green), and the same is done with the Z population (Fig 2-2A and 2B, panel ii, 
pink), together, the profiles exhibit a large region of overlap (Fig 2-2B, panel iii). Additional 
gates on the FSC versus SSC profile can be set to more conservatively describe L or Z 
populations, namely, gates “L-A” and “Z- A”, respectively (Fig 2-2B, panel iv). These back-gates 
minimize cross-contamination based on light scattering parameters, and also, incorporate 
discrimination based on Hoechst dye parameters (Fig 2-2B, panel iv). Thus, in this back-gating 
approach, a gate set on “Hoechst Blue”/“Hoechst Red” fluorescence plot is used to set a gate 
based on the “FSC”/“SSC” plot. This approach effectively discriminates cells based on both 
Hoechst dye fluorescence and light scatter parameters.  
As MPI substages represent successive stages of germ cell development, there is an 
extensive overlap on FSC versus SSC plot, between all adjacent MPI populations, not only L and 
Z. Consequently, we applied the back-gating protocol to all MPI populations (Fig 2-2C). In 
addition, on the “FSC”/“SSC” plot, RS population (Fig 2-2D, panel i, blue), which is abundant 
and morphologically diverse, overlaps with PreL, L and Z populations (Fig 2-2D, panel i). 
Similarly, MII cells (Fig 2-2D, panel ii, yellow), overlap with P and D populations (Fig 2-2D, 
panel ii). To accommodate for the overlaps from RS and MII cell types, we additionally 
discriminate at the level of DNA content, on the “Hoechst Blue” histogram (Fig 2-2D, panel iii). 
Thus, our typical two-way sort, e.g. of L and P populations, will involve a) Debris and dead cell 
exclusion, b) Exclusion based on DNA content, where the gate is limited to 4C on “Hoechst Blue” 
histogram (Fig 2-2D, panel iii) and c) setting of the back- gates “L-A” and “P-A” on the 
“FSC”/“SSC” dot plot to specify the final L and P populations before sorting (Fig 2-2D, panel iv). 
Our final sorting tree is depicted in Fig 2-3E. The range of cell numbers collected in an hour, can 
be found in Fig 2-2F, and contain the numbers from up to ten successful sorts, using mice of 
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various ages. Typically, we couple the sorting of PreL or L with P, and Z with D. Indeed, some 
populations like P and D can be collected much faster, without much sacrifice to purity, if they 
are sorted without the rate- limiting L or Z cells. Also note, that Spg and PreL populations can be 
sorted without back- gating (Fig 2-2F, as indicated by “*”), if sorted alone and with strictly 
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Fig 2-2. Gating and back-gating strategies for isolating MPI populations. (A) Gating on 
individual spermatogenic populations based on Hoechst fluorescence. A large meiotic gate 
encompasses smaller gates containing cells of individual MPI substages, including preleptotene- 
(PreL, red), leptotene- (L, green), zygotene- (Z, pink), pachytene- (P, dark green) and diplotene- 
(D, magenta) spermatocytes. Gates enriched in pre-meiotic spermatogonia (Spg, orange), round 
spermatids (rSP, blue) and meiosis II spermatocytes (MII, yellow) are also outlined. (B) Back-
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gating approach. A particular gate on the Hoechst fluorescence plot (Fig 2-3A) can be viewed on 
the FSC vs. SSC plot. Here, L spermatocytes (panel i) and Z spermatocytes (panel ii) defined by a 
fluorescence gate in Fig 2-3A, display particular characteristics on the “FSC”/“SSC” plot (green 
and pink dots, respectively). iii) When viewed on the same plot, L and Z share similar light 
scattering parameters and partly overlap. iv) Based on regions of minimal overlap on the 
“FSC”/“SSC” plot, “L-A” gate is created to restrict contamination from the Z gate, and “Z-A” 
gate is made to restrict contamination from the L gate. (C) Back-gating approach applied to all 
MPI substages. Individual spermatogenic populations defined by gates on Hoechst fluorescence 
plot (“Hoechst Blue”/“Hoechst Red”, Fig 2-3A) are used to set gates on the light scattering plot 
(“FSC”/“SSC”). A gate set on “FSC”/“SSC” plot and appended with “-A” (e.g., P-A) marks a 
“back-gate” of a gate (e.g. “P”) set on the “Hoechst Blue”/“Hoechst Red” plot. (D) DNA content-
restricting gate helps eliminate contamination from non-MPI cell types. The light scattering 
profile of MPI spermatocytes overlaps with that of other spermatogenic cells in the testis. (i) 
Abundant and morphologically diverse haploid rSP cells (blue) overlap with PreL, L and Z cells. 
(ii) MII spermatocytes (yellow) overlap with P and D cells. (iii) A gate specifying DNA content 
on “Hoechst Blue” histogram can be restricted to include only the 4C content where L and P cells 
are found, and to exclude haploid and diploid cells that fall outside of this gate. Thus, for example, 
a two-way sort for L and P involves exclusion based on “Hoechst Blue” parameters and on (iv) 
specification of back-gates “L-A” (light green, outlined subset) and “P-A” (dark green, outlined 
subset). (E) Gating tree. The tree indicates the sequential gating and back-gating procedure 
applied to Hoechst-labeled testicular single cell suspension before sorting. Gates that have “-A” 
appended to them were the final sorting gates, such that sorting of L spermatocytes involved 
collecting cells from the “L-A” gate. (F) The range of numbers of cells collected from ten 
different sorts. The wide range largely reflects the difference in the ages of mice used (2–5 
months old) and the adjustment, from experiment to experiment, in the size of gates and back-
gates set. Populations that can be sorted without back-gating are indicated by “*”.  
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Detailed characterization and purity assessment of sorted MPI cells  
To assess the identity and the extent of homogeneity of sorted MPI cells, we performed 
co-immunostaining of sorted cells with well-characterized nuclear markers of MPI. Specifically, 
we examined the distribution of phosphorylated histone H2AX (γH2AX) and synaptonemal 
complex protein 3 (SYCP3), markers of double stranded-breaks (DSBs) and meiosis-specific 
synaptonemal complex (SC), respectively. We also used DNA stain DAPI to visualize these cells’ 
dynamic MPI chromatin distribution. Representative MPI substages are shown in Fig 2-3, as 
imaged by the confocal fluorescence microscopy. Profound changes in chromatin dynamics are 
marked by the changing shape and number of DAPI-labeled chromocenters (Fig 2-3). The 
assembly of axial elements to which sister chromatids are attached, and the SC, which connects 
homologous chromosomes, are marked by progressive elongation and thickening of SYCP3. 
Indeed, SYCP3 aggregates are observed in PreL spermatocytes and long thick SYCP3 fibers in P 
spermatocytes, the latter indicative of fully synapsed autosomes with assembled SCs (Fig 2-3). 
Increasing amounts and intensity of γH2AX signal in early meiocytes, namely, the PL, L and Z, 
mark DSB initiation and accumulation, while disappearance of γH2AX in late MPI reflects DSBs 
resolution, with an exception of an intense, well defined γH2AX signal in P spermatocytes 
corresponding to partially synapsed sex chromosomes within the sex body (Fig 2-3).  
Classification of sorted cells, based on the intensity and distribution of DAPI, γH2AX 
and SYCP3 signals, can be straightforward when the observed cells exhibit known distribution of 
these markers. Indeed, many of these marker patterns have been previously observed [27, 104-
106]. However, examination of hundreds of cells after sorting reveals a number of “non-typical” 
cells, commonly observed in our sorts, whose MPI substage classification can be challenging. 
These cells, which have not been well documented in literature, include cells that transition from 
one MPI substage to another and those at the very beginning or the end of a substage. Thus, the 
“non-typical” category may include early and late PreL cells, early and late L cells and late L 
cells transitioning to Z.  
	   45	  
  
 
Fig 2-3. Immunofluorescence analysis of MPI progression. Spread nuclei were double labeled 
with γH2AX (green) and SYCP3 (red) and counterstained with DAPI (blue). Staging was 
deduced from changing, stage-specific labeling patterns of these markers. Fluorescence images 
generated by confocal microscopy show representative MPI substages including the preleptotene- 
(PreL), leptotene- (L), zygotene- (Z), pachytene- (P), diplotene- (D) spermatocytes, and an 
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Routine and extensive post-flow cytometry IF analysis of cells based on DAPI staining, 
SYCP3 and γH2AX, allowed us to better document the diversity of MPI cells. For such routine 
examination, we used upright fluorescent microsope, since, confocal microscopy, while 
producing images of very high quality and resolution, is an involved technique that precludes 
quick cell-by-cell analysis of tens or hundreds of sorted cells, as is required after each sort. Based 
on IF staining, we defined approximate early-, mid- and late- boundaries of early MPI substages, 
as they appeared in our partly squashed cell preparations of meiotic nuclei (Fig 2-4). Indeed, 
early through late PreL, L and Z spermatocytes exhibit unique patterns of DAPI, γH2AX and 
SYCP3 staining (Fig 2-4 and Figure Legend) and a combination of these patterns can be used as a 
staple of a particular substage. As there is no ambiguity related to the identification of P and D 
spermatocytes, we do not present their characterization here.  
The categorization based on IF is both, consistent with, and elaborates on previous 
descriptions of MPI substage specifications, with only a few examples of the latter shown in Fig 
2-4. For instance, we observe that late PreL (lPreL) cells often exhibit diffuse and irregular 
SYCP3 patterns. We label these as late PreL cells because they most often appear in our PreL-
specific sorted fraction. However, these lPreL cells can also be considered as transitional PreL to 
L cells, since they exhibit few to numerous SYCP3 aggregates (Fig 2-4C). Consistently, similar 
cells, with SYCP3 aggregates have been previously placed in either PreL [84, 104-107] or L [84, 
104-108] category. Some ambiguities associated with substage identification still remain. One is 
the difficulty to distinguish with certainty SCP3-negative and γH2AX-negative early PreL cells 
from differentiated B Spg, which give rise to the PreL cells.  
Extensive categorization based on the described markers was critical for subsequent 
quantification of percent purity of cells after sorting (Table 2-1). Significantly, most 
spermatogenic populations sorted by our approach are of very high-purity, with a range of 75 to 
95 percent (for individual data and statistical analysis see Supplementary Fig 2-4). In all the 
sorted fractions, we were able to greatly reduce contamination from non-meiotic and post-meiotic 
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cell types. Importantly, we were able to enrich for individual L and Z spermatocytes, enabling 
separation of now all individual MPI spermatocytes in high-purity form.  
 
  
Fig 2-4. Immunofluorescence characterization of early MPI sorted cells.  Images show 
examples of sorted PreL- (A–C, preleptotene), L- (D–G, leptotene) and Z- (H– I, zygotene) 
spermatocytes. Staging was deduced from DAPI, SYCP3 and γH2AX patterns. Early to mid PreL 
cells exhibit numerous peripheral DAPI chromocenters corresponding to satellite DNA (A–C). 
(A) Early PreL (ePreL) nucleus shows punctate γH2AX foci and absence of SYCP3. (B) Mid 
PreL (mPreL) nucleus showing foci and patches of γH2AX and weak, diffuse SCP3 staining and 
(C) a nucleus with late PreL and L characteristics (PreL-L) exhibits numerous SYCP3 aggregates 
and a decrease in DAPI foci along the rim of the nuclear periphery. PreL-L cells often exhibit 
intense γH2AX signal. (D–G) From early L (eL) to late L (lL) nuclei exhibit a progression from 
short to longer stretches of SYCP3 and from sparse foci to large intense and partly homogenous 
γH2AX. At least two types of eL cells can be observed, one PreL-like (D) but with lower γH2AX 
signal, and a more typical one (E). (H,I) In early Z (eZ), long, interrupted SYCP3 fibers are 
observed throughout the cell. Polarized concentration of thickening SYCP3 fiber ends marks 
telomere bouquet base. Mid Z (mZ) exhibits long, thin SYCP3 stretches. By late Z, chromosome 
axes are formed and appear as long thin fibers; levels of γH2AX decrease. Bar - 10 µm.  
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Table 2-1. Percent purity quantification based on immunofluorescence analysis after cell 
sorting. MPI substage purity was calculated as (cell type observed/total cells counted by IF)*100. 
MPI substage purity was assessed based on at least eight different sorts, with a range of 30-150 
cells counted per sorted population. The smaller counts are representative of very pure 
populations, where minimal cell counts were required to establish purity.  
  
COLLECTED 
OBSERVED Spg PreL L Z P D
Spermatogonia (Spg) 80-91% 5-10% 3% 0 0 0
Preleptotene (PreL) 5-10% 75-92% 5-10% 0 0 0
Leptotene (L) 0 5-10% 60%-80% 5-10% 0 0
Zygotene (Z) 0 0 10-15% 75-90% 3% 2%
Pachytene (P) 0 0 3% 10-15% 81-95% 4-10%
Diplotene (D) 0 0 0 0 5-7% 82-95%
Other 4-5% 1-2% 1% 1% 1-2% 2-3%
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Conclusion  
In summary, we provide an optimized Hoechst-based flow cytometry method for isolating 
individual MPI populations from Hoechst dye labeled testicular cell suspension. We offer 
improvements in sample preparation and show that back-gating technique and DNA content 
restriction can significantly improve the resolution and separation of early MPI meiocytes. It 
should be noted, however, that a user of the protocol will probably have to do several flow 
cytometry sorting experiments to best adjust the gates and back-gates. To evaluate sorted MPI 
cell purity, we urge users of flow cytometry methodology to employ immunofluorescence 
staining routinely, and resolve ambiguities with the markers mentioned above, and other meiotic 
and spermatogonial markers that are available.  
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ABSTRACT 
Protocols for purification of murine male germ cells by FACS based on Hoechst 33342 (Ho342) 
dye staining have been reported and optimized. However, the protocols are often challenging to 
follow, partly due to difficulties related to sample preparation, instrument parameters, data 
display, and selection strategies. In addition, troubleshooting of flow cytometry experiments 
usually requires some fluency in technical principles and instrument specifications and settings. 
This unit describes setup and procedures for analysis and sorting of male meiotic prophase I 
(MPI) cells and other germ cells. Included are procedures that guide data acquisition, display, 
gating, and back-gating critical for optimal data visualization and cell sorting. Additionally, a 
flow cytometry analysis of spermatogenesis-defective testis is provided to illustrate the 
applicability of the technique to the characterization and purification of cells from mutant testis.   
 
INTRODUCTION  
A flow cytometer measures and reports on multiple characteristics of illuminated single 
cells as they flow in a fluid stream. Based on characteristics such as cell size, relative complexity, 
and relative fluorescence intensity, the cells can be enriched and sorted. Details on these and 
many other aspects of flow cytometry are described elsewhere (e.g., Givan, 2011). Practically, 
however, a user of FACS technology must be concerned with challenges related to flow 
cytometry experiment setup, analysis, and troubleshooting.  
FACS offers a unique opportunity to study cells of an organ as complex as the adult testis. 
Indeed, FACS is the dominant technology for purification and enrichment of particular male germ 
cell types. A major aspect of testis complexity is cellular heterogeneity in terms of cell type, size, 
morphology, DNA content, and developmental stage. Because of this inherent cell complexity as 
well as other aspects of testis biology, including the simultaneous presence of different stages of 
germ cell development and an unequal abundance of cell types, FACS from an adult testicular 
cell suspension requires strategic enrichment for a particular population of interest. The vital 
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nucleic acid−binding dye Hoechst 33342 (Ho342) enables the enrichment of individual mouse 
meiotic prophase I (MPI) populations using FACS [28, 79, 81, 82]. This takes advantage of the 
dye’s unique properties, including wide fluorescence emission spectra, sensitivity to chromatin 
state and integrity, and fluorescence shifts that are associated with differences in Ho342 
concentration within the cell [109, 110]. Furthermore, the accessibility of DNA to various 
fluorochromes varies at different stages of spermatogenesis, due to changes in chromatin 
structure during differentiation [111]. Indeed, the differences in chromatin compaction among 
cells in MPI and between other testicular cell types makes them amenable to resolution by FACS 
after staining with Ho342. This unit presents hands-on aspects of flow cytometry analysis and cell 
sorting of a Ho342-stained testicular cell suspension.  
Basic Protocol 1 describes the optimization of photomultiplier tube (PMT) voltages in a 
sample-specific manner using controls. This first procedure in a flow cytometry protocol is 
important for placing Ho342/PI-stained testicular cell suspension on appropriate scales for 
forward scatter (FSC), side scatter (SSC), Ho342-blue, Ho342-red, and PI detection, so as not to 
miss either the small and dim cells or the big and bright cells during analysis. Basic Protocol 2 
describes how, using these optimized PMT voltages, to achieve a working flow cytometry profile 
of a Ho342/PI-stained testicular cell suspension using a series of basic gates drawn around cells 
of interest. This profile is a founder profile for other more selective and specific gating strategies. 
Basic Protocol 3 develops a gating strategy to specify testicular subpopulations of interest. This 
protocol utilizes gates and back-gates to analyze and subsequently sort individual MPI 
subpopulations (including pre-leptotene [PL], leptotene [L], zygotene [Z], pachytene [P], and 
diplotene [D] spermatocytes), as well as other testicular populations (including premeiotic 
spermatogonia [Spg]). The strategy is optimized to yield significant enrichment of these 
populations. Basic Protocol 4 describes Ho342/PI-based flow cytometry analysis of mutant testis 
to demonstrate the applicability of the setup and gating practices established on wild-type (WT) 
testis. Support Protocol 1 describes preparation of testicular cell suspensions for FACS, and 
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processing for staining and flow cytometry. Finally, Support Protocol 2 describes how analyze 
the purity of sorted cells using immunofluorescence with well-characterized germ cell markers.  
 
BASIC PROTOCOL 1: Optimization of PMT voltage using control cells 
The photodetection system of a cytometer consists of PMTs along with wavelength- 
specific mirrors and filters. The mirrors and filters partition the light emitted from cells onto a 
series of separate PMTs according to wavelength, so that the PMTs detect signals from different 
wavelengths. PMTs detect and amplify weak signals generated by scatter and fluorescence light. 
The signal amplification is achieved by applying a voltage to the PMTs (amplification gain). 
Baseline PMT voltages are set as part of the cytometer performance, which is measured daily 
according to the manufacturer’s instrument-specific guidelines. BD Biosciences Software, used in 
this protocol, utilizes a Cytometer Set- tings and Tracking (CS&T) assay to set color-specific 
PMT values for the detection of a dynamic range of fluorescence intensities (from dim to bright). 
Since baseline PMTs are typically optimized using fluorescent beads rather than cells, it is 
important to also optimize PMT settings for the cells of interest in order to establish the 
appropriate fluorescence detection range. Optimizing PMT voltages for a specific experimental 
setup is therefore critical for optimal fluorescence signal detection, sensitivity, and resolution.  
The objective of this protocol is to optimize PMT voltages for cells stained with Ho342 
and propidium iodide (PI) in order to establish the detection range of negatively and positively 
stained cells, and to minimize the contribution of electronic noise to the signal. Specifically, the 
user is instructed to set optimal FSC and SSC voltages and fluorescence PMT voltages using four 
control samples of murine testicular cell suspensions: unstained, single stained (PI or Ho342), and 
double stained (Ho342 and PI). These controls are also used to help define positive/negative 
boundaries in the data, providing controls for alive and dead cells, and stained and unstained cells. 
These boundaries can be used to eliminate unwanted populations from the start. The optimized 
control settings and gates can be reused from experiment to experiment, provided that the 
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Table 2-2. Fluorochrome specifications (top) and laser and optics device configuration (bottom). 
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Materials  
Control samples (see Support Protocol 1)  
Unstained cells, Ho342-stained cells, PI-stained cells, Ho342/PI-stained cells  
 
FACS cytometer (BD FACSAria III or similar) equipped with:  
Excitation optics: near-UV (375-nm) and blue (488-nm) lasers  
Detection optics: filter combination consisting of 450/40 bandpass 
(Ho342-blue detection), 670 longpass (Ho342-red and PI detection), and 610 dichroic longpass 
mirror (beam splitter)  
 
FACS analysis software (BD FACSDiva or similar)  
 
See Table 2-2 for fluorochrome specifications and laser and optics device configuration 
 
1. Create the following working plots displaying parameters to be optimized:  
FSC-A vs. SSC-A plot on a linear scale (dot plot or a contour plot display)  
PI histogram plot on a logarithmic scale  
Ho342-blue vs. Ho342-red on a linear scale (contour plot display)  
In the sample study shown in Fig 2-5, FSC, SSC, and Ho342 fluorescence signals were acquired 
with linear amplification and plotted on a linear scale. The data plotted show the area 
measurements (specifically, the integrated intensity) of signals, with the FSC and SSC axis labels 
appended with “-A” to indicate area. PI fluorescence signals were also acquired with linear 
amplification but plotted on a log scale. Whether or not the acquired signal amplification is 
linear or logarithmic is a property of the cytometer and refers to the way the signals from cells 
are processed or “summarized” from signals to data.  
 
See Critical Parameters and Troubleshooting section on data display for information on dot 
versus contour plots and linear versus exponential or bi-exponential scales.  
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Fig 2-5. FACS analysis of control adult murine testicular cells. All signals were acquired with 
linear amplification. Signals are plotted as area integrated intensity values. Percent values on 
plots represent percent of parent population (the latter identified below). Gate name is specified 
above the percent value. (A) Acquired unstained cells (1 × 106) depicted as a contour 
(probability) plot of FSC vs. SSC. Cells are bound by contour and are located outside of contour 
as single dots. These outlier dots usually represent 2.5% to 5% of the total population, depending 
on the probability of the contour set. (B) Acquired unstained (left, 1 × 106) and PI-stained (right, 
1 × 106) cells depicted on a PI histogram plot. Left panel: Live PI-negative cells are found within 
an “Alive” interval gate (in blue) to the left of the gate. Dead cell exclusion is based on PI 
fluorescence. Right panel: PI-stained control sample. PI-positive cells (to the right of blue interval 
gate) are excluded from the gate, and thus from subsequent analysis. The parent of the “Alive” 
gate includes all cells. (C) Hoechst fluorescence profile of Hoechst-stained cells visualized on a 
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Hoechst-blue/Hoechst-red contour plot. Since no PI was added, all cells (or 99.9%) appear as live 
cells. (D) Hoechst fluorescence profile of Hoechst/PI- stained cells visualized on a Hoechst-
blue/Hoechst-red contour plot. Cells in red with low Hoechst-blue and mid to high Hoechst-red 
indicate PI-positive dead cells based on “Alive” gate analysis.  
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2. Run and acquire the unstained sample on the FSC/SSC plot (Fig 2-5A). While the sample is 
running, optimize FSC and SSC voltages by adjusting both voltages up or down to place the 
unstained cells on the scale of the FSC/SSC plot.  
Adult testicular cell suspensions are complex and diverse in terms of cell size and morphology. 
The complexity is reflected in the broad range of FSC and SSC values, which are proportional to 
cell size and complexity, respectively. The aim is to distribute cells broadly on the FSC axis in 
order to visually maximize the resolution of both small and large MPI cells. If the goal was, 
instead, to optimize the view of D-spermatocytes (some of the largest cells found in the testis) the 
user might decrease the FSC voltage. While compacting the smaller cells into a tighter 
distribution on the FSC/SSC plot, the downward shift in FSC would encapsulate all large cells 
and expand their resolution on the plot, forcing the overall cellular profile to shift towards the 
lower left corner of the plot.  
 
3. Run and acquire the unstained sample on the PI histogram plot (Fig 2-5B, left panel). Adjust 
the PI voltage up and down while the sample is running to position the PI-negative population in 
the first decade of the logarithmic plot.   
The PI-negative (alive) population should appear close to zero on the axis.   
4. On the PI histogram plot, draw an interval gate called “Alive” around the major PI-negative 
live cell population (Fig 2-5B, left panel, blue gate).   
The major histogram corresponding to live cell peak should appear pushed of the axis and 
bounded by the gate on the right and the y axis on the left. On the four-decade logarithmic axis, 
the left end of the gate is pushed of the axis to accommodate the rest of the live, PI-negative cells. 
  
 
5. Run and acquire the PI-stained sample on the PI histogram plot (Fig 2-5B, right panel, blue 
gate). In the presence of dead cells, observe a histogram shift to the right of the “Alive” gate, 
accompanied by a decrease in the percentage of live cells as measured by the “Alive” gate.   
If necessary to better resolve the shifted PI-positive population, adjust PI voltage to move the 
population to the right (towards a higher decade on the logarithmic scale) and readjust the 
“Alive” gate boundary.   
 
6. Run and acquire the Ho342-stained sample on the Ho342-blue/Ho342-red plot (Fig 2-5C). To 
optimize the Ho342 fluorescence PMT voltages, adjust Ho342-blue and Ho342-red voltages up 
and down while running the sample to maximize the resolution of Ho342-blue/Ho342-red cell 
profile on the linear axis. The population as a whole should appear to tilt diagonally across the 
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plot.   
Since the “Alive” cell gate represents a subset of all acquired events, the total cells acquired on 
the Ho342 plot (or any other plot you wish to create) have an “Alive” gate value associated with 
them. The Ho342-stained sample exhibits an “Alive” gate value of 99.9%, because this control 
has not been stained with PI, and thus PI-positive cells cannot be detected.   
 
7. Run and acquire the Ho342/PI-stained sample on the Ho342-blue/Ho342-red plot (Fig 2-5D). 
View live cells by examining cells within the “Alive” gate on a Ho342/PI plot (Fig 2-5D, black 
cells and contour lines).   
In Fig 2-5D, note that percent live cells decreases to 88.9%. PI-positive cells (in red) have low 
Ho342-blue in combination with mid and high Ho342-red characteristics.  The cells outside the 
“Alive” gate (PI-positive, dead cells) can be marked by a different color (red in Fig 2-5D). One 
way to do this is to create an inverted “Alive” gate, which will represent all cells outside of the 
“Alive” gate. It is often useful to visualize “dead” cells on the Ho3342/PI plot, even though these 
cells are eliminated by exclusion from the “Alive” cell gate on the PI histogram plot. It is useful 
to view these PI-positive cells to assure that the major (diagonally leaning) Ho342 cell 
population doesn’t overlap with the dead cells. Otherwise, it would be difficult to separate the 
two populations, and the PMTs would need to be adjusted to account for that.  It is important to 
remember that the PI-positive population only represents the percentage of dead cells/debris 
currently present in the final sample, and does not reflect how many cells in total have died. One 
reason is the use of DNase I enzyme during sample preparation, which eliminates any leaked 
DNA from cells with broken membranes. Such dead cells may escape true marking by PI, since 
they may be found in the debris category of the testicular cell suspension profile.   
 
8. Save the cytometer settings with optimized PMT values and apply these settings when running 
future FACS experiments with Ho342/PI-stained testicular single-cell suspensions.  
Optimized PMT voltage settings can be reused from experiment to experiment, until any aspects 
of the cytometer configuration are changed (e.g., when new baseline PMT values are set).  
 
BASIC PROTOCOL 2:  Setup of working flow cytometry profile 
This protocol describes a basic gating strategy to set up a working visual profile of 
Ho342/PI-stained testicular cells. The gating setup can be used as a foundation for all subsequent 
gating strategies (see Basic Protocol 3). The specific goal of this protocol is to optimize 
visualization of a Ho342- and PI-stained testicular cell suspension using debris exclusion based 
on low light scattering parameters, dead cell exclusion based on PI fluorescence, and DNA 
content exclusion based on Ho342-blue fluorescence.  
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Materials  
FACS cytometer and analysis software (see Basic Protocol 1)  
Ho342/PI-stained testicular cell suspension (see Support Protocol 1)  
 
1. Apply optimized PMT settings (see Basic Protocol 1).   
2. Create four working plots:   
FSC-A vs. SSC-A on a linear scale (dot plot or contour plot display) ;  
PI histogram plot on a logarithmic scale  
Ho342-blue histogram plot on a linear scale Ho342-blue/Ho342-red on a linear scale (dot plot or 
contour plot display)   
3. Run and acquire at least 500,000 events (cells). Examine acquired cells in the plots above.   
4. On the FSC/SSC plot, draw a gate called “Cells” to exclude cells with low FSC and SSC 
values (Fig 2-6A, blue gate).   
The “Cells” gate should appear as a “child” (or subset) of all acquired events.  The FSC cutoff 
eliminates debris and some haploid cell types of relatively small size, such as early spermatids. 
Because haploid cells are highly abundant, they can easily contaminate other testicular cell 
populations if not eliminated. Events that exhibit low FSC in combination with mid and high SSC 
values are also eliminated from the analysis, as the eliminated cells are mostly elongated 
spermatids. Information on the enrichment of elongated spermatids by FACS can be found in 
[112].   
 
5. Draw an “Alive” interval gate on the PI histogram plot to include PI-negative alive cells and 
exclude PI-positive dead cells (Fig 2-6B, blue gate), based on the threshold established in Basic 
Protocol 1.   
The “Alive” gate should represent a subset of the “Cells” gate.   
6. Draw a “DNA” gate on the Ho342-blue histogram (Fig 2-6C, blue gate) to refer to DNA 
content. Manipulate cell inclusion or exclusion based on the Ho342-blue signal proportional to 
DNA content. Eliminate low Ho342-blue events from the analysis to eliminate debris and 
unstained cells.   
In Fig 2-6C, the peak at <50,000 relative fluorescence units (RFU) was eliminated. The “DNA” 
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gate should be manipulated based on sorting needs. If haploid cells are not collected, the gate 
should be drawn to entirely eliminate the Ho342-blue signal corre- sponding to haploid cells (Fig 
2-6C, the tallest peak, from 50,000 to 80,000 RFU).  
 
7. View cells on a Ho342-blue/Ho342-red plot, as they appear after serial gate selection using the 
“Cells," “Alive,” and “DNA” gates.  
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Fig 2-6 FACS analysis of adult murine testicular cells based on Hoechst and PI fluorescence 
and light scattering. All signals were acquired with linear amplification. Signals are plotted as 
area integrated intensity values. Percent values on plots represent percent of parent population 
(the latter identified below). Gate name is specified above the percent value. (A) Debris exclusion 
based on low light scattering. Cells (inside blue gate) are distinguished from debris (outside of 
blue gate) based on low light scatter viewed on a FSC/SSC contour (probability) plot. “Cell” gate 
represents a debris- exclusion gate (or cell-inclusion gate) that excludes debris as well as 
relatively small cells, such as haploid cells. The parent of the “Cells” gate includes all cells 
acquired (1 × 106). (B) Dead cell exclusion based on PI fluorescence. Alive PI-negative cells 
appear within an “Alive” gate in blue. The parent of the “Alive” gate is the “Cells” gate in (A), 
thus live cells form a subset of cells selected by the “Cells” gate. (C) DNA content exclusion 
based on Hoechst-blue fluorescence. Populations that fall within the blue “DNA” gate include 
cells with 1C through 4C DNA content. Low Hoechst-blue events are eliminated and correspond 
to debris and dead cells. The parent of the “DNA” gate is the “Alive” gate in (B). (D) Hoechst 
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profile of testicular cells after serial selection with “Cells," “Alive,” and “DNA” gates. This 
working profile of Hoechst/PI-stained testicular cells will be the basis for subsequent gating and 




	   64	  
BASIC PROTOCOL 3:  Setup of gates and sorting of control testicular subpopulations 
The gating protocol below is divided into three parts. The first identifies regions of 
interest based on Ho342 fluorescence. These regions include haploid germ cells (round and 
elongated spermatids), diploid germ cells (secondary spermatocytes), early MPI cells (L and Z 
spermatocytes), late MPI cells (P and D spermatocytes), premeiotic diploid Spg, and PL 
spermatocytes that undergo last replication before meiosis. The second describes gating (on 
Ho342 fluorescence) and back-gating (on FSC and SSC) strategies for specifying testicular 
subpopulations based on both Ho342 fluorescence and light scatter, and enriches for individual 
MPI substages and premeiotic Spg. The third describes sort setup for optimal enrichment and 
purity of individual fractions. Finally, details are provided for sorting the testicular single-cell 
suspension using these established gates. General information on principles behind flow sorting, 
including drop formation and practical aspects of sorting, can be found throughout this book, and 
elsewhere [103, 113, 114].  
Materials  
Ho342/PI-stained testicular cell suspension (see Support Protocol 1)  
5% (v/v) newborn calf serum (NCS) in Gey’s balanced salt solution (GBSS; Sigma), filtered 
through 40-µm nylon cell strainer  
5-ml round-bottom polystyrene tubes 35-µm cell strainer cap (BD Falcon)  
FACS cytometer and analysis software (see Basic Protocol 1)  
 
Identify regions of interest based on Ho342  
1. Set up a working flow cytometry profile of Ho342/PI-stained testicular cells based on the 
selection gates drawn on the FSC/SSC plot (“Cell” gate), PI plot (“Alive” gate), and Ho342-
blue/Ho342-red plot (see Basic Protocol 2).  
 
Perform gating  
2. On the resulting Ho342-blue/Ho342-red plot, draw gates R0 through R7 around regions of 
interest (Fig 2-7A), as follows:  
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Contour (probability or density) plots are recommended for fluorescence display. On a contour 
(probability) plot, major populations are located within the contours lines. Con- tour plots 
commonly show 90% to 95% of data bounded by the contour lines, depending on contour 
probability set. Contour plots provide more accurate data representation than dot plots, because 
they can more precisely localize and distinguish subsets of cells [115].  
 
a. Draw the R0 gate around the densest region on the plot, with low Ho342-blue and low Ho342-
red characteristics. This region contains haploid sperm. Check that this population maps back to 
the 1C DNA content on the Ho342-blue histogram plot (Fig 2-6C).   
As a rule, gates should be drawn around visually distinct populations. On a contour plot, such 
populations are bound or separated by contours. The latter case results from populations being 
not large enough to form a contour-bound density. Similar to the R0 gate, all gates drawn on the 
Ho342-blue/Ho342-red plot should be viewed on the Ho342-blue histogram plot (Fig 2-6C) to 
ensure that the selected cell population is consistent with the expected DNA content of that 
population.   
 
b. Draw the R1 gate around the region with mid Ho342-blue and mid Ho342-red characteristics. 
On the Ho342 plot, this region is high in cell density and contains secondary spermatocytes with 
2C DNA content.   
c. Draw gates R2 and R3 by “splitting” the single density contour R2+R3. Cumulatively, this 
single contour contains early MPI cell types with 4C DNA content (L and Z spermatocytes). 
Individually, the R2 region (left) contains more L spermatocytes and the R3 region (right) 
contains more Z spermatocytes.   
The content asymmetry of contour R2+R3 can be reflected in the FSC/SSC plot (Fig 2-7B), which 
portrays profiles of R2+R3 as one gate, and reveals slight density polarization, suggesting a 
difference in cell scatter characteristics that L and Z spermatocytes are known o exhibit.   
 
d. Draw gates R4 and R5 by splitting the single density contour R4+R5. Cumulatively, these 
regions contain late MPI cell types with 4C DNA content (P and D spermatocytes), with R4 (left) 
containing more P and R5 (right) containing more D spermatocytes.  
As for R2+R3, the content asymmetry of R4+R5 can be observed on the FSC/SSC plot (Fig 2-7B) 
as a single gate with left-right density polarization, suggesting a difference in cell scatter 
characteristics that P and D spermatocytes are known to exhibit.  
 
e. Draw R6 gate. This region contains premeiotic diploid Spg with 2C DNA content. In Fig 2-7A, 
this population “sits” on top of the haploid cell population, such that if you limit the “DNA” gate 
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on the Ho342-blue histogram (Fig 2-7C), eliminating haploid cells from view, and then view the 
limited cell profile on the Ho342 plot, the R6 region should remain and form a distinct density, as 
it gains more probability weight once the highly dense haploid density has been eliminated.  
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Fig 2-7. Gating and back-gating strategies for isolating individual MPI populations. All 
signals were acquired with linear amplification. Signals are plotted as area integrated intensity 
values. (A) Gating on individual testicular populations based on Hoechst-blue/Hoechst-red 
fluorescence. R0 (blue) is enriched in haploid spermatids; R1 (purple) is enriched in meiosis II 
(MII) spermatocytes; R2 (green) is more highly enriched in leptotene (L) than in zygotene (Z) 
cells; “R3” (pink) is more highly enriched in Z than in L spermatocytes; R4 (dark green) is 
enriched in pachytene (P) spermatocytes; R5 (purple) is enriched in diplotene (D) spermatocytes; 
R6 (orange) contains spermatogonia (Spg); R7 (red) is enriched in pre-leptotene (PL) 
spermatocytes. The R2+R3 contour represents the region from which R2 and R3 originated and 
indicates highly similar cells. The R4+R5 contour represents a region from which R4 and R5 
gates originated. (B) Contours R2+R3 (blue) and R4+R5 (black) from the Hoechst plot (A) are 
depicted (for analysis only) on the FSC/SSC plot to indicate the polar or lobed nature of these 
regions, an indication of two potentially distinct populations within a common density. These 
contours are divided into individual regions (R2, R3, R4, R5) in (A). (C) Back-gating involves 
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visualization of a particular gate from the Hoechst plot (A) on an FSC/SSC plot, where it is 
possible to observe overlaps between populations based on scatter. Note overlap of R2 (green) 
with R3 (pink), of R3 with R4 (dark green), and of R4 with R5 (purple). Based on regions of 
minimal overlap on the FSC/SSC plot, the L, Z, P, and D gates are created to enrich for their 
respective spermatocyte populations. Back-gates serve to restrict contamination in gates drawn on 
the Hoechst plot, resulting in more pure populations during sorting. (D) Back-gating to enrich for 
Spg (R6 in A) and MII germ cells (R1 in A). A shift of the R6 population (red) towards 
increasing SSC values suggests contamination of a more prominent population, which also 
appears to shift towards increasing FSC values. The smaller contaminating lobe indicates 
contamination with somatic cells. The Spg back-gate eliminates the contribution of this 
population from analysis and sorting.  
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Perform back-gating  
3. On the FSC/SSC plot, draw back-gates to further specify the testicular populations of interest.  
Back-gating involves setting gates on regions previously defined based on Ho342 charac- 
teristics (R0 through R7) in terms of differences in scatter characteristic. The back-gates drawn 
on the FSC/SSC plot thus form the “child” gates of the Ho342 gates (Fig 2-7A) and can be 
associated with particular Ho342 fluorescence. This dual selection, first on Ho342 and then on 
FSC/SSC, minimizes the overlap based on fluorescence and allows for a more narrow and 
precise definition of particular populations.  
 
a. Draw back-gates L, Z, P, and D (Fig 2-7C).  
Note that gates that appear distinct on the Ho342 plot (e.g., R2 and R3, or R4 and R5 in Fig 2-
7A) in fact overlap based on their FSC/SSC characteristics (green and purple contour overlaps 
corresponding to R2/R3, R3/R4, and R4/R5 overlaps in Fig 2-7C). Creation of L, Z, P, and D 
back-gates separates these populations based on light scattering parameters.  
 
b. Draw back-gates Spg and meiosis II (MII).  
In Fig 2-7D, the extension of the original R6 gate (orange) to the right towards increasing SSC, 
marks contamination with somatic cells. Thus, if the Spg back-gate is not drawn on top of the R1 
gate (defined based on Ho342), sorting of the R6 gate would result in a fraction contaminated 
with soma.  
 
c. Examine the gating tree formed from sequential gating and back-gating (Fig 2-8).  
 
Sort testicular subpopulations  
4. Perform cytometer-specific preparation for sorting, including optimization of side streams and 
drop delay [113].   
5. Determine populations to sort using a two-way system that allows two populations of interest 
to be sorted at a time into a collection device that holds two tubes. Refer to gating tree in Fig 2-8 
for the following pairwise combinations:  
a. L and P spermatocytes based on L and P back-gates   
b. L and D spermatocytes based on L and D back-gates   
c. PL spermatocytes alone from gate R7   
d. PL with P or D spermatocytes   
e. Spg spermatocytes from gate R6 alone or Spg with MII spermatocytes from  back-gate R1   
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When sorting, limit “DNA content” to contain only the population range of fractions to be sorted. 
For example, when sorting Z and D populations, limit DNA content from the beginning of Z to the 
end of D.   
 
6. Prepare tubes for cell collection during cell sorting. Coat two empty 5-ml polypropylene round-
bottom tubes with 5% NCS in GBSS by pipetting with a plastic transfer pipet, leaving 1 ml for 
cells to drop into.   
7. Run the experimental sample (prepared in Support Protocol 1, and used immediately after step 
18 of that protocol). Adjust flow rate to 1500 to 2500 events/sec.   
The efficiency of sorting is affected by the flow rate, which reflects the speed of sorting. Sorting at 
high flow rates (>3500 events/sec) results in contamination of sorted cells. When flow rate starts 
to appreciably decrease with time, and you find yourself needing to increase flow rate, stop to 
check if the cell suspension has accumulated debris or clumps. Add more DNase I and resuspend, 
or use a new aliquot of Ho342/PI-stained cell suspension.   
 
8. Acquire and record pre-sort data to adjust sorting gates, if necessary. Pre-record at least 
250,000 events. Adjust sorting gates and back-gates if necessary.   
9. Proceed with sorting populations of interest based on the sorting gates adjusted in pre-sorting 
step above.   
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Fig 2-8. The gating tree. The gating tree formed from sequential gating and back-gating applied 
to a Hoechst/PI-stained testicular single-cell suspension before cell sorting.  
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BASIC PROTOCOL 4:  Flow cytometry analysis of spermatogenesis-defective testis 
This protocol describes the application of Ho342 and PI staining to flow cytometric 
analysis of testicular germ cells from spermatogenesis-defective mice. The example here uses a 
mutant lacking the Maelstrom protein (Mael−/−), which is essential for spermatogenesis [116]. 
Similar analyses can be used to investigate and purify germ cells from other spermatogenesis-
defective testes. This analysis demonstrates that the Ho342-stained cell profile of adult Mael−/− 
testis is consistent with the known phenotype, which is characterized by failure to complete MPI 
and a lack of P and D spermatocytes and all subsequent cells of spermatogenesis [116].  
Flow cytometry exploration of mutant populations can be done in two ways: by applying 
a WT analysis strategy and by performing de novo analysis. In the first scenario, mutant flow 
cytometry profiles are acquired using WT settings, including PMT values and gates. This analysis 
is useful for direct comparison of WT and mutant testis profiles. In the second scenario, PMTs 
and gates are adjusted and set up de novo for the mutant sample. Both scenarios follow steps 
outlined in the Basic Protocols 1 and 2. However, in the second scenario, PMTs and gates are 
adjusted independently of WT settings and accommodate mutant testicular cell profile, 
specifically. In this protocol, the second scenario is explored.  
 
Materials  
Ho342/PI-stained Mael−/− testicular cell suspension (see Support Protocol 1)  
FACS cytometer and analysis software (see Basic Protocol 1)  
 
1. Adjust FSC, SSC, Ho342-blue, Ho342-red, and PI PMT voltages (see Basic Protocol 1).   
As in Basic Protocol 1, this step involves acquiring the Ho342/PI-stained sample and adjusting 
the voltages up/down while running the sample, until the population is on scale.   
 
2. Set up the working flow cytometry profile of Ho342/PI-stained cells, drawing serial gates 
“Cells," “Alive,” and “DNA Content” as described (see Basic Protocol 2).   
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The “Cells” and “DNA Content” gates for Mael−/− cells are shown in blue in Fig 2-9 (panels A 
and B, respectively).  On the FSC/SSC plot (Fig 2-9A), the occupied range of FSC and SSC 
values is smaller for Mael−/− than for the WT testis (compare to WT in Fig 2-7A). Mael−/− testis 
is smaller and far less complex than WT, and does not contain cells beyond early pachynema, the 
time of spermatogenesis arrest in this mutant. Very small cells (like elongated spermatids) and 
very large cells (like D spermatocytes and MI cells) are therefore absent from Mael−/− testis and 
do not contribute to the overall flow cytometry profile.  On the Ho342-blue plot (Fig 2-9B), the 
1C peak corresponding to haploid cells is completely absent (compare to WT in Fig 2-7C). Also 
observe the lack of the bimodal 4C peak, as compared to wild-type profile in Fig 2-7C. The 
bimodal distribution of cells with 4C DNA content is characteristic of the presence of L/Z and 
P/D populations. Disappearance of the bimodal peak is consistent with the presence of L/Z and 
absence of P/D populations.   
 
3. Draw gates around the major populations on Ho342-blue/Ho342-red plot as de- scribed (see 
Basic Protocol 3, step 2).   
Upon cell sorting, Mael−/− gate R6 contains Spg cells, gate R7 contains PL cells, and gate 
R2+R3 contains L and Z cells (Fig 2-9C), all like WT. However, unlike WT, the population within 
the R2+R3 gate also contains atypical cell types with a mix of LZ or ZP characteristics. These 
aberrant cells are characteristic of the reported mutant phenotype [116].   
 
4. View gates the originally drawn on the Ho342 plot (Fig 2-9C) on the FSC/SSC plot (Fig 2-9D), 
and then draw back-gates on the FSC/SSC plot to minimize contamination from adjacent or other 
populations, where appropriate (Fig 2-9D, R6 gate with Spg back-gate displayed only).   
Note the separation of the R6 gate into two populations, one expanding along the FSC axis and 
the other expanding along the SSC axis. This separation suggests the presence of two different 
populations. Indeed, the extension of the R6 contour profile to the right (towards increasing SSC) 
indicates the presence of somatic cells. However, upon sorting, if the Spg back-gate has been set 
accurately, there should be no contamination of the Spg fraction with soma, since these appear 
distinct based on the scatter profile.   
 
5. On the FSC/SSC plot, examine the other gates originally drawn on the Ho342 plot (Fig 2-9C) 
to establish whether back-gates need to be drawn.   
Note the polarity of the resulting R2+R3 density, indicated by the two-lobed contour in Fig 2-9E. 
As in WT, the polarity of this contour is consistent with the presence of two populations, with the 
left lobe containing more L than Z spermatocytes, and the   right containing more Z 
spermatocytes. In addition, the right lobe contains more of the aberrant Z cells and unusual cells 
having both Z and P characteristics.  
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Fig 2-9 Gating and back-gating strategies for isolating individual MPI populations from a 
Mael−/− testicular cell suspension. All signals were acquired with linear amplification. Signals 
are plotted as area integrated intensity values. Percent values on plots represent percent of parent 
population (the latter identified below). Gate name is specified above the percent value. A) Debris 
exclusion is based on low light scattering parameters. Cells (inside blue gate) are distinguished 
from debris (outside blue gate) based on low light scatter characteristics viewed on the FSC/SSC 
contour (probability) plot. The parent of the “Cells” gate includes all cells acquired (500,000 
cells). Observe that the light scatter profile of Mael−/− cells exhibits very few cells (outside 
major contour lines) with relatively high FSC characteristics (>150,000 units). This is apparent 
when comparing to WT (Fig 2-6A). B) DNA content based on Hoechst-blue fluorescence. Note 
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that the Mael−/− Hoechst-blue profile lacks the 1C peak and the bimodal 4C peak observed in 
WT mice (compare to C). This is because Mael−/− mice arrest before pachynema is complete, 
and thus lack the second part of the 4C peak that is characteristic of the P and D spermatocyte 
population. Populations that fall within the blue DNA gate include cells with 2C through 4C 
DNA content. Low Hoechst-blue events are eliminated and correspond to debris and dead cells. 
The parent of the “DNA” gate is the “Alive” gate from Fig 2-6B. C) Gating on individual 
testicular populations of interest based on Hoechst fluorescence. Colored regions represent gates 
drawn based on Hoechst-blue/Hoechst-red fluorescence. Gates shown: R6, R7, and R2+R3 
containing spermatogonia (Spg), pre-leptotene (PL) spermatocytes, and a mix of L, Z, and 
aberrant cells, respectively. D) Back-gating approach to enrich for Spg. “Spg” is a back-gate of 
the R6 gate drawn on Hoechst fluorescence in panel A. The two shifts of the R6 population, one 
towards increasing FSC and the other towards increasing SSC, suggest the existence of two 
populations. Indeed, the population with the SSC shift indicates contamination with somatic cells 
present in this area of the FSC/SSC plot, and the “Spg” back-gate eliminates the contribution of 
this contaminating population from analysis and sorting. E) View of R2+R3 gate (originally 
drawn on the Hoechst fluorescence plot; panel C) on the FSC/SSC plot. Observe the polarization 
of the R2+R3 gate, and the formation of two lobes, indicative of the presence of two populations. 
F) Final gating tree indicating the sequential gating and back-gating procedure applied to the 
Hoechst/PI-stained testicular single-cell suspension before cell sorting.  
 
  
	   76	  
SUPPORT PROTOCOL 1: Preparation of stained single-cell suspensions from adult 
murine testis 
This protocol describes testis isolation, seminiferous tubule digestion into a single-cell 
suspension, and Ho342 and PI staining for FACS. Because of the histological organization of the 
testis, as well as the anatomical organization of germ cells within the testis proper, both 
enzymatic and mechanical dissociation methods are necessary to achieve a single- cell suspension 
that contains good amounts of the different types of testicular germ cells. Additionally, enzymatic 
digestion is critical for removing testicular somatic cells from the germ cells and testicular tissue, 
thus minimizing the somatic contribution to the overall testicular cell profile. This protocol has 
been described previously [28] and is presented here with minor adjustments. For additional or 
alternate information on preparation of adult murine testicular single-cell suspensions and Ho342 
staining, refer to the following references [28, 78-83]. 
These steps describe the preparation of suspensions from both WT and Mael−/− knock- 
out mice. Spermatogenesis-defective testes often share fundamental characteristics, in- cluding 
small testicular and a significant reduction in cell number and complexity. Thus, the sample 
preparation described here should be applicable to other types of spermatogenesis-defective testes.  
 
Materials  
Wild-type male mice (C57BL/6 J), 2-4 months old (Jackson Laboratory)  
Mutant male mice (Maelstrom knockout, Mael−/−), 2-5 months old [116] 
 
Gey’s balanced salt solution (GBSS; Sigma)  
Collagenase/DNase solution (see recipe), ice cold  
Trypsin/collagenase/DNase solution (see recipe), prewarmed (35°C)  
2.5% (w/v) trypsin (10×) (Gibco)  
1 mg/ml DNase I (Invitrogen, cat. no. 18068-015) in 50% (v/v) glycerol  
10 mg/ml Hoechst 33342 (Ho342, aqueous solution; Life Technologies)  
0.4% (w/v) trypan blue Newborn calf serum (NCS)  
1 mg/ml propidium iodide (PI; Sigma)  
 
Dissection tools: scissors, straight and angled fine-tipped forceps  
15-ml sterile conical tubes (BD Falcon)  
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35°C shaking water bath or incubator  
Plastic disposable transfer pipets  
100- and 40-µm nylon cell strainers (Falcon)  
Hemocytometer  
Phase-contrast microscope  
Sterile 5-ml polypropylene culture tube  
12 × 75−mm tube with 35-µm cell strainer cap (BD Falcon)  
 
Isolate testis  
1. Sacrifice one WT or two Mael−/− adult male mice according to institutional animal care 
guidelines.   
Use one WT mouse each for an unstained control, a PI-stained control, a Ho342-stained control, 
and a Ho342/PI-stained control. Use two mutant mice for each experimental sample, because the 
Mael−/− testis is smaller and has fewer cells.  Prepare and run each control or experimental 
sample separately (not in parallel) so that cells can be sorted immediately after staining.   
 
2. Remove WT testis (or both Mael−/− testes) and place in a Petri dish on ice con- taining 1 ml 
ice-cold GBSS.   
3. Use a pair of forceps to remove the tunica albunigea.   
4. Transfer each decapsulated WT testicle into a separate 15-ml tube on ice containing 6 ml 
collagenase/DNase solution. For Mael−/− mice, transfer all four testicles into a single tube 
containing 6 ml of the same solution.   
 
Digest testis  
5. Shake tubes in a horizontal position at 120 rpm for 10 min at 35°C. Halfway into the 
incubation, gently pipet the testicles up and down two or more times to facilitate tubule dispersion.  
 
 The temperature and agitation speed are the same for all incubation steps, unless noted 
otherwise. All pipetting steps should be performed using disposable plastic transfer pipets.  At the 
end of incubation, tubules should be thin and dispersed, but not extensively sheared.   
 
6. For WT samples only, stand the tube vertically and allow tubules to settle for 2 min at room 
temperature. Remove the supernatant (enriched in interstitial testicular cells), leaving just enough 
liquid to cover the settled tubules.   
Although many interstitial somatic cells are removed with the supernatant, a large population 
still remains and will appear in the final digest.  This step is omitted with the smaller mutant 
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testes because of the risk of losing germ cells along with the somatic cells.   
 
7. Add 6 ml prewarmed (35°C) trypsin/collagenase/DNase solution to the tube and gently pipet 
the tubules up and down ten times to aid tubule fragmentation. Incubate 12.5 min at 35°C.   
8. Add 60 µl of 2.5% trypsin, pipet ten more times, and continue incubating for another 12.5 min.  
 
 The tubules should appear fragmented and the solution dense with cells. If necessary, additional 
pipetting and gentle periodic tube inversion can aid tubule fragmentation.   
 
9. Pipet the final suspension ten more times and pass through a 100-µm nylon cell strainer.   
 
Prestain cells with Ho342  
10. Set aside a 100-µl aliquot of cells for counting, then proceed immediately with Ho342 
prestaining.   
11. Add 10 µl of 1 mg/ml DNase I to the remaining suspension, followed by 10 µl (for WT) or 5 
µl (for Mael−/−) of 10 mg/ml Ho342. Pipet up and down ten times and then incubate for 20 min, 
pipetting again halfway into the incubation.   
For Mael−/− cells, it may be necessary to increase (e.g., double) the amount of DNase I here and 
in step 14 in order to eliminate clumps, because mutant testis contains many dead cells.  
 
12. While cells are prestaining, dilute the 100-µl aliquot of cells (step 10) as follows, then count 
the number of cells in a 10-µl aliquot on hemocytometer under a light microscope. Count live 
cells based on trypan blue exclusion.  For WT: dilute 1:6 by adding 200 µl GBSS and 300 µl of 
0.4% trypan blue For Mael−/−: dilute 1:2 by adding 100 µl of 0.4% trypan blue.   
Alternatively, WT cells may be diluted 1:4 by adding 100 µl GBSS and 200 µl of 0.4% trypan blue. 
 Assessing accurate cell numbers is important for subsequent staining with Ho342 and for 
achieving a proper dye-to-DNA ratio, critical for good resolution of Ho342-stained testicular 
cells on a Ho342-blue/Ho342-red plot. See discussions on Ho342 fluorescence and DNA-binding 
[117] and the importance of Ho342 concentration [101]. One affect of too much Ho342 is 
excessive cell death and formation of clumps/debris in the suspension. Loss of cells and over-
staining will change the final overall Ho342-stained cellular profile and decrease the overall 
resolution. On the other hand, too little Ho342 results in under-staining and poor separation of 
individual populations. The importance of the ratio of DNA-binding fluorochrome concentration 
to the number of binding sites (DNA content, cell number) in equilibrium staining obeys the law 
of mass action and is described UNIT 7.2 [118].   
 
13. When prestaining incubation is complete, add 600 µl NCS to inactivate the trypsin and pipet 
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up and down five times.   
 
Stain cells with Ho342  
14. Add 10 µl of 1 mg/ml DNase I followed by 10 mg/ml Ho342 at a final concentration of 6 µg 
Ho342 per million cells. Pipet up and down ten times and incubate 25 min, pipetting again at the 
halfway point and the end of incubation.   
15. Filter suspension through a 40-µm nylon cell strainer and keep on ice until sorting and 
analysis (up to 30 to 60 min).   
 
Stain cells with PI and perform sorting  
16. Prior to sorting, add 5 µl of 1 mg/ml DNase I to the Ho342-stained suspension and pipet up 
and down gently.   
Addition of DNase I immediately before sorting is important for disaggregating clumps, which 
may otherwise clog the flow cytometer nozzle.   
 
17. Transfer 2 ml suspension to a sterile 5-ml polypropylene culture tube and add PI stock 
solution to a final concentration of 2 µg/ml. Incubate 5 min at room temperature.   
Typically, no sample dilution is necessary before sorting. The final concentrated samples (50 to 
100 million cells, depending on age of the mouse) are usually at a good concentration for 
processing at a flow rate of 2000 to 3000 events/sec. A lower flow rate may be achieved by 
diluting the sample to 1−2 × 106 cells/ml with GBSS.   
 
18. Filter cells through a 35-µm cell strainer cap into a 12 × 75−mm tube and keep on ice until 
analysis.  FACS should be initiated within 30 to 60 min of this step.   
  
SUPPORT PROTOCOL 2: Analysis of purity of sorted cells by immunofluorescence on 
nuclear spreads  
After isolation of cells by FACS, they can be verified by monitoring the expression of 
meiotic and premeiotic germline markers. This protocol describes a procedure for labeling flow-
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sorted cells with antibodies against SYCP3, γH2AX, and DMRT1. SYCP3 is a structural 
component of meiosis-specific synaptonemal complex (SC). Since SC develops gradually, its 
accumulation and differential distribution uniquely characterize a particular stage of MPI. γH2AX 
is a phosphorylated form of histone H2AX, which also shows differential and dynamic staining 
throughout MPI. Typically, meiotic germ cells can be distinguished from premeiotic Spg by the 
presence of SYCP3 and by unique γH2AX staining patterns. However, due to the presence of 
many different types of Spg, and due to the similarity between differentiated Spg and pre-
leptotene cells, staining of sorted Spg and PL fractions for DMRT1 is also recommended. 
DMRT1 is a transcription factor that is present in Spg (both undifferentiated and most 
differentiated), but absent starting from the PL stage of spermatogenesis and onwards [119, 120]. 
The protocol below is performed according to Gaysinskaya et al. (2014) with minor modifications. 
Nuclear spreads are prepared as described by Peters et al. (1997) with minor modifications.  
 
Materials  
See Chapter 2.1 for details. Additional materials used here include mouse anti-DMRT1 primary 
antibody (200 µg/ml Santa Cruz Biotechnology, cat. no. H0712).  
 
1. Analyze staining on a fluorescence microscope to score sorted fraction purity.   
Typically, at least 50 cells are used to quantify the purity of Spg, Z, P, and D germ cells, and at 
least 75 cells are used to quantify the purity of PL and L germ cells.  Extensive characterization 
and classification of sorted cells based on the intensity and distribution of DAPI, yH2AX, and 
SYCP3 signals are described elsewhere [27, 28, 104-106].  Analysis of MPI cells from sorted PL, 
L, Z, P, and D fractions is presented in Figs 3 & 4 [28]). Quantification of percent purity based 
on immunofluorescence after sorting can be found in [28].  Analysis of premeiotic Spg cells is 
presented in Fig 2-10. 
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Fig 2-10. Immunofluorescence characterization of spermatogonia (Spg) after FACS. (A-C) 
Spread nuclei show examples of sorted Spg positive for DMRT1, a gonad-specific tran- scription 
factor expressed in all undifferentiated and most differentiated Spg. Different expression patterns 
and intensities of DMRT1 are consistent with DMRT1 expression in different types of Spg. (D) 
Pre-leptotene (PL) spermatocytes are negative for DMRT1. In all panels, the DMRT1 signal was 
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COMMENTARY  
Background Information  
Ho342-based dye staining protocols for enrichment of murine MPI populations have been 
previously reported [28, 79, 81, 82]. These and similar protocols vary in the degree of enrichment 
for individual MPI populations. More often than not, populations directly adjacent to one another 
on a Ho342-blue/Ho342-red plot are purified as a mix of leptotene/zygotene (L/Z) and/or 
pachytene/diplotene (P/D) spermatocytes [81-83, 121]. In addition, other testicular cell 
populations (including Spg and post-MPI cell types, such as haploid spermatids or meiosis II 
cells) show varying degrees of resolution on Ho342 plots [79, 81-83, 121]. Moreover, differences 
in testicular Ho342 fluorescence profiles observed between laboratories are likely due not only to 
differences in instrumentation, configuration, and settings, but also to differences in sample 
preparation, especially Ho342 staining methods. Nevertheless, Ho3342-based discrimination of 
individual MPI populations is a dominant and successful method for enrichment of highly pure 
testicular cell populations of interest, and is a critical tool for discriminating MPI cell types. The 
latter is especially important due to the absence of markers that can uniquely and unambiguously 
differentiate MPI subpopulations. For instance, although the synaptonemal complex protein 
SYCP3 exhibits differential pattern and intensity of staining, it is present in L, Z, P, D, and up to 
MII spermatocytes.  
 
Critical Parameters and Troubleshooting  
A number of references address critical aspects and difficulties in analysis and interpretation of 
flow cytometry data. Some of them focus on resolving particular problems, and others on general 
aspects of flow cytometry. Examples that fall into the first category include advice and guidelines 
for flow cytometry analysis of DNA content (e.g., [118]) or side populations [122]. Examples 
within the second category may, for example, provide guidance to improve data representation 
and visualization [115]. Several critical aspects of this protocol related to cytometer settings and 
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flow cytometry data display are addressed below.  
 
Cytometer settings  
To set up a flow cytometry experiment with specific fluorophores, the user must know what 
lasers are available for excitation, and what mirrors and filters are available for detection. 
Collectively, this is part of the optics configuration, which forms a system of light illumination 
and detection. The optics configuration must be set up with particular fluorophores in mind. For 
example, to excite Ho342, a cytometer equipped with a 375-nm near-UV laser or UV or violet 
lasers can be used. For detection, bandpass filters are used to filter light that is close to the 
emission peak of the fluorescent dye used (e.g., 461 nm for Ho342). For a 450/40 filter, the 
spectral band transmit- ted to the detector is 430 to 470 nm (450 ± 20 nm). Thus, one way to 
detect Ho342-blue is to use a 375-nm laser and a 450/40 bandpass filter in front of the PMT. In 
addition to band- pass filters, longpass filters are used to transmit wavelengths of light equal to or 
longer than a specified wavelength, and mirrors can serve as beam splitters to direct light of 
different wave- lengths in different directions.  
An awareness of particular instrument specifications and settings can enable the use of a 
different but similar instrument, if necessary. In the authors’ hands, similar profiles have been 
obtained from Ho342/PI-labeled testicular single-cell suspensions using two different instruments 
equipped with different Ho342-detecting lasers: a BD FACSAria III (BD Biosciences) equipped 
with a 375-nm laser, and a MoFlo cytometer (Dako Cytomation) equipped with a Coherent 
Enterprise II laser-emitting MLUV at 351 nm. Mirror and filter settings were adjusted in an 
instrument- specific manner. Using the BD FACSAria III, Ho342 detection was achieved by first 
splitting the Ho342 emission using a 610-nm dichroic longpass filter, and collecting Ho342-blue 
and Ho342-red emissions using a 450/40-nm bandpass filter and a 670-nm longpass filter, 
respectively. Using the MoFlo cytometer, Ho342 emission was also split using a dichroic mirror, 
and detection of Ho342-blue and Ho342-red was achieved using 450/65-nm and 670/30-nm 
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bandpass filters, respectively.  
 
Data display  
It is often best to choose contour plots over dot plots for data display. A contour plot (also called 
a probability plot) graphically displays relative frequencies of cells present at each point in the 
plot, thus providing a third dimension (frequency) to two-dimensional data. If probability is used 
to calculate contour levels, then the percentage of total number of events in outer and inner 
contour levels can be specified and adjusted for better visual view of populations of interest. In 
contrast to the dot plot, the contour plot becomes more accurate as the number of cells from 
which data are collected increases.  
Biexponential plots are useful for accurate visualization of populations with low or 
background fluorescence, and are appropriate for viewing negative populations and drawing gates 
accurately around the major negative population. A great guide for FACS data pre- sentation is 
offered in Herzenberg et al. (2006).  
 
Immunofluorescence analysis  
DMRT1-staining of earlier (less differentiated) Spg can be much stronger than stain- ing in later 
(more differentiated) Spg. On meiotic nuclear spread preparations, DMRT1 immunofluorescence 
staining of differentiated Spg can be quite low and somewhat punctate. For example, DMRT1 
staining of Spg that morphologically resemble PL spermatocytes can be very weak. Importantly, 
however, even weak DMRT1 staining seems to be highly specific, and it is unambiguously absent 
in control cells such as L, Z, P, and D cells, among others.  
 
Anticipated Results  
Based on immunofluorescence analysis after cell sorting, the purity of subpopulations falls within 
the following ranges: Spg, 80% to 91%; PL, 75% to 92%; L, 60% to 80%; Z, 75% to 90%; P,82% 
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to 95%; and D, 82% to 95% [28]. Often, the prevalence of L spermatocytes is lower than that of 
PL, Z, P, D, or Spg. Haploid cells can be enriched from the R0 fraction with a purity of >95% 
(Fig 2-7A).  
 
Time Considerations  
The fresh solutions needed to prepare testicular cell suspensions and to perform staining and 
immunofluorescence analysis can be made in ~30 min. Preparation of the cell suspension requires 
~1.5 to 2 hr. Setting up the flow cytometer and cell sorter requires ~1 hr. Sorting gate adjustment, 
during which all gates and back-gates are checked for overlaps and adjusted, takes ~30 min. If 
necessary, PMTs are adjusted as well. Additionally, as mice of different ages may exhibit 
somewhat different prevalences of individual MPI cells relative to each other and to other cell 
types, the gates and back-gates may need adjustment to accommodate slight shifts in the Ho342 
profile and variations in cell type abundance. Cell sorting can take up to 4 or 5 hr. The sample 
should be held at 4°C during sorting, and should typically stand on ice for no more than a total of 
6 hr after preparation.  
 
Supplementary Material  
Refer to Web version on PubMed Central for supplementary material (doi: 
10.1002/0471142956.cy0744s72).  
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Chapter 3 
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Introduction 
Cytosine DNA methylation is an epigenetic mechanism implicated in stable repression of 
Transposable Elements (TEs), X chromosome inactivation and monoallelic expression of 
imprinted genes [4, 123]. In mammalian cells, cytosine methylation occurs predominantly in the 
CpG context and is established by specialized enzymes known as DNA methyltransferases [56, 
124]. Methyltransferase DNMT1 acts on hemimethylated CpG substrates and plays a key role in 
the maintenance of DNA methylation following the replication of the genome [55, 125]. In the 
absence of pre-existing DNA methylation, new cytosine methylation patterns are introduced by 
de novo methyltransferases DNMT3A and DNMT3B [55]. 
While DNA methylation is generally stable in differentiated somatic cells, 
preimplantation embryos and primordial germ cells (PGCs) experience genome-wide remodeling 
of DNA methylation [7, 46]. Global reduction of DNA methylation levels in PGCs is required for 
resetting of imprinting marks and acquiring totipotent developmental potential [52, 126]. 
Extensive remodeling of DNA methylation in PGCs also results in transcriptional changes, 
including expression of TEs [47, 74, 127, 128]. TEs are genomic DNA sequences that have the 
ability to become mobile and integrate into the genome [61]. TEs account for at least 40% of the 
mammalian DNA, are highly interspersed, and play a major role in shaping the mammalian 
genome structure, gene expression and epigenetic topology of chromatin [68]. TEs are classified 
by their mode of mobilization, either via a DNA (DNA transposons) or an RNA 
(retrotransposons) intermediate [61]. Although several families of retrotransposons co-exist in the 
genome, in placental mammals, including mice, Long INterspersed Element-1 (LINE-1 or L1) is 
the major category and contributes to over 20% of genome size [68]. While the vast majority of 
the estimated 600, 000 L1 elements in the mouse genome are old and mutated, and thus no longer 
capable of mobilization, a subset of intact, evolutionarily young copies could pose significant 
danger to the host by inserting into the genome, deleting and rearranging DNA or otherwise 
modifying the genome [62, 72]. To ensure robust transposon silencing, germ cells utilize a 
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specialized class of small RNAs, namely PIWI-interacting RNAs (piRNAs). In male fetal germ 
cells, piRNAs aid DNA methylation and repressive chromatin machineries to specifically repress 
transcription of young and potentially retrotranspositionally competent L1 loci. Transposon 
silencing is critical for normal differentiation of germ cells as abrogation of de novo DNA 
methylation and piRNAs in fetal male germ cells leads to high levels of L1 expression, 
accumulation of DNA damage and cell death in meiosis [129].  
In a generally held view, once established in primordial male germ cells by the time of 
birth (through concerted efforts of de novo DNMTs and a their catalytically inactive accessory 
factor DNMT3L [126, 128]), DNA methylation levels remain stable and high during subsequent 
stages of spermatogenesis that take place after birth. However, this notion does not account for a 
long-standing observation of transient expression of L1 at the onset of meiosis as indicated by 
expression of L1-encoded protein ORF1p [94, 116, 130-133]. Although L1ORF1p expression in 
the wild type testis is weak when compared to that in various DNA methylation and piRNA 
mutant germ cells, the expression raised the possibility of transposon surveillance relaxation. A 
potential relaxation of transposon silencing at the onset of meiosis was hypothesized to be 
reflective of a change in DNA methylation [134]. 
Since L1 activity can be detrimental to the fitness of the host [62, 72], the coincidence of 
L1 expression in the WT during MPI is intriguing due to the potential of L1 to undermine key 
meiotic events of homologous chromosome synapsis and meiotic recombination [94, 116, 130, 
133, 135]. Before entering MPI, preleptotene (PL) spermatocytes undergo a final round of DNA 
replication (meiotic S phase), which is much longer than the mitotic S-phase in the same 
organism [16-18, 20, 21]. MPI is also exceptionally long, lasting about 2 weeks [136], during 
which time the chromosomes undergo dramatic changes in their organization. MPI is subdivided 
into leptotene (L), zygotene (Z), pachytene (P), and diplotene (D) stages, based on their unique 
nuclear and chromatin morphology, although a change from one stage to the next involves rather 
gradual morphological transitions, but no proliferation [11]. After last DNA replication in PL 
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stage, the homologs begin to pair along their lengths and it is in the context of this unique pairing 
that key meiotic events occur. The initiation of homolog pairing takes place in L spermatocytes, 
with SPO11-mediated programmed meiotic double-strand breaks (DSBs) [137]. However, early 
homologous pairing may occur prior to DSB formation, during pre-meiotic S phase [27]. The L-
to-Z (L/Z) transition is marked by a chromosome configuration called the “bouquet”, where 
chromosome ends cluster and “integrate” into the nuclear envelope in a polarized fashion [86]. 
Homologous chromosomes become tightly paired at various points along their lengths in Z via 
prominent meiosis-specific structure, the synaptonemal complex. By P, the chromosomes synapse 
and complete meiotic recombination [138]. P is an extremely busy stage of MPI, exhibiting a 
dramatic increase in overall RNA and protein synthesis in preparation for the next phase of 
spermatogenesis [33]. At D, synaptonemal complex disassembles and homologous chromosomes 
de-synapse, remaining connected only at chiasmata, the physical remnants of homologous 
recombination [139].   
To explore the molecular basis of L1 expression in wild type male meiosis we set out to 
precisely characterize the dynamics of L1 expression and to determine genome-wide DNA 
methylation levels of spermatocytes in the course of MPI. We find that DNA methylation levels 
of mouse spermatocytes are reduced at the onset of meiosis by replication-coupled passive DNA 
demethylation. In contrast to the accepted view of rapid DNA methylation maintenance within 
several minutes after DNA replication, we observe a gradual and slow process of DNA 
remethylation over the period of several days.  
  
	   91	  
Results 
Transient L1ORF1p expression in MPI of male germ cells 
Evidence of L1ORF1p expression in WT meiosis is counterintuitive and puzzling since it 
is often a sign of concern [77, 116, 140, 141], however, it is also intriguing since it suggests a 
possibility of relaxed transposon control in wild-type MPI. Although several groups have seen 
L1ORF1p expression previously in male mice during MPI, most either attribute it to background 
levels in immunofluorescence staining or do not comment on the observed L1ORF1p expression 
at all [94, 116, 131-133]. One potential reason for lack of consistent reporting on L1ORF1p 
expression in meiosis is its examination relative to DNA methylation and piRNA mutants that 
exhibit excessive levels of L1ORF1p compared to the wild type. To provide a better temporal 
resolution of L1ORF1p expression during MPI in adult WT testis, we performed 
immunofluorescence analysis using the combination of anti-L1ORF1p antibody with well-
characterized antibodies against acrosome-specific marker sp56 (Fig 3-1), and DSB marker 
γH2AX for accurate staging of spermatogenesis (Fig 3-2) [142-145]. Spermatogenesis, which in 
mice takes ~ 35 days, is divided into three main parts, (1) the mitotic proliferation of Spg, (2) 
meiosis of spermatocytes and (3) spermiogenesis, or differentiation of spermatids into mature 
sperm. Spermatogenesis occurs within the seminiferous tubule of testis, where Spg are found at 
the basement membrane, but spermatocytes and spermatids are found progressively further from 
the membrane and towards the lumen, where mature sperm will be released (Figs 1-2, 3-1 and 3-
2). The complex differentiation program involves many distinct steps resulting in an ability to 
distinguish the various types of undifferentiated Spg, differentiating Spg, meiotic and postmeiotic 
cells by their microscopical appearance [11]. In the testis of an adult mouse, cells at all stages of 
spermatogenesis are found simultaneously. Any given testicular cross-section will reproducibly 
account for a unique arrangement of up to four different cell types at different phases of 
spermatogenesis, with twelve possible permutations classified as the twelve stages (stages I 
through XII) of the seminiferous cycle (Fig 1-2) [11]. 
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By evaluating L1ORF1p and other markers in the context of the seminiferous cycle, we 
established that L1ORF1p is reproducibly expressed during a particular window of MPI (Figs 3-1 
and 3-2). Specifically, L1ORF1p expression begins approximately at the L/Z transition, persists 
through Z until mid-P but disappears in late P spermatocytes. L1ORF1p was also observed in 
round and elongating spermatids. In terms of the seminiferous cycle, the window of L1ORF1p 
expression in MPI spermatocytes corresponds to L/Z through mid-P spermatocytes found at 
stages X-VII (Fig 3-1). DSBs are a hallmark of Leptonema, and are progressively reduced 
(repaired) in Z, P and D. Using γH2AX staining in combination with L1ORF1p, we 
observe that L1ORF1p expression is indeed found in L/Z and Z spermatocytes, which are 
also positive for γH2AX (Fig 3-2). However, interestingly, in spermatocytes with most 
intense γH2AX staining, namely, in late L and L/Z transition [138, 145], no or extremely 
low L1ORF1p expression is observed, followed by more pronounced and intense 
expression in Z and early- and late- P spermatocytes. This result suggests that at the peak 
time of DNA nicks and breaks in early MPI, which is in theory a perfect opportunity for 
L1 insertion, WT meiosis seems to be protected from retrotransposition. Importantly, our 
analysis demonstrates that transient L1ORF1p expression is a characteristic feature of MPI in 
adult testis.  
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Fig 3-1. L1ORF1p expression in MPI of male germ cells. Temporal expression of L1ORF1p 
(green) was evaluated in testicular cryosections in the context of seminiferous epithelial cycle 
composed of stages I-XII. Haploid spermatids are identified based on numbers 1 through 16 
according to degree of differentiation (only some are highlighted here). The basal membrane is 
outlined by the bright cross-reacting red staining. Following spermatogenic progression based on 
acrosome development marked by sp56 (red) and DNA stain, DAPI (blue), it is determined that 
cytoplasmic L1ORF1p is first seen in L/Z spermatocytes at stage XI (or X-XI) and persists from 
Z (stages XI-XII) to mid-P spermatocytes (stages I through VI-VII). L1ORF1p is not detectable 
in late P cells found stages VII-X, but is evident in the cytoplasm of elongating spermatids (see 
stages VII-IX) and is also detected as small dots in early round spermatids.  The sp56 staining for 
spermatids beyond step 13 is difficult to see here, since the acrosome spreads very thin at this 
time. The selection inside the white box of the merged image (top row), is shown as a close-up 
inset in the DAPI-containing image row, and represents a single confocal plane in an otherwise 3-
D stacked image, highlighting the cytoplasmic distribution of L1ORF1p in meiotic prophase I 
spermatocytes. Bar = 10 micron.  
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Fig 3-2. L1ORF1p expression in MPI in the context of meiotic Double Strand Breaks 
(DSBs). The composite image shows immunofluorescence staining of testicular cryosections with 
L1ORF1p (green) and phosphorylated histone variant and a DSB marker γH2AX (red), 
counterstained with DNA dye, DAPI (blue).  The seminiferous epithelial cycle is marked by 
stages I-XII. During MPI progression, L1ORF1p is first seen in L/Z spermatocytes (seminiferous 
cycle stages X-XI), persists in Z (stages XI-XII) through mid-P spermatocytes (stages I through 
VI-VII). L1ORF1p is not detectable in spermatocytes at stages VII-X corresponding to tubules 
containing PL/L and late-P spermatocytes. L1ORF1p is also evident as small dots in the nucleus 
of early round spermatids, and in the cytoplasm of elongating spermatids. L1ORF1p is also 
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Genome-wide DNA methylation analysis of adult MPI male germ cells 
Given that L1ORF1p expression is indeed seen in wild type meiosis, we questioned the 
expectation of robust L1 silencing in MPI. Since DNA methylation is crucial for L1 repression, 
we posited if L1ORF1p expression in WT MPI is associated with hypomethylation of L1 
elements. In our pilot experiments, we tested L1 DNA methylation by bisulfite conversion 
followed by PCR amplification with L1-specific primers and sequencing. Indeed, we observed 
decreased L1 DNA methylation in early MPI cells. This early observation led us to wonder if L1 
demethylation is L1-specific or is a product of genome-wide demethylation. The latter idea relies 
on the fact that LINE elements are highly abundant and dispersed throughout the genome, and 
thus may serve as markers of other genomic events. To test these possibilities we investigated 
DNA methylation profiles, or methylomes, of individual MPI substages. 
We enriched for individual MPI stages using Fluorescence Activated Cell Sorting 
(FACS) as previously described (Methods and Procedures) [28, 146]. We obtained two 
biological replicates for each stage: Spg, PL, L, Z, P, D and epididymal Spz germ cells from adult 
mouse testis. The purity of FACS-enriched MPI cells was verified by immunofluorescence with 
meiosis-specific (SYCP3, γH2AX) and Spg-enriched (DMRT1, DMRT6) markers as previously 
described [28, 146] (Methods and Procedures). For genome-wide analysis of DNA methylation 
at a single-CpG resolution, we performed Whole-Genome Illumina Bisulfite DNA Sequencing 
(WGBS) on genomic DNA extracted from FACS-enriched individual MPI stages. We used 
Bismark software for WGBS-Seq data alignment and methylation calling [147, 148]. On average, 
over 90% of the reads in each sample were aligned to the mouse reference genome 
(NCBI37/mm9) at least once (Table 3-1, Protocol 1 in Chapter 4). We spiked all our samples 
with an un-methylated phage lambda DNA to monitor bisulfite conversion efficiency, which 
resulted in more than 99.7% conversion rate for all samples (Protocol 3-1 in Chapter 4). 
Additionally, we used mouse epidydimal sperm DNA (sequenced at lower coverage) as a highly 
methylated control. Each biological replicate accounted for 87-94% of all genomic CpGs in the 
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mouse genome, with average CpG coverage of 3x–6x per individual sample (Table 3-2, Protocol 
1). Two biological replicates per data point exhibited high inter-individual Pearson correlation 
(Table 3-3) allowing for accurate comparison between the groups. Methylation levels at non-
CpG sites, CHG and CHH were negligible (0.3-0.4%), thus we focused on CpG DNA 
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Our analysis showed high median (> 84%) levels of CpG methylation in pre-meiotic Spg, 
P and D spermatocytes and haploid Spz (Fig 3-3A, Table 3-4, Protocol 2 in Chapter 4). This is 
consistent with a generally held view of high DNA methylation levels in adult spermatogenesis. 
Intriguingly, we uncovered an extended window of reduced global DNA methylation during early 
MPI demarcated by a pronounced drop in DNA methylation (~13pp) levels in PL followed by 
progressive gain of DNA methylation in L and Z spermatocytes, returning to pre-meiotic levels 
by P (Fig 3-3A, Table 3-4, Protocol 2). We estimate that the period of overall hypomethylation 
lasts up to 70 hours corresponding to the duration of PL, when hypomethylation occurs, and L 
and Z stages, when incomplete remethylation occurs. This analysis demonstrates the existence of 
transient relaxation of DNA methylation in PL, and suggests that DNA re-methylation occurs 
gradually, taking several developmental stages to reach Spg- or Spz-like levels.  
Next, we wanted to know how DNA methylation is distributed on chromosomal and 
regional scales. To examine chromosome-wide distribution of DNA methylation in individual 
MPI stages, we summarized DNA methylation levels over a distance of 100 kb non-overlapping 
windows spanning the length of the chromosome. We found that global hypomethylation in PL is 
chromosome-wide (Fig 3-3B) and this was true for both biological replicates and all 
chromosomes examined. Thus, the drop in DNA methylation levels between Spg and PL is a 
genome-wide event that is not limited to certain chromosomes. This analysis also showed that the 
return of DNA methylation in MPI appeared predominantly as a chromosome-wide, gradual 
process.  
To determine if DNA hypomethylation in PL is specific to a particular genomic 
annotation or is widespread, we examined the DNA methylation dynamics of exons, introns, 
intergenic and repetitive regions, as well as functionally specialized sequences such as promoters 
(+/-1000bp from TSS) and CpG Islands (CGIs) (Fig 3-3C, Table 3-5). Generally, DNA 
methylation levels at exons, promoters and CGIs (with average DNA methylation levels of < 
70%, < 20% and <0.5% at all stages, respectively) are lower than average DNA methylation 
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levels at introns, intergenic regions and repetitive DNA. Similarly to the genome-wide DNA 
methylation profile, most of these genomic features are also subject to transient demethylation in 
PL (most prominently at introns, repeats and intergenic regions), except for CGIs whose 
methylation levels are already very low (Fig 3-3C, Table 3-5). The recovery of DNA methylation 
at these features also followed the general trend observed for the whole genome reaching pre-
meiotic levels by P. The DNA methylation profile at promoters and exons exhibits an additional 
drop in DNA methylation levels between P and D, perhaps related to changes in transcription.  
The global analysis of DNA methylation in MPI indicates that repetitive DNA exhibits 
comparable DNA methylation dynamics as non-repetitive genomic regions (Fig 3-3C, Table 3-
5). Indeed, major classes of TEs, namely, the LINEs, SINEs, LTRs and DNA also experience 
transient demethylation in PL (Fig 3-3D). Our analysis suggests that L1 DNA becomes 
hypomethylated in PL preceding L1ORF1p expression in L or L-to-Z spermatocytes. This 
suggests that global genome-wide TRDM at meiotic onset may explain transient relaxation of 
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Fig 3-3. Global DNA methylation dynamics in MPI. (A) Global changes in DNA methylation 
reveal transient DNA demethylation in PL, followed by a gradual regaining of DNA methylation. 
DNA methylation was summarized as means of non-overlapping bins of 500 CpGs for individual 
biological replicates. Box-and-Whisker plot shows the maximum, upper quartile, median, lower 
quartile and minimum of data. Median percent DNA methylation for both replicates is specified 
underneath the boxplot. Spg (blue), PL (red), L (green), Z (orange), P (purple), D (light blue) and 
Spz (grey). (B) Chromosome-wide DNA methylation levels were plotted across chromosome 
length (chromosome 13, replicate 1 is shown). DNA methylation was averaged using sliding non-
overlapping bins of 100 kbp. PL (red) exhibits the lowest overall DNA methylation levels, except 
at regions of “switching” in DNA methylation pattern, where L spermatocytes (green) exhibit the 
lowest DNA methylation levels instead. The levels in Spg, P, D and Spz are very similar, 
resulting in a blend marking the upper limit of the DNA methylation trace. DNA methylation of L 
and Z (orange) progressively increase. (C) Box-and-Whisker plot of DNA methylation levels 
across various genomic features. The average DNA methylation levels were aggregated as 
consecutive, non-overlapping averages of 100 CpGs. Averages were combined for biological 
replicates. (D) Box-and-Whisker plot of DNA methylation levels across different classes of 
transposable elements: LINE, Short Interspersed Nuclear Elements (SINE) and Long Terminal 
Repeats (LTR) retrotransposons and DNA transposons.  The average DNA methylation levels 
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We were motivated to examine DNA methylation dynamics of chromosome X (chrX), 
due to its unique meiotic behavior which includes transcriptional silencing in Z-to-P transition 
and heterochromatic condensation into an XY body, known as meiotic sex chromosome 
inactivation (MSCI) [30]. X chromosome inactivation in meiosis is regulated by DNA 
methylation and other epigenetic mechanisms [30]. We examined DNA methylation dynamics on 
chrX and compared it to two autosomes of comparable length, chromosomes 1, 2 and 3 and to all 
autosomes combined. The data show that chrX, like other chromosomes, exhibits transient DNA 
demethylation in meiotic onset followed by remethylation, although chrX tends to be 
hypomethylated at all stages (Fig 3-4A). Interestingly, DNA methylation levels in Spg-to-PL and 
PL-to-L transitions are distinctly less correlated to each other on chrX as compared to the 
autosomes, suggesting differences in the dynamics of chrX demethylation and remethylation (Fig 
3-4B).  
Cumulatively, using FACS-enrichment of MPI substages and genome-wide WGBS 
approach we were able to, for the first time, measure DNA methylation dynamics in individual 
stages of MPI, detect dynamic changes in wild-type DNA methylation levels in MPI and reveal 
existence of transient relaxation of DNA methylation (TRDM). 
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Fig 3-4. DNA methylation dynamics on chromosome X (chrX) compared to autosomes. 
Biological replicate 1 (left panel) and 2 (right panel): were examined independently. CpG 
methylation was averaged in bins of 100 CpGs  (A), and then Pearson correlation was calculated 
(B). The number of different CpGs (CpG loci) evaluated for biological replicates 1 and 2 were as 
follows: chrX (214,981 and 266,439), chr1 (6,983,222 and 7,564,250), chr2 (1,022,879 and 
1,103,479), chr3 (805,182 and 875,167), chr19 (383,441 and 412,451) all minus chrX (no chrX) 
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Genome-wide DNA methylation pattern in PL overlaps with replication timing pattern  
We wanted to understand the cause of transient hypomethylation in PL. A clue came 
from visual inspection of patterns of chromosome-wide DNA methylation levels (Fig 3-3B and 
Fig 3-5A). Focusing on PL DNA methylation pattern one can observe many regions of relative 
DNA hypomethylation interrupted by a few prominent regions of relative hypermethylation (Fig 
3-5A, red trace, boxed region shows an example of a transition from hypomethylated to 
hypermethylated region in PL). We found that every chromosome, and both biological replicates 
possessed such prominent subchromosomal domains (Fig 3-5A, e.g. boxed region). The domains 
that show higher relative DNA methylation levels in PL, show lower DNA methylation levels in 
L, resulting in an apparent switch in DNA methylation traces in PL and L when compared to the 
rest of the chromosome (Fig 3-5A, e.g. boxed region and zoom, observe PL, red trace and L, 
green trace).  
Some resemblance of this pattern to the Giemsa chromosome staining, or R/G banding 
pattern, led us to consider DNA methylation in the context of replication timing domains. 
Replicating domains are large-scale genomic territories that replicate at particular times during S-
phase [149, 150]. Global early or late replication timing profiles appear relatively preserved 
between different cell lines and cell types tested, although there are many tissue-specific 
differences [150, 151]. Remarkably, an overlay of the chromosome-wide DNA methylation 
pattern from our data with replication timing domains (from a mouse CH12 cell line) 
(http://www.replicationdomain.com) revealed a strong overlap between the two (Figs 3-5A and 
3-5B) [152]. Specifically, in PL cells, we observe an overlap between relative-hypermethylated 
DNA regions (Fig 3-5A, most prominent one is outlined) and late replicating domains (Fig 3-5B) 
(Figs 3-5A and 3-5B, red trace). Correspondingly, an overlap is observed in PL between large-
scale hypomethylated regions (Fig 3-5A, sample hypomethylated region is outlined) and early 
replicating domains (Fig 3-5B). Interestingly, a switch between DNA hypo- and 
hypermethylation in PL (Fig 3-5A, enlarged subset) is marked by an opposite switch in DNA 
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methylation pattern in L spermatocytes (Fig 3-5A, red and green traces for PL and L, 
respectively). This switch in DNA methylation pattern in PL-to-L transition is consistent with the 
genomic coordinates of the transition from early to late replication timing domains (Fig 3-5B, 
enlarged subset). The overlap between DNA methylation pattern and replication timing pattern in 
PL was true of both biological replicates examined independently and all chromosomes (see Fig 
3-6 for a another chromosome example).  
Since our data suggests a link between DNA methylation in PL and replication timing we 
hypothesized that DNA hypomethylation in PL is related to replication. It has been shown that 
replication timing may be estimated from sequence coverage of unsynchronized cells [153].  
Sequence coverage was also used to evaluate underreplication in Drosophila polytene 
chromosomes [154]. To this end, we evaluated the uniformity of genome sequencing coverage in 
our WGBS data. Specifically, we summarized read frequency over a distance of 5kb non-
overlapping windows spanning the length of the chromosome and corrected for the difference in 
total read count between the samples (Methods and Procedures). Remarkably, in our analysis, we 
observe consistently lower sequencing coverage in the hypermethylated domains/late replication 
timing domains in PL (Fig 3-5C), disappearing in L, consistent with the lack of replication in L 
phase.  
Together, these observations make us hypothesize that the observed hypomethylation 
represents hemi-methylated DNA after replication but prior to re-methylation. The observation 
that regions of the genome in early replication timing domains show hypomethylation earlier (in 
PL) than regions of the genome in late replication timing domains (L) is consistent with this 
hypothesis; note that the estimated length of mouse PL stage is ~2 days (including S-phase which 
is ~20 hours) and the length of L stage is 1-2 days [13, 136]. 
To further confirm PL cells we obtained by FACS-enrichment are replicative, we injected 
mice with EdU and after 2h performed FACS enrichment, followed by EdU detection of PL cell 
fraction, a population with a characteristic S-phase ploidy span of 2N-4N. Indeed, at least 70% 
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our FACS-enriched PL cells are EdU-positive, with the majority of EdU patterns corresponding 
primarily to middle and late S phase (Fig 3-7) [27, 155].  
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Fig 3-5. DNA methylation pattern in PL overlaps with replication timing. (A) Plot of CpG 
DNA methylation of MPI stages, pre-meiotic Spg and post-meiotic Spz, across chromosome 14, 
which is ~125 Mbp long. Chromosome-wide DNA methylation was averaged using sliding non-
overlapping windows of 100 kbp. The procedure was performed on every chromosome, and both 
replicates, independently. (B) Replication timing (RT) data from CH12 cells (mouse B-cell 
lymphoma) (http://www.replicationdomain.com) and (C) Genome sequencing coverage after 
WGBS, viewed in SeqMonk program. Shown, for each sample is the read count quantification of 
sequence coverage summarized as averages of sliding non-overlapping 5 kbp windows and 
corrected for largest data set. 
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Fig 3-6. DNA methylation pattern in PL overlaps with replication timing, an example of 
chromosome 16. Biological replicate 1 is shown on the left, and replicate 2 on the right. (A,D) 
DNA methylation, (B,E) Replication Timing (RT) and (C, F) Genome sequencing coverage for 
two biological replicates. Replication timing (RT) data (in B and E) is from CH12 cells (mouse 
B-cell lymphoma) (http://www.replicationdomain.com). Genome sequencing coverage after 
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Fig 3-7. Relationship between replication timing and DNA methylation. (A) Replication 
timing (RT) data from CH12 cells (mouse B-cell lymphoma) 
(http://www.replicationdomain.com) was correlated with CpG DNA methylation corresponding 
to late RT domains. Note an existence of a prominent switch in correlation directionality from PL 
to L. Biological replicates (Reps) were processed individually and are shown in light and dark red. 
(B) The PL cell fraction enriched by FACS contains replicating cells. More than 70% of FACS-
enriched PL cells are EdU+, enriched in mid- and late- S phase, based on the characteristic EdU 
staining patterns. 
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Differentially methylated regions are found throughout MPI 
Given the global differences in DNA methylation between Spg and PL and throughout 
MPI, we wanted to better understand the remethylation dynamics and to examine if all of the 
changes in DNA methylation are due to TRDM in early MPI. Thus, we identified regions that 
exhibit significant differences in DNA methylation patterns between individual MPI stages and 
examined their dynamics during MPI. We used bsseq approach to identify differentially 
methylated regions (DMRs) between contiguous MPI stages in a statistically-principled, 
coverage-conscious and biological replicate-aware manner (Protocol 3 in Chapter 4) [156]. For 
DMR analysis we required that each CpG used for the estimation of DNA methylation be covered 
at least once in all 4 samples (2 biological replicates per 2 stages). This selection resulted in a 
median CpG coverage of 3X-7X per sample (or 6X-14X per biological duplicate) and an overall 
coverage of >77% of all genomic CpGs (Table 3-6).  
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Table 3-6. Summary of CpG coverage for the analysis of Differentially Methylated regions 
(DMRs). Only CpGs in common between all four samples of a pairwise comparison (two 
biological replicates per group) were included in the analysis. 
 
  
Table S7: Characteristics of pairwise comparisons for large DMR block analysis
CpG coverage # CpGs covered % Total CpGs evaluated
WT Spg vs PL comparison  (median)  (in common) (# CpGs in common/total # CpGs)




WT PL vs L comparison




WT L vs Z comparison




WT Z vs P comparison




WT P vs D comparison




* Percent total CpGs is based on  21,722,957  CpGs in mm9 genome
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We identified DMRs between Spg and PL, PL and L, L and Z, Z and P and P and D (Fig 
3-8A, Table 3-7). More than 99% of all DMRs between Spg and PL are hypomethylated with 
respect to PL, and more than 98% of DMRs between Z and P become remethylated in P (Fig 3-
8A,B Table 3-7). Relatively few DMRs are thus detected between P and D, cumulatively 
implicating only ~ 190 Mbp of DNA, as compared to ~ 1.3 Gbp of DNA implicated in DMRs 
formed between Spg and PL (Table 3-7). Consistent with our earlier findings that in PL 
spermatocytes DNA hypomethylation is enriched in early replicating domains, we find that 
genome-wide, ~60% of all early replication timing domains overlapped with hypomethylated 
DMRs (Methods and Procedures). Conversely, in L, there is a pronounced enrichment of 
hypomethylated DNA in late replication timing sequences. Thus, DMR analysis is in good 
agreement with our replication timing analysis.  
We used DMR analysis to elaborate on remethylation dynamics. Large hypomethylated 
DMRs present in PL become gradually remethylated in L and Z, thus, DMRs between these 
stages exhibit a progressive decrease in mean methylation difference (Fig 3-8B, Table 3-7) and 
become progressively smaller in size (Fig 3-8C, Table 3-7). Indeed, the DMRs present between 
Spg and PL included up to ~56% of all CpGs evaluated, while those between PL and L, and L 
and Z included ~ 41% and ~3% of all CpGs, respectively (Fig 3-8D, Table 3-7).  
Overall, these DMR dynamics primarily reflect demethylation in PL followed by 
remethylation of the same CpGs in L and Z. Indeed, by examining how many DMRs overlap with 
each other, we find that DMRs formed between Spg and PL account for up to 75% of all DMRs 
identified between PL and L and up to 63% between L and Z (Methods and Procedures). The 
gradual remethylation of hypomethylated DMRs in PL is also reflected by the decreasing 
genomic size of DMR blocks between PL and L, and L and Z as compared to the large DMR 
blocks between Spg and PL, a feature that results in no single DMR exactly matching the 
genomic coordinates of the original DMRs between Spg and PL (Fig 3-8C, Table 3-7).  
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Interestingly, although global levels of DNA methylation in Z are reflective of being 
remethylated relative to the preceding stages, Z is still hypomethylated relative to P (Fig 3-2, Fig 
3-8A,B).  Accordingly, during Z to P transition, we observe that up to ~ 57% of all CpGs in 
common between Z and P undergo a subtle burst of remethylation, from around 81% in Z to 88% 
P, suggesting that the bulk of remethylation that reaches pre-meiotic or almost Spz-like levels 
occurs between Z and P stages of MPI. Indeed, the original DMRs formed between Spg and PL, 
can explain up to 75% of all DMRs observed between Z and P (Methods and Procedures). We 
find that gradual remethylation concerns all genomic features examined (exons, introns coding 
sequences and repeats) (Table 3-8B) and, in Z, up to 60% of these features are still 
hypomethyalated compared to P, although mean DNA methylation difference at the 
hypomethylated DMRs is relatively small. In P less than two percent of these features are found 
in hypomethylated DMRs relative to D, due to remethylation.  
Intriguingly, while P and D share very similar DNA methylation profiles overall (Fig 3-
3A), a subset of DMRs is observed between them. These DMRs reveal hypomethylation from P 
to D that involves only up to 8% of all examined CpGs in common and relatively small mean 
genomic size (~12 Kbp, as compared to ~35 kbp in PL) (Fig 3-8A-C, Table 3-7). Considering 
that original DMRs formed between Spg and PL account for only 50% of all DMRs found 
between P and D, it is likely that the hypomethylation observed in late MPI (P-D) is unrelated to 
TRDM. Together, the above analysis suggests that genome-wide remethylation during TRDM is 
not uniform and results in existence of DMRs throughout MPI. The data also point to the 
emergence of TRDM-independent DMRs that could be associated with other events taking place 
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Fig 3-8. DMRs are found throughout MPI. (A) Heatmap showing DNA methylation profile of 
all individual DMRs in MPI. Each horizontal line represents DNA methylation level of a DMR 
for an individual group (column) of a pairwise comparison, where low-to-high DNA methylation 
is scaled according to red (low)-to-green (high) color scale. The main direction of change in DNA 
methylation, either hypomethylation (hypo) or hypermethylation (hyper) for a particular pairwise 
comparison is indicated above the plots with accompanying percentages of all DMRs exhibiting 
this change. The plot was prepared with ‘gplots’ R package using heatmap.2 function, with data 
ordered based on mean DNA methylation difference between the groups. (B) Boxplot showing 
DNA methylation value distribution at DMRs in MPI between two consecutive stages. (C) 
Smoothed DNA methylation at DMRs for Spg and PL (top), PL and L (middle), and L and Z 
(bottom). The DMR blocks are shown with pink shading, were Spg and PL DMRs are largely 
hypomethylated with respect to PL, L is largely hypermethylated with respect to PL with DMRs 
appearing smaller due to remethylation. The L and Z comparison exhibits fewer DMRs, the 
majority of which are hypermethylated in Z. (D) The proportion of CpGs accounted for by 
hypomethylated DMRs, hypermethylated DMRs or not DMRs. 
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Table 3-7. Results summary of Differentially Methylated regions (DMRs). Only CpGs in 
common between all four samples of a pairwise comparison (two biological replicates per group) 
were included in the analysis. (A) DMRs between wild-type (WT) samples. See Protocol 3 (in 
Chapter 4) for details on computational DMR analysis. The computational comparison was 
performed in a temporally progressive manner, such that the difference between stages is 
calculated, as Group 1 (stage n) - Group 2 (stage n+1). For example, in WT Spg vs PL 
comparison, the difference is calculated as (Spg - PL). Note, that what is hypermethylated in Spg, 
is hypomethylated in PL. (B) Analysis of remethylating DMRs (DMRs that are still 
hypomethylated relative to the next stage). DMR coordinates were imported into SeqMonk 
program and percent of exons, introns, coding sequences (CDS) and repetitive sequences covered 
by DMRs was quantified. (C) DMRs between WT and Mael knock-out (KO) samples. The 
computational comparison between Mael-/- and WT was calculated, as Group 1 (Mael-/-) - Group 
2 (WT). For example, in Mael-/- Spg vs WT Spg comparison, the difference is calculated as 
(mutant Spg - WT Spg). 
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Gene expression dynamics in MPI 
In view of the presence of TRDM-dependent and independent DMRs throughout MPI, 
and prior evidence of correlation, at gene promoters, of hypermethylation with gene silencing, 
and undermethylation with gene expression [43, 157, 158], we wondered if hypomethylated 
DMRs associate with gene transcription. To obtain gene expression profile, we performed RNA-
seq of FACS-enriched individual MPI cell populations. We used TopHat with Bowtie2 to align 
the reads to the mouse genome (mm9), and HTSeq package to count the reads [159, 160]. RNA-
seq statistics are found in Table 3-8. Subsequently, we used EdgeR to obtain normalized counts 
per million (CPM) and perform differential expression analysis [161, 162]. For the analysis of 
transcript abundance, we converted normalized counts to Reads Per Kilobase of transcript per 
Million mapped reads (RPKM).  
Analysis of RNA-seq data confirmed that our FACS-enriched populations were free of 
testicular somatic cells (Fig 3-9A) [163, 164]. Examination of gene expression characteristic of 
Spg confirmed enrichment of differentiated Spg (as indicated, for example, by expression of 
Dmrt1, Dmrt6, Kit) and lack of undifferentiated type A Spg or spermatogonial stem cells  (based 
on low expression of Plzf/Zbtb16 and Thy1) (Fig 3-9B) [120, 165]. A wide panel of genes 
expressed in MPI, including those involved in homologous chromosome pairing [166], meiotic 
initiation and meiosis-specific sister-chromatid cohesion [166, 167], DSB formation, DNA 
damage response and recombination [167] (Fig 3-9C-F), confirmed and expanded on the 
expression patterns of these genes during MPI. The RNA-seq experiment also confirmed that 
collected PL cells are highly enriched in replication-associated transcripts including replication-
dependent histone genes (Fig 3-9G-H) [168], but not transcripts encoding isoforms of 
replication-independent variant H3.3 (Fig 3-9I) [169]. It is worth noting that although earlier 
studies on RNA synthesis in MPI offered invaluable insights into the many global and specific 
features of MPI transcription [81, 164, 170-173], most studies were performed on total juvenile 
testes or limited enriched MPI populations. 
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Fig 3-9. Transcript abundance of select genes in MPI germ cells. Transcript abundance is 
expressed as RPKM. Prominent transcripts from (A) testicular somatic cells, including Sertoli, 
Leydig and Macrophage cells, were examined to assess the level of contamination, and included 
Amh, Ccl2, Cd9, Cyp11a1, Cyp17a1, Fn1, Fshr, Gap43, Gata1, Gata4, Gpc3, Lhcgr, Lum, 
Mmp12, Mmp9, Pla2g4a, Rlf, Star, Tead2 and Vcam1. Meiosis-specific genes Mlh3 are exhibited 
for relative comparison. Transcript abundance of genes associated with (B) differentiated and 
undifferentiated Spg, (C) meiosis-specific synaptonemal complex  (SC) formation, where Sycp2 
and Sycp3 encode components of the axial elements and Sycp1, Syce1-3 make up central element 
of the SC,  (D) meiotic onset (Stra8), meiosis-specific sister-chromatid cohesion complex (Smc1b, 
Rec8, Rad21l and Stag3), recognition of meiotically-programmed DSBs (yH2AX) and other early 
meiosis-associated genes (e.g., Mei1), (E-F) DSB formation and repair and recombination, were 
evaluated. (G-H) Replication-dependent histone variant genes are highly expressed and enriched 
in PL spermatocytes. Twelve replication-dependent histone variant genes with high transcript 
abundance are shown. Selected, are whose genes that were recently shown, by quantitative RT-
PCR (and in some instances in situ hybridization), to be highly enriched in early spermatocytes at 
9-dpp testis, but not 2-dpp (gonocytes), 25-dpp (enriched in round spermatids) or 60-dpp 
(enriched in haploid cells) [168]. (I) Two genes, H3f3a and H3f3b, encoding replication-
independent histone H3.3 were examined. 
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We first examined overall transcription dynamics in MPI. It is known that transcriptional 
upregulation and high levels of RNA synthesis occur in P spermatocytes and these changes are 
associated with reprogramming of gene expression [81, 164, 174]. Indeed, we observe that 
prominent changes in gene expression occur from Z to P and P to D spermatocytes (Fig 3-10A). 
However, changes in gene expression are also associated with other MPI transitions, as evident 
from the dynamic mean RNA expression values (Fig 3-10B). To identify changes in gene 
expression, we performed differential expression analysis between consecutive MPI substages. 
The significantly differentially expressed genes were defined as exhibiting (1) fold change of at 
least 1.5 and (2) an average pairwise expression value of at least 1 Count Per Million (CPM) and 
(3) false discovery rate of less than 0.05. Based on this criteria, the Spg to PL transition involved 
upregulation of ~2250 genes (with top genes including H2afx and other histones) and 
downregulation of ~3475 genes. Interestingly, during PL stage there is an increase in transcript 
abundance of many genes unique to MPI (Fig 3-9D-F). The PL to L transition involved 
upregulation of ~1700 genes (top genes included Spo11 and Meiob), and downregulation of 
~1730 genes (top genes included Stra8). The L to Z transition was associated with upregulation 
of ~2240 genes (including meiotic DSB repair genes Msh4, Hormad1 and Hormad2) and 
downregulation of ~2990 genes (top genes including Stra8, Mei1 and Prdm9 which were 
upregulated earlier in PL). The transition from Z to P involved upregulation of ~3900 genes 
(many related to sperm function), and downregulation of ~3680 genes (among top genes are X-
linked genes). P to D transition involved upregulation of ~3600 genes (including many zinc 
finger genes, and genes associated with protein modifications, like ubiquitination), and 
downregulation of ~3200 genes (many associated with nucleic acid metabolism).  
We evaluated transcript abundance of genes associated with passive or active DNA 
demethylation. Our RNA-seq data is consistent with an idea of passive replication-dependent 
DNA demethylation in PL, but does not support a significant role for Tet-mediated active DNA 
demethylation, due to the absence of Tet1 and Tet2 and very low transcript abundance of Tet3 
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(Fig 3-10A). However, locus-specific TET-mediated DNA demethylation could not be excluded 
and 5-hydroxymethylcytosine (5hmC), a product of TET-mediated oxidation of 5mC, is present 
in PL and early MPI cells [175]. PL cells also seem to lack transcripts for genes involved in other 
means of active DNA-demethylation, including Activation-Induced Cytidine Deaminase 
(Aicda/Aid), Apolipoprotein B MRNA Editing Enzyme (Apobec1), Thymine DNA Glycosylase 
(Tdg) and Single-Strand-Selective Monofunctional Uracil-DNA Glycosylase 1 (Smug1) (Fig 3-
11A Fig).  
We also evaluated transcript abundance of genes associated with maintenance or de novo 
DNA remethylation. PL is enriched for DNMT1, a maintenance methyltransferase that associates 
with replication foci and remethylates hemimethylated DNA generated during replication (Fig 3-
11A).  [176, 177] and contains Uhrf1, which is essential for targeting DNMT1 to chromatin 
during S phase [176, 178]. We observe low abundance of transcripts associated with de novo 
DNA methylation, including DNMT3A and DNMT3B, and very low abundance of Dnmt3l 
transcripts (Fig 3-11A). These observations are consistent with previously reported down-
regulation of DNMT3A and DNMT3l based on RT-qPCR and protein localization studies in 
juvenile testis [56]. However, low transcript abundance does not rule out the contribution of de 
novo DNA methylation to remethylaton, and indeed, protein levels of DNMT3A and isoform 
DNMT3A2 are detectable by immunofluorescence, although barely detectable for DNMT3B in 
EdU-positive PL cells (Fig 3-11B). However, it is important to note that transcripts for Dnmt3l 
are nearly absent in PL (~0.5 RPKM), and DNMT3l stimulates de novo DNA methylation by 
DNMT3A and DNMT3B [179]. Our RNA-seq data supports passive replication-driven DNA 
demethylation, and remethylation of DNA primarily by a maintenance-related mechanism, and 
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Fig 3-10. DMRs found in mid- and late- MPI are correlated with gene transcription in late 
MPI and Spz. (A) Heatmap showing clustering of gene expression in Spg, MPI, sperm and soma. 
Shown are expressed genes with RPKM values of < 25 (genes with RPKM<1 in all eight samples 
were eliminated from this analysis), accounting for 80% all expressed genes throughout MPI 
(12128 genes). Genes with >25 RPKM were excluded from this analysis to allow simultaneous 
visualization of the majority of genes for all the samples using “heatmap.2” function from ‘gplots’ 
package in R. Data was sorted based on ascending RPKM values in Spg sample. (B) The mean 
and median normalized RPKM values for all expressed genes (n=15170) is shown. (C) 
Enrichment of overlap between promoters within hypomethylated DMRs and upregulated genes 
was measured by overlap ratio analysis. ‘Up genome’ denotes ratio of all upregulated genes at a 
particular MPI stage or Spz relative to all genes expressed in the genome at the time; ‘up in 
promoter DMR’ denotes ratio of upregulated genes inside promoter DMRs, relative to all genes 
found inside the DMRs; ‘up out promoter DMRs’ indicates a ratio for upregulated genes outside 
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of promoter DMRs, relative to all genes found outside of DMRs. The asterisk (*) indicates a p-
value of < 0.05 as calculated using Fisher’s exact test. For each pairwise comparison, the 2x2 
table containing the (a) number of up genes inside the promoter DMRs (b) number of genes 
outside the promoter DMRs, (c) number of other genes inside and (d) number of other genes 
outside, was formed and Fisher’s exact test performed. 
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Fig 3-11. Examination of transcript abundance and proteins associated with passive or 
active DNA demethylation or remethylation. (A) Transcript abundance of genes associated 
with passive or active DNA demethylation. (B) Immunolfuorescence of proteins associated with 
de novo DNA methylation, Dnmt3a, Dnmt3a2 and Dnmt3b, in the context of EdU staining for 
replicative DNA and DNA counterstaining with DAPI. 
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The transcriptional activity of sex chromosomes becomes suppressed during male 
meiosis due to epigenetic chromatin modifications associated with meiotic sex chromosome 
inactivation, or MSCI [30]. Accordingly, global reduction of expression levels of protein-coding 
genes on chrX has been observed in P spermatocytes [81, 172, 173]. Indeed, our analysis shows 
sharp reduction of gene expression on chrX in P spermatocytes and maintenance of low 
transcription in D spermatocytes (Fig 3-12A,B), however, consistent with previous reports, 
transcriptional reactivation of some genes is observed in D [81]. Pairwise comparison of 
transcript abundance between consecutive MPI stages reveals that although gene transcription on 
chrX is strongly correlated between Spg and PL, PL and L, and L and Z, there is a decrease in 
transcript abundance during L to Z transition as well, and this is not a general phenomenon, since 
chr1 exhibits upregulation of transcription at this time instead (Fig 3-12A). Indeed, mean 
transcription levels for chrX reveal that there is a gradual decrease in gene transcript abundance 
on chrX as early as PL to L transition (Fig 3-12B), with highest levels of expression observed in 
pre-meiotic Spg, epididymal Spz and testicular somatic cells (Fig 3-12B). In view of our 
observed gradual remethylation dynamics on chrX (and genome-wide) (Fig 3-4) and gradual 
shutdown of transcription on chrX (Fig 3-12A,B), a progressive gain in DNA methylation after 
TRDM in MPI is coincident or may be correlated with the establishment of MSCI.  
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Fig 3-12. Transcript abundance of chromosome X (chrX)-linked and chromosome 1 (chr1)-
linked genes. (A) Mean transcript abundance (RPKM) was examined for meiotic prophase I 
stages and pre-meiotic Spg in a pairwise manner for genes on chrX or chr1. For best visual 
analysis, the majority of genes, with RPKM values of less than 50, were evaluated, while the 
outliers were removed. Spearman’s rank correlation coefficient (rho), and p-value were computed 
for each pairwise analysis. (B) Mean and Median RPKM values (y-axis) for all genes expressed 
from chromosome X. 	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Differentially methylated regions are associated with gene transcription. 
Although the relationship between DNA methylation and transcription is complex, 
promoter DNA methylation can inhibit transcription, directly or indirectly (e.g., via recruitment 
of repressive complexes and histone deacetylases) [42, 43, 157]. Similarly, although many CpG-
rich promoters are unmethylated in all cell types independent of the state of gene expression, 
promoter hypomethylation is associated with transcriptional activation in developmental and 
disease contexts [180-182]. To determine the extent of association of gene expression with DNA 
hypomethylation in MPI, we identified those promoters that were enriched by at least 90% of 
their length in hypomethylated DMRs. Next, we evaluated the degree of overlap between these 
hypomethylated promoter DMRs and genes upregulated during MPI (Table 3-9C, Methods and 
Procedures). The analysis suggested that an overlap between promoter hypomethylation and 
gene upregulation is not random for DMRs that become hypomethylated in Z, P and D, since the 
overlap ratio was higher for upregulated genes inside the promoter DMRs than outside the 
promoter DMRs and genome-wide (Fig 3-10C, Table 3-9). To test the significance of the 
enrichment of hypomethylated DMRs with upregulated genes we performed Fisher’s exact test 
(Methods and Procedures) (Fig 3-10C, significance marked by asterisk, Table 3-9). The 
statistical analysis, which was mindful of upregulated genes inside the promoter DMRs, 
upregulated genes outside of promoter DMRs and all other genes inside or outside promoter 
DMRs, revealed a significant association between a small subset of genes that becomes 
hypomethylated in Z and transcriptionally upregulated in P, D and Spz. Similarly, a significant 
association existed between a subset of genes that becomes hypomethylated in P and 
transcriptionally upregulated in D and Spz, while hypomethylation of more than a thousand 
promoters in D was associated with upregulation of these genes in D and Spz (Fig 3-10C). 
Importantly, PL and L stages were not associated with transcriptional upregulation, suggesting 
that hypomethylation in early MPI is independent from transcriptional upregulation. While 
relationship between gene expression and DNA methylation is complex, and unmethylated 
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promoter CpGs are not necessarily associated with active transcription (especially constitutively 
unmethylated regions) [183]. Our results indicate that there is a significant association between 
coding-gene promoter hypomethylation in Z, P and D and gene expression in P, D and Spz. 
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Table 3-9. Enrichment of 
overlap between DMRs and 
gene expression. We 
measured an overlap ratio 
between gene promoters 
inside hypomethylated DMRs 
and transcriptionally 
upregulated genes. Fisher’s 


































These results are summarized in Figure 5C.
Hypo PL Hypo PL Hypo PL Hypo PL Hypo PL Hypo PL
up PL up L up Z up P up D up Spz
up 2239 1701 2226 3892 3598 5172
total 24395 24395 24395 24395 24395 24395
up/total 0.0917811 0.0697274 0.0912482 0.1595409 0.1474892 0.2120107
up in 516 427 437 834 731 1422
total in 6351 6351 6351 6351 6351 6351
up in/total in 0.081247 0.0672335 0.0688081 0.1313179 0.1151 0.2239017
up out 1723 1274 1789 3058 2867 4435
total out 18044 18044 18044 18044 18044 18044
up out/total out 0.0954888 0.0706052 0.0991465 0.1694746 0.1588894 0.2457881
Hypo L Hypo L Hypo L Hypo L Hypo L
up L up Z up P up D up Spz
up 1701 2226 3892 3598 5172
total 24395 24395 24395 24395 24395
up/total 0.0697274 0.0912482 0.1595409 0.1474892 0.2120107
up in 24 17 46 44 75
total in 382 382 382 382 382
up in/total in 0.0628272 0.0445026 0.1204188 0.1151832 0.1963351
up out 1677 2209 3846 3554 5782
total out 24013 24013 24013 24013 24013
up out/total out 0.0698372 0.0919918 0.1601632 0.1480032 0.2407862
Hypo Z Hypo Z Hypo Z Hypo Z
up Z up P up D up Spz
up 2226 3892 3598 5172
total 24395 24395 24395 24395
up/total 0.0912482 0.1595409 0.1474892 0.2120107
up in 17 33 34 41
total in 136 152 152 152
up in/total in 0.125 0.2171053 0.2236842 0.2697368
up out 2209 3859 3564 5816
total out 24243 24243 24243 24243
up out/total out 0.0911191 0.15918 0.1470115 0.2399043
Hypo P Hypo P Hypo P
up P up D up Spz
up 3892 3598 5172
total 24395 24395 24395
up/total 0.1595409 0.1474892 0.2120107
up in 44 55 84
total in 238 238 238
up in/total in 0.1848739 0.2310924 0.3529412
up out 3848 3543 5773
total out 24157 24157 24157
up out/total out 0.1592913 0.1466656 0.2389783
Hypo D Hypo D




up in 1333 2220
total in 6735 6735
up in/total in 0.1979213 0.3296214
up out 2265 3637
total out 17660 17660
up out/total out 0.1282559 0.2059456
Table S9: Measuring an overlap ratio between promoters in hypomethylated 
Differentially Methylated Blocks and upregulated genes in WT germ cells
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Wild-type meiotic onset is accompanied by transposon expression, which if not silenced 
results in TE reactivation and meiotic demise  
Landmark reactivation of TEs in MPI is observed in various mutants defective in DNA 
methylation and piRNA pathway mutants [77, 94, 116, 140, 141]. These mutants, including 
Dnmt3l-/-, Miwi2-/- or Mael-/-, exhibit a complete block of spermatogenesis due to defects in 
homologous chromosome synapsis, DNA damage, derepression of L1 retrotransposons and 
apoptosis in MPI [77, 116, 141]. These mutants seem to exhibit massive TE reactivation 
specifically in MPI, and not before [77, 116]. Thus, it has been suggested that meiosis is a “weak 
link” when it comes to TE control. The reasons for this TE reactivation pattern in the mutants 
remain poorly understood, although recent evidence suggests that in the absence of DNA 
methylation (in the case of Dnmt3l mutant) premature loss of H3K9me2 triggers TE re-activation 
[77]. We thus wondered if DNA demethylation at the onset of meiosis in PL contributes to TE 
expression, and thereby creates an opportunity for massive TE activation in those mutants that are 
defective in transposon silencing. Thus, we hypothesized, that a window of relaxation of TE 
control in wild type MPI, via TRDM, may serve as a developmental window of opportunity for 
TE de-repression in various DNA methylation and piRNA pathway mutants exhibiting abberant 
TE upregulation in MPI. Thus, our data on L1Orf1p expression suggests that it may not be that 
the mutants create an opportunity for TE expression, but that the opportunity is already there in 
the WT MPI, and the mutants are simply taking advantage of it. 
We investigated Mael-/- and performed WGBS-seq and RNA-seq analysis on FACS-
enriched Spg, PL and a combined spermatocyte population we call “LZp” [146]. The LZp 
population was collected as a single population due to the difficulty to separate normal L and Z 
spermatocytes from abnormal cells with mixed L and Z characteristics and a minor population of 
abnormal P-like spermatocytes [116]. WGBS-seq on FACS-enriched spermatocytes from Mael 
mutant yielded comparable Illumina sequencing read number, quality, alignment and bisulfite-
conversion rate statistics as WT samples (Table 3-10). We find that similarly to WT, Mael-/- 
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exhibits TRDM, followed by DNA remethylation (Table 3-2), suggesting that regain of DNA 
methylation at most genomic sequences does not depend on MAEL expression. Nevertheless, the 
overall levels of DNA methylation in pre-meiotic Spg were lower than in the WT, suggesting the 
inheritance of low DNA methylation from Spg precursors. We speculate that DNA methylation 
defects in Spg precursors arise after birth and are uncoupled from fetal defects in DNA 
methylation, since it was previously shown that in the Mael mutant DNA methylation at L1 
recovers to WT-like levels by birth [127].  
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We observe that Mael mutant maintains relatively high DNA methylation levels at major 
classes of TEs, namely, the LINE (Fig 3-13A), SINE, LTR and DNA (Fig 3-14), despite the 
lower starting levels in mutant Spg compared to WT Spg. However, we find that in Mael-/-, the 
young L1 families with intact and potentially active members, including some of the youngest 
members like L1Md_Gf, exhibit much lower levels of DNA methylation from the start (Fig 3-
13B). This is in contrast to the relatively higher levels of DNA methylation at older families of 
LINEs, like Lx8 (Fig 3-13B). These results suggest an important role for MAEL in piRNA-
mediated DNA methylation of younger families of L1.  
We asked if TRDM of potentially active LINEs in PL contributes to their transcription in 
WT and Mael-/- mutants. First we evaluated overall gene transcript abundance in Mael-/- 
compared to WT using principal component analysis of normalized RNA counts (Fig 3-15).  This 
analysis revealed that transcriptomes for Spg, PL and spermatocytes, but not testicular somatic 
cells, cluster separately and thus differ. Indeed, while transcript abundance for most genes was 
similar between the WT (Fig 3-15B, solid lines) and Mael-/- (Fig 3-15B, dashed lines), there 
were many genes that appeared changed. Gene enrichment analysis on significantly 
downregulated genes revealed that over a thousand genes were downregulated in Mael-/- PL and 
these were related to processes of spermatogenesis, gamete generation and chromosome 
organization. Several thousand genes also appeared upregulated in Mael-/- and these genes were 
most significantly associated with defense responses including immune response and response to 
stress.   
To analyze RNA abundance of TE we used RepEnrich strategy in order to account for 
most TE-derived RNA in our data, by way of counting both, uniquely mapped and multi-mapped 
reads [184]. In the WT, we find that transcript abundance for repeat elements as a whole shows 
an overall decrease from Spg onwards, with lowest levels in Spz (Fig 3-13C, green). This is in 
contast to Mael-/-, which exhibits gradual upregulation of TEs from Spg onwards, until the 
highest levels in meioitic LZp population (Fig 3-13C, magenta). The testicular somatic cells in 
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both, WT and Mael-/-, exhibited similar levels of TE abundance. Intriguingly, we find that in 
WT, Spg to PL and PL to L transitions are accompanied by transcriptional upregulation of many 
class LINE elements (Fig 3-13D, top). This upregulation includes all classes of potentially active 
L1 elements (Fig 3-13D, bottom), whose expression begins to decrease in Z and is essentially 
extinguished by P (Fig 3-13D, bottom). Intriguingly, in the WT, P-to-D transition involves a 
dramatic upregulation of LINEs and potentially active LINE members (Fig 3-13D). Our findings 
provide evidence that in WT MPI, TE transcription occurs in PL and increases through L stages, 
demonstrating that meiotic onset contributes to TE expression. In view of our DNA methylation 
analysis, it is plausible that TRDM in PL and L contribute to this transposon expression. In view 
of this finding, it is interesting that TE upregulation in the Mael-/- also commences in PL, 
suggesting that Mael-/- takes advantage of the natural TE derepression at meiotic onset (Fig 3-
13E). However, unlike in the WT, Mael-/- bypasses TE silencing of young, potentially active 
LINE-1 elements with this subset of TEs further increasing in transcript abundance from PL to 
LZp (Fig 3-13F). This is not the case for the majority of transcripts derived from old, inactive 
LINE sequences, which after their initial upregulation in PL are downregulated later in MPI, in 
cells of the LZp population (Fig 3-13G). LINE1 subfamilies particularly enriched in the young 
and active members, namely, the L1Md_Gf, L1Md_A and L1Md_T, are among the top 
upregulated retrotransposons in the mutant, emphasizing element-specific defects. Our data 
suggest that pre-meiotic replication in PL contributes to derepression of TE silencing in Mael-/- 
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Figure 1. DNA methylation dynamics of major classes of transposable elements in WT and Mael-/- MPI. Raw CpG DNAme values from both 
replicates were pooled and averaged in consecutive, non-overlapping bins of 100 CpGs. Transient relaxation of DNA methylation at TEs is an 
observed feature of both, WT and Mael-/- meiotic onset in PL. Similar levels of DNAme is observed in WT and KO MPI for comparable stages, 
although lower DNAme values are noticeable as outliers (represented as circles below the whiskers), particularly for LINE elements. WT 
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Fig 3-13. Dynamics of MPI DNA methylation and transcript abundance in wild-type and 
Mael-/- testis. (A) DNA methylation profile of class LINE retrotransposons in WT and Mael-/-. 
WT samples include Spg (blue), PL (red), L (green), Z (orange), P (violet), D (purple), Spz (grey). 
Mael-/- samples include Spg, PL and LZp in red color. DNA methylation was analyzed as 
averages of consecutive, non-overlapping bins of 100 CpGs. (B) Examples of DNA methylation 
profiles corresponding to two different LINE types are shown. One, L1Md_Gf, is a young family, 
containing members with full-length, potentially active elements. Another, Lx8, contains ancient 
and inactive members. (C) Analysis of transcript abundance of repetitive elements for wild-type 
and Mael-/- after processing with RepEnrich. A beanplot was prepared with ‘beanplot’ R package. 
(D) A pairwise differential expression analysis is represented as fold change in normalized 
transposon counts (counts per million) between WT MPI stages. The horizontal barplot shows 
log2(FC) on the x-axis and a different LINE transposon from Repeat masker, on the y-axis. Top 
panels depict all class LINE elements, while bottom panels depict select LINE-1 families that 
contain young and potentially active members (L1Md_T, L1Md_Gf and L1Md_A) and their 
progenitors (L1Md_F, L1Md_F2 and L1Md_F3). The differential expression analysis was 
performed in EdgeR. (E) Differential expression analysis (represented as in (D)) is shown for 
Mael-/-. The log2(FC) of normalized transposon counts is shown for mutant PL compared to 
mutant Spg (red), and mutant LZp compared to mutant PL (green), where the same level red and 
green bars represent a particular class LINE element. (F) The log2 (FC) of normalized transposon 
counts for select LINE-1 members. (G) The log2(FC) of normalized transposon counts for those 
LINE elements in Mael-/- that exhibit upregulation during PL to Spg transition (red), but 
downregulation (green) in LZp, contrary to the potentially active LINE-1 elements that exhibit 
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Fig 3-14. DNA methylation dynamics of major classes of transposable elements in wild type 
(WT) and Mael-/- MPI. DNA methylation levels from both replicates were pooled and averaged 
in consecutive, non-overlapping bins of 100 CpGs. CpGs from LINE, SINE, LTR and DNA 
transposons were examined. Mutant MPI exhibits similar dynamics as the WT in terms of 
hypomethylation followed by remethylation, but mutant Spg starts with somewhat lower DNA 
methylation levels. WT samples include Spg (blue), PL (red), L (green), Z (orange), P (violet), D 




Fig 3-15. Transcriptome comparison between wild-type and Mael-/- MPI. RNA-seq reads 
were processed with RepEnrich pipeline to obtain transcriptional landscape of repetitive elements 
in wild-type (WT) and Mael-/- germ cells. (A) MDS plot of normalized counts. WT samples are 
in black, and mutant in red. (B) Density plot of transcript abundance (log2(FPKM)) for WT (solid 
lines) and Mael-/- (dashed lines). 
A B
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Discussion 
 In this study we provided evidence for genome-wide transient relaxation of DNA 
methylation (or TRDM) at the onset of meiosis in adult male mice. Our findings are most 
consistent with TRDM by passive replication-coupled DNA demethylation in pre-meiotic S 
phase. This conclusion is based on a genome-wide drop of DNA methylation levels and low 
sequencing read coverage at early replicating domains in PL, a measure of underreplication. We 
also observe a hypomethylated (but DNA replicated) state of late replicating domains in L, the 
first stage of MPI. This is an unexpected finding since maintenance DNA methylation occurs 
within 2 minutes following the incorporation of cytosine in the new DNA strand during mitotic 
replication [185, 186]. Additionally, robust maintenance of DNA methylation in S-phase is 
further supported by an observation of similar levels of DNA methylation in G0/G1 and G2/M 
phases in primary dermal fibroblasts [187]. Thus, hypomethylation at late replicating domains in 
L may suggest a delay in maintenance DNA methylation in pre-meiotic S-phase. Another 
possibility, is that having fewer replication origins in meiotic S phase [17, 20], may contribut to 
the late replicating regions undergoing replication so late that their full remethylation only occurs 
in L or PL-to-L transition. Additional possibility is substrate limitation, namely, meiotic S phase 
cells being constrained in the number of methyl groups or methyl group donors. Interestingly, 
limitation of S-adenosylmethionine (primary methyl group donor) was found to induce cell cycle 
arrest in G1 and block entry into S phase [188]. Additionally, methionine depletion reduced 
progression rate through S phase but did not block DNA replication of cells that commit to S 
phase [188]. Thus, it is plausible that limiting levels of methyl groups could contribute to 
prolonged meiotic S phase. It is also plausible that some other gene products, important for timely 
remethylation, are absent or limiting, during pre-meiotic S phase. 
Our data do not support a significant role for active DNA demethylation in PL due to the 
lack of Tet1, Tet2, Aicda/Aid, Apobec1, Tgd and Smug1 expression, and very low Tet3 transcript 
abundance. However, locus-specific Tet-mediated DNA demethylation could not be excluded and 
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5-hydroxymethylcytosine (5hmC), a product of Tet-mediated oxidation of 5mC, is present in PL 
and early MPI cells [175]. Cumulatively, these data suggest that DNA demethylation during 
transient relaxation of DNA methylation in PL is a result of passive replication-dependent 
mechanism.  
Our study suggests that reacquisition of DNA methylation after hypomethylation in pre-
meiotic S phase is a gradual and uneven process that creates initially large hypomethylated 
domains that disappear by P when the genome attains pre-meiotic DNA methylation levels. Our 
data suggest that DNA methylation returns gradually to pre-meiotic levels over the period of up 
to 70 hours (the approximate time it takes to proceed through L and Z stages of MPI) [13]. As of 
now, the dynamics of remethylation after TRDM cannot be explained by their preferential 
enrichment for specific genomic features. In addition to TRDM-dependent DMRs, we have also 
uncovered narrow domains of apparent TRDM-independent hypomethylation between P and D. 
Our analysis suggests that many of these hypomethylated domains overlap promoters of genes 
transcribed at P, D and later in spermatogenesis and likely arise by active DNA demethylation.  
 We have previously proposed that transient relaxation of transposon silencing in MPI 
indicated remodeling of meiotic chromatin [134].  However, it remained unknown whether the 
phenomenon is limited to transposons or is a reflection of a broader, genome-wide process. This 
work establishes that transient relaxation of transposon silencing is likely the product of a global 
change in DNA methylation levels of meiotic chromosomes. Interestingly, our RNA-seq 
experiments revealed two periods of increased expression of LINE RNA – first at the time of 
TRDM and second at P-to-D transition. Despite lower LINE RNA expression levels during the 
former, L1ORF1p expression is readily detected in early MPI. In contrast, a sharp increase in 
LINE RNA levels in the P-D window does not lead to the appearance of L1ORF1p. Absence of 
detectable levels of L1ORF1p at this time may be suggestive of efficient translational control of 
LINE RNAs. Intriguingly, the upregulation of LINE RNA we observe in P to D transition, also 
corresponds to activation of piRNA surveillance [189]. It is thus plausible that a burst in 
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retrotransposon transcription during P-to-D transition is involved in nucleating piRNA-mediated 
immunity at this time, instead of making ORF1p protein. Additionally, during late P, a large 
number of genes are transcribed but remain translationally repressed until many days later, when 
translation resumes in elongating spermatids [190]. It is plausible, that at this time uncoupling of 
transcription and translation occurs for LINE transcripts as well, which might explain the re-
appearance of L1ORF1p in round spermatid nucleus and then in elongating spermatid cytoplasm, 
but not in P/D. (in this study, and [130]).  
 An intriguing and still open question is that of a purpose or function of TRDM in 
meiosis. Some existing data allow us to consider several possibilities. First, is that TRDM is 
merely a byproduct of remodeling of meiotic chromosomes in preparation to subsequent events in 
MPI. Protracted pre-meiotic S-phase is not only the time of the last round of DNA replication 
before meiosis but also is the time of loading of numerous meiosis-specific cohesin complexes 
onto chromosomes [191, 192]. Conceivably, these and other changes might necessitate 
uncoupling of maintenance DNA methylation from DNA replication to allow efficient meiotic 
chromosome remodeling in preparation for subsequent meiotic events. In this regard, TRDM 
fulfills a role of a sensitive marker informing us of as yet not well-understood changes to meiotic 
chromosomes.  
Second, could reducing DNA methylation facilitate key MPI processes including 
homolog search and synapsis, meiotic chromosome structure and meiotic recombination? This 
idea is supported by prior studies in fungi and plants demonstrating strong effects of DNA 
methylation on the genomic landscape of meiotic recombination [193-195]. DNA 
hypomethylation was also found to correlate with increased recombination rates in Prader-
Willi/Angelman syndrome imprinted region [196]. Of note, is that in the female germline, 
gonadal PGCs enter MPI at the point of their lowest levels of genome-wide DNA methylation. 
Thus, the identification of TRDM at the onset of meiosis in the male germline suggests that germ 
cells of both sexes and not just fetal oocytes enter meiotic prophase with lowered levels of DNA 
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methylation. This similarity strengthens the notion that reducing DNA methylation levels might 
be required for normal progression of meiotic processes.  
Comparison of DNA methylation dynamics and transposon expression between wild type 
and Mael-/- mice points to the critical role of preexisting DNA methylation levels for the 
successful progression and completion of meiosis. Thus, another possibility is that TRDM 
contributes to germ-cell quality control by exposing genomes with insufficient DNA methylation 
of transposons. This idea builds upon observations of transient L1ORF1p expression in wild-type 
mice and massive L1ORF1p overexpression in piRNA or DNA methylation-deficient mutant 
animals. The combination of DNA methylation and RNA expression analyses suggests that 
TRDM brings germ cells close to widespread reactivation of transposons thus necessitating 
extensive DNA methylation in pre-meiotic germ cells. It is also important to note, that this 
potential role of TRDM is reminiscent of events during fetal oogenesis where differential L1 
expression drives selective elimination of oocytes with excessive L1 levels [197]. Importantly, 
regardless of the specific functional role of TRDM in meiosis, this work reveals an additional step 
in epigenetic programming of the male germ cells and contributes to our understanding of the 
epigenetic context of meiosis.  
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Final Short Summary 
My work shows that when postnatal male germ cells enter meiosis, they undergo 
genome-wide transient relaxation of DNA methylation (TRDM). We find that in the course of 
TRDM, germ cells briefly release transposable elements from repression. Our data suggest that 
genome-wide reduction of DNA methylation levels during TRDM occurs by a passive, DNA 
replication-coupled mechanism. In contrast to robust maintenance DNA methylation within 
minutes after DNA synthesis in mitotically dividing cells, remethylation of meiotic chromosomes 
is a gradual and uneven process across the genomic landscape. TRDM may create a permissive 
environment for the efficient reciprocal exchange of genetic information between parental 
chromosomes in meiosis or ensure gamete quality. My work has an important implication for 
understanding why many mutations, like the one in Maelstrom, exhibit sensitivity and subsequent 
germ cell demise in MPI. Namely, my research implicates the epigenetically relaxed state of 
meiotic onset in this sensitivity.  
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Chapter 4 
Materials and Methods 
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4.1 Mice 
Adult C57BL/6J male mice (2–5 month old mice) (Jackson Laboratory) were used as a 
source of adult testes. All experimental procedures were performed in compliance with ethical 
regulations and approved by the IACUC of Carnegie Institution for Science. The Mael knock-out 
strain was described in [116]. 
 
4.2 Germ cell isolation 
Adult testes were dissected out of mice and processed for Fluorescence Activated Cell 
Sorting (FACS) as described in Chapter 2 of this thesis for WT and Mael-/- mice [28, 146]. 
FACS-enriched WT germ cells included Spg and PL, L, Z, P and D spermatocytes. Only the Spg, 
PL and a combined LZp cell populations were FACS-enriched from Mael-/- testes. Testicular 
somatic cells were obtained from both, WT and Mael-/- mice [28, 146]. Cell purity after sorting 
was evaluated based on immunofluorescence analysis of nuclear spreads with antibodies against 
proteins enriched in either pre-meiotic Spg (DMRT1, DMRT6) [119, 120] or meiotic cells 
(SYCP3, yH2AX), as described before [28, 146]. We have determined that our Spg population is 
enriched in differentiated, rather than undifferentiated Spg. This conclusion is based on the 
absence or low abundance of DMRT1, presence or high abundance of DMRT6, and presence of 
heterochromatic foci, as evaluated by DAPI staining. Note, that the collected PL cells were 
negative for DMRT1, however, some cells contained DMRT6 puncta. Cell counts based on the 
detailed IF analysis, as described before [28, 146], were conducted with sorted cell fractions used 
for subsequent analysis exhibiting a purity of >85% for Spg, 75-85% for PL, 65-85% for L, >80% 
for Z, > 90% for P, >90% for D. 
 
4.3 Immunofluorescence (IF) 
IF on testicular sections or meiotic spreads was performed as described before [28, 146]. 
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Briefly, a 50 µl aliquot of sorted cells was mixed with 50 µl hypotonic buffer (30 mM Tris-Cl, 50 
mM sucrose, 17 mM sodium citrate dehydrate, 5 mM EDTA in water) and incubated at RT for 30 
min. Cells were pelleted at 5000 rpm for four minutes, 80 µl supernatant was removed and cells 
re-suspended with 65 µl of 100 mM sucrose, pH 8.2. Next, 30 µl of the suspension was applied to 
a glass slide (Superfrost Plus, VWR) dipped just before in a solution of 1% paraformaldehyde, 
pH9.2, supplemented with 0.1% Triton X-100. The pH of all solutions was set using 50 mM 
sodium borate. Nuclei were dried overnight (O/N) in a slightly opened humid box over water. 
Finally, the slides were washed for one minute in 0.2% Photoflo (Kodak), dried at RT, and stored 
at minus 20°C. Frozen slides were thawed at 42°C, followed by serial washes, five minutes each, 
of 0.5% Triton X-100 in 1X PBS, 0.05%Triton X-100 in 1X PBS and 1X PBS. Slides were 
treated with blocking buffer (2% BSA, 0.05% Triton X-100) for 30 minutes and incubated O/N at 
RT with primary antibodies (1:750 anti-SCP3, Abcam, #ab15093 and 1:1000 anti-phospho- 
Histone γH2A.X, Millipore, #05-636) in blocking buffer supplemented with 10% normal donkey 
serum). After washes as above, cells were incubated with secondary antibodies (1:500 donkey 
anti-rabbit 594, Life Technologies, #A21207 and 1:1000 donkey anti-mouse 488, Life 
Technologies, #A21202). Slides were subsequently washed as described above and 
counterstained for 5 min in 0.1 µg/ml 4,6-diamidino-2-phenylindole (DAPI) in PBS. After a rinse 
in PBS, the slides were mounted in Vectashield (Vector Laboratories) and sealed with nail polish. 
To quantify percent purity, between 100 and 250 spread cells from each sorted cell population, 
were scored and classified after each sort.  
A laser-scanning confocal microscope (Leica DM6000, Exton, PA or Zeiss) was used for 
imaging cryosections. For imaging meiotic spreads, an upright fluorescence microsope was used 
(Olympus BX61). All images were analyzed in ImageJ. 
The following primary antibodies were for immunofluorescence (IF): monoclonal anti-
γH2AX (Mouse, 1mg/ml, 1:1000, Millipore 05-636), polyclonal anti-SYCP3 (Rabbit, 1mg/ml, 
Abcam, ab15092. IF: 1:500 dilution), polyclonal anti-ORF1p (Rabbit, 1mg/ml, a kind gift from 
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Dr. Martin. IF: 1:500 dilution) [130], monoclonal anti-DMRT1 (Mouse, 200 µg/ml, Santa-Cruz, 
sc-10222. IF: 1:200 dilution), polyclonal anti-DMRT6 (Rabbit, a kind gift from Dr. Zarkower. IF: 
1:200 dilution) [120], monoclonal anti-sp56 (Mouse, Pierce, MA1-10866. IF: 1:750), anti-
DNMT3a, anti-DNMT3A2, and anti-DNMT3B (rabbit, a kind gift from Shoji Tajima. IF: 1:1000-
1:5000 dilution). The following secondary antibodies (2mg/ml) were used in this study: donkey 
anti-rabbit Alexa Fluor 594 (1:500), donkey anti-rabbit Alexa Fluor 488 (1:500 for SCP3, ORF1p 
and 1:200 for DMRT6), donkey anti-mouse Alexa Fluor 488 (1:1000 for yH2AX, 1:200 for 
DMRT1). 
 
4.4 Cryosections  
After dissection of the testis, the tunica was removed, the testis was fixed (2% PFA in 
PBS) at 4C for 4 hours, shaking. Samples were passed through a sucrose (dissolved in water) 
gradient (10% for 1h, 20% for 1h, 30% overnight at 4C), embedded in OCT and stored at -80 C. 
Sections of 10 µm were used for IF.  
 
4.5 EdU labeling  
Adult mice 1-3 months old were injected with 12.5µg/g of body weight EdU (0.5mg/ml 
DMSO stock) dissolved in 200µL water. Mice were sacrificed 2 hours after injection and 
processed for FACS or for cryosections as described above. EdU detection with Click-iT EdU 
Alexa Fluor Kit was performed as described in the manual (Invitrogen).  
 
4.6 Whole Genome Bisulfite Sequencing (WGBS) 
WGBS Background. WGBS is a process whereby input DNA is treated with sodium bisulfite 
and sequenced. The sodium bisulfite method, development by Hayatsu [198], involves the 
conversion of cytosine (C) to uracil (U), while methylated C (5mC) is protected because it does 
not react with bisulfite. Mouse chromosomes contain 42% mean (G + C) content and less than 
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5% 5’-CpG-3’ (CpG) content [68].  The Cs that occur in CpG dinucleotide context are often 
highly methylated in mammals, while non-CpG cytosines are predominantly unmethylated. Thus, 
since most Cs in the genome are not methylated, after bisulfite conversion of Cs into Us, followed 
by the amplification of bisulfite-treated DNA by PCR and sequencing, unmethylated Cs are 
replaced with Ts resulting in a nearly C-less genomic sequence [148]. By comparing the modified 
DNA with the original reference sequence, the methylation state of the original DNA can be 
inferred. Thus, bisulfite conversion combined with next-generation sequencing can accurately 
measure DNA methylation at specific genomic loci, at single-base resolution. Subsequently, 
computational tools are used to map BS-seq reads to the genome, determine the methylation state 
of any given C and detect and measure differential methylation between two samples. In this 
study, we use Bismark software for BS-Seq data alignment and methylation calling [147, 148] 
and bsseq software package [156] for accurate estimation of DNAme at single CpG level and 
statistically principled differential methylation analysis. An extended commentary and 
computational protocols on every aspect of BS-Seq analysis can be found in the Methods and 
Procedures section of this chapter.  
 
WGBS experimental setup. Each biological replicate consisted of pooled cells from 2-3 
different animals from different FACS procedures. Two biological replicates (2x) were used for 
WT samples Spg, PL, L, Z, P, D and epididymal spermatozoa (Spz). Spz was obtained by 
pushing sperm out of the epididymus. For Mael-/-, 1x Spg, 3x PL and 2x LZp biological 
replicates were used.  
 
Genomic DNA (gDNA) preparation. gDNA was prepared as follows. FACS-enriched cells 
stored at -80 C in nuclease-free 1.5 ml Eppendorf tube, were hand-homogenized in 100µl tail 
lysis buffer using disposable pellet pestle (Kimble Kontes). Up to 300µl tail lysis buffer, and 5µl 
of Proteinase K (Life Technologies, 20mg/ml) were added to the samples and the samples were 
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incubated at 55 C for 2-3 hours. At the end of lysis, 2µl of Linear Acrylamide (Ambion, 5mg/ml) 
were added to samples. DNA was extracted with Phenol Chloroform Isoamyl Alcohol (25:25:1, 
pH 8.05-8.35) (Life Technologies, #15593) using Phase Lock Gel (PLG) Light tubes (5 Prime). 
One microliter of RNase A (Thermo Scientific, #EN0531, 10 mg/ml) was added to the aqueous 
phase, and the samples were incubated at 37 C for 30 min, transferred to a PLG tube and mixed 
with chloroform. The aqueous phase was processed for DNA precipitation using Ethanol. Prior to 
the addition of sodium acetate, 2 µl more of Linear Acrylamide was added to the sample. DNA 
pellet was resuspended in 15-20µl EB (pre-heated at 65 C) and kept overnight at room 
temperature. The DNA was quantified with picoGreen assay (Molecular Probes) using 
SpectroMax microplate spectrophotometer. 
 
WGBS library preparation. The library was prepared based on Illumina’s ‘WGBS for 
Methylation Analysis’ protocol. Isolated mouse gDNA was spiked with approximately 0.1% 
unmethylated cl857 Sam7 Lambda DNA (Promega) and sheared to fragments with a range of 
200-600 bp using a Covaris M220 Ultrasonicator. The diluted fragmented gDNA was 
concentrated and end-repaired. Afterwards, the samples were processed for adenylation and 
adaptor ligation. Methylated Illumina adapters with indexes AD001-AD016, AD018-AD023, 
AD025 and AD027 were used. The adaptor-ligated DNA fragments were processed for bisulfite 
conversion according to the manufacturer’s protocol (EZ DNA methylation Gold kit, Zymo 
Research). Bisulfite-treated DNA underwent 15 rounds of PCR amplification. The PCR amplified 
samples were used for Illumina cluster generation and sequencing using Illumina TruSeq RNA 
Sample Prep Kit v2 components. The BSC libraries were sequenced on Illumina HiSeq2000 
platform, yielding 100bp Paired-End (PE) reads. WT biological replicate one was sequenced at a 
different time from WT biological replicate number two. All Mael-/- samples, Spz and somatic 
cells were sequenced at once. Sequencing was performed by Allison Pinder in our core facility. 
Each sample was run in a single lane, spiked with 5% Illumina PhiX genomic DNA control to 
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increase library diversity, as per Illumina recommendation. Data were downloaded onto our 
servers in FASTQ format for processing.  
 
WGBS read alignment and extraction of DNA methylation evidence. We used Bismark 
program [147, 148] for mapping bisulfite-converted reads to mouse genome assembly 
NCBI37/mm9 (Table 3-1). For estimation of bisulfite rate conversion, reads were aligned to 
Lambda genome. Bismark version 0.13.0 was used, except where noted otherwise. The alignment 
was performed with respect to the bisulfite-treated Watson (original top) and Crick (original 
bottom) strands, and not their reverse complements, as the library was prepared in a strand-
specific (directional) manner [147]. No trimming was performed prior to alignment [199]. After 
alignment Bismark de-duplication module was used to remove PCR duplicates, defined as reads 
that have the same orientation, and start and end at the same position. Of the duplicated reads, the 
remaining read is randomly chosen (Table 3-1). 
After alignment and de-duplication of reads, we used Bismark to extract and summarize 
CpG methylation evidence present in the unique alignments. A piece of CpG “evidence” is an 
alignment that overlaps cytosine position of a CpG in the reference genome and was either a T 
(indicating a lack of methylation) or a C (indicating presence of methylation) in the alignment. 
After extraction of CpG (and non-CpG) evidence, the CpG evidence was filtered based on 
evaluation of methylation bias (M-bias) plots. Based on the M-bias plot, we excluded the first 6 nt 
from 5’ end of read 1 and 10 nt from read 2, and the last 1 nt from 3’ end of both reads prior to 
the extraction of methylation. Subsequently, we extracted CpG coverage into a file containing 
information for both strands. Finally, we merged strand-specific information. The final output 
text file contained chromosome (chr) name, chr start, chr end, CpG methylation percentage, count 
C and count unmethylated C. The results are summarized in Table 3-2, while Protocol 1 
summarizes computational steps taken to perform this analysis. Appendix contains scripts 1-7 
used to process fastq files into final file containing CpG methylation evidence. These final DNA 
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methylation files were then typically analyzed with bsseq package. The files were imported into 
bsseq using read.bismark() function. For the analysis of all mappable CpGs per sample, mean 
coverage and “raw” DNA methylation levels were calculated using getCoverage() and getMeth() 
functions, respectively in bsseq. 
 
Bioinformatics analysis of global DNA methylation levels. Correlation between replicates of 
WGBS data (Table 3-3) was performed as follows. Biological replicates were compared pairwise 
(e.g., Spg1 with Spg2). Final Bismark output files containing CpG methylation and coverage 
were imported into R using <read.bismark> function from bsseq package. Once imported, these 
files are considered bsseq format files. DNA methylation was extracted and summarized in non-
overlapping bins of 500 CpGs using rep() function, followed by aggregation of data and 
computation of mean values, using aggregate() function in R.  Pearson correlation coefficient 
was then calculated using cor() function in R.  
Global DNA methylation analysis was performed using bsseq package [156]. For the 
analysis of WT samples, two replicate groups were formed.  Each one consisted of 7 samples 
(Spg, PL, L, Z, P, D and Spz) and made up a single Bsseq object. Only those CpGs that were 
covered by at least one read in all samples (common CpGs) were analyzed. The summary of 
DNA methylation analysis for CpGs in common, between samples of an individual biological 
replicate group, can be found in Table 3-4 and Protocol 2 outlines the steps taken to perform this 
analysis in bsseq. Since only these common CpGs were involved in data analysis, the overall 
DNA methylation levels for each sample slightly differs from “raw” DNA methylation values 
obtained for all mappable CpGs of a given sample.  
For plotting DNA methylation across the length of the chromosome (e.g., Fig 3-3B), a 
custom python script was used and DNA methylation was averaged using sliding non-
overlapping windows of 100 kbp.  
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Annotation used for DNA methylation analysis. For most annotation, we used UCSC genome 
browser database (http://genome.ucsc.edu). The following genomic feature annotations were 
directly extracted from UCSC Table Browser based on mm9 genome: introns, exons, CpG 
Islands and repeats annotated by RepeatMasker (RMSK) (http://repeatmasker.org). Promoter 
coordinates were extracted from the UCSC/knownGene transcriptome file by taking +1kb to -1kb 
relative to the TSS, in a strand-conscious manner. Intergenic regions were extracted from the 
UCSC Table Browser by (1) extracting BED file containing ‘chrom, txStart and txEnd’ via 
‘selected fields from primary and related tables’ output format (2) uploading the new file as a 
custom track and specifying ‘custom track’ in the  <group> category of table browser (3) using 
<intersection> to create and intersection of the custom track with itself, selecting the ‘Base-pair-
wise intersection (AND) of User Track and User Track’ option for intersection, and ‘Complement 
User Track*’. The geneID and geneSymbols were obtained from specifying the selected fields in 
the output format and selecting knownGene (name), and kgXref (geneSymbol) fields. A custom 
script was used to change ucsc_ids to geneSymbols in the BED files.  
 
Analysis of sequencing coverage after WGBS. For chromosome-based visualization, 
deduplicated bam files from BS-seq were sorted using Samtools. To make the simultaneous 
analysis of multiple files for each MPI stage, Spg and Spz possible, individual chromosomes were 
analyzed separately (extracted from sorted bam files). Biological replicates were analyzed 
separately for independent assessment. The files were uploaded into SeqMonk and read coverage 
was quantitated in the following manner: running, non-overlapping window probes of 5kb were 
created to span the chromosome length. Read counts (the probes) were quantitated using the 
SeqMonk’s Read Count Quantitation approach where we counted all reads and corrected for total 
read count based on the largest data set. For overall coverage quantitation, running, non-
overlapping window probes of 5kb were created to span the chromosome length. Probe read 
counts were quantitated using the SeqMonk’s Read Count Quantitation approach where we 
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counted all reads and corrected for total read count based on the largest data set. Data store 
summary report was exported.  
 
Determination of overlap between datasets. Generally, overlaps were computed using bedtools 
intersect. For example, for intersecting DNA methylation with late replicating regions, <intersect 
–wa –wb> was used, with replication timing (RT) file (-a) and DNA methylation file (-b). The 
RT file contained <chr RT/start RT/end RT/RT value>. The CpG methylation file contained <chr 
C/start C/end C/methylation level. Pearson correlation between DNA methylation values and RT 
values was performed using cor() function in R. 
 
Analysis and Annotation of Differentially Methylated Regions (DMRs). DMR analysis was 
performed using Bsseq package with previously optimized settings for DMR blocks [156, 199]. 
Bsseq employs local likelihood method, aggregating information from neighboring CpGs in a 
coverage-conscious manner and uses the combined data from two biological replicates to estimate 
DNA methylation at single CpG level. For this analysis we required that each CpG be covered at 
least once in all 4 samples compared pairwise (two biological replicates per two stages). This 
selection resulted in a median CpG coverage of 3X-7X per sample (or 6X-14X per duplicate) and 
an overall coverage of > 77% of all genomic CpGs (Table 3-7). Protocol 3 contains pipeline for 
the computational analysis of DMRs used in this study. 
For analysis of DMRs and replication timing, genomic coordinates of hypomethylated 
regions were obtained from DMR blocks and intersected with early or late replication timing 
(RT) coordinates. For every region within A (early or late RT domain) a number of intersections 
with B (DMR block) were computed. To calculate the proportion of an overlap between DMR 
blocks formed between Spg and PL (‘WTSpgPL’ DMRs) and all other DMR blocks, <bedtools 
intersect –wa –wb> was utilized, using a file containing WTSpgPL DMRs as (-a) and separate 
files, each containing DMRs between WT PL and L, L and Z, Z and P, P and D as (-b). 
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Subsequent processing of the output involved adding the number of all intersections that matched 
WTSpgPL DMRs and normalizing to the total number of DMRs for a particular pairwise 
comparison.  
Annotation from Illumina’s iGenomes (genes.gtf), based on the RefSeq dataset (dating 
July, 2015), was used for annotating DMRs with genes.  
To measure enrichment of overlap between transcriptionally upregulated genes and 
hypomethylated promoter DMRs, we measured a ratio of overlap between them and compared 
the ratio to the ratios obtained for upregulated genes outside promoter DMRs and genome-wide 
(Table 3-9). If the overlap ratio for genes inside promoter DMRs was same or similar to the other 
ratios then, an overlap was considered random. Subsequently, we used Fisher’s exact test to 
examine strength of overlap between DMRs and gene transcription. For each set of DMRs, a 
custom python script was used to form a 2x2 table containing significantly upregulated genes that 
overlapped with DMRs, significantly upregulated genes that fell outside of DMRs, all genes 
found inside of the DMRs, and all genes found outside of the DMRs. To evaluate the significance 
of overlap, we calculated p-values using Fisher’s exact test.  
 
4.7 RNA-Sequencing 
Total RNA preparation. Total RNA was isolated from FACS-enriched fractions from adult 
C57BL6 male mouse testis. In most cases, due to the limited availability of enriched cells, total 
RNA from 2-4 mice (2-4 independent FACS enrichment sessions) was pooled to create one 
sample. Moreover, early MPI cells including PL, L and Z are not very transcriptionally active, 
compared to the cells of late MPI, the P and D. For example, P spermatocytes, have been recently 
estimated to produce relatively large amounts of RNA per cell (~12 pg) similar to an average 
liver cell (~15pg) [172]. Thus, while it is straightforward to collect biological replicates for late 
MPI, similar amounts of RNA for early MPI are obtained only from multiple independent FACS 
sorts. Thus, for WT, six samples were obtained, and included Spg, PL, L, Z and P. For Mael-/-, 3 
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samples were obtained, and included Spg, PL and LZp. Mael KO LZp was collected as one 
fraction since the defects observed in Mael KO MPI cells make it difficult to differentiate L and Z 
and Z-like and P-like cells [116, 146]. 1ul of RNA was used for evaluation on the BioAnalyzer. 
For RNA-seq, one biological replicate was used for WT Spg, PL, L, Z, P, D, Soma and Spz; For 
Mael-/- 2x Spg, 3x PL, 1x LZp and 2x Soma were used. 
 
rRNA depletion of total RNA. Ribosomal RNA (rRNA) was removed from total RNA (up to 
50ng) using Ribo-Zero Gold rRNA Removal Kit according to the manufacturer’s protocol.  
 
cDNA library preparation. The TruSeq RNA Sample Preparation Kit v2 was used to prepare 
cDNA library from ribosomal RNA depleted RNA. The libraries were prepared by Allison Pinder 
of Carnegie’s Sequencing Core facility as described in the manufacturer’s protocol (Pub. Part no.: 
15026495) following low sample protocol. DNA fragments were enriched with PCR for 15 
cycles. One microliter of the resulting library was used for validation and quantification analysis, 
using Agilent Technologies 2100 Bioanalyzer and Agilent DNA-1000 chip. The cDNA libraries 
were sequenced as single end 50-mers using the Illumina HiSeq2000 platform, yielding a total of 
~ 246 million reads (26-66 million total reads per sample).  
 
RNA-seq quality validation and read mapping. The quality of the raw RNA-seq libraries was 
evaluated using fastQC (http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). The 
fastQC-reported  “Per base sequence quality” measure was very good, with more than 92% of all 
reads having a quality score of more than 30, and mean quality score of more than 36. This score 
is based on Phred-scale quality, where a score of 20 corresponds to one error in every 100 base 
calls, or 99% accuracy, and all of our samples exhibit a very high score across all 50bp, with only 
minor decrease in quality at position 50. Although the “ per base sequence content” exhibited a 
characteristic to Illumina RNA-Seq bias in the first 11 bases (related to library preparation steps), 
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we did not trim away these nucleotides, since their overall quality was still high, and the trimming 
method has been shown to be most beneficial for intermediate quality threshold of 20 to 30, 
whereas all, except the last basepair in our data exhibit per base sequence quality of 30 or above.  
 
RNA-seq read alignment. The read alignment was performed with TopHat (v2.0.7) [160, 200] 
(https://ccb.jhu.edu/software/tophat), using short read mapping program Bowtie 2 (v2.0.6).  
During the alignment, we provided a transcriptome file that contained gene annotation. The reads 
were processed based on NCBI37/mm9 mouse genome and UCSC RefSeq gene annotation 
obtained from Illumina iGenomes (dating July, 2015). Alignment statistics are found in 
Supplementary Table.  
 
Bioinformatics analysis of RNA-seq. We used HTSeq package to count sequencing reads that 
overlap with gene transcriptome (http://www-huber.embl.de/users/anders/HTSeq/doc/count.html) 
[159]. Specifically, we used <htseq-count –s no –a 10 input.sam iGenomes.gtf> command. The 
output is a tab-delimited text file containing counts for each gene (gene id and number of read 
counts). Subsequently, to evaluate differential expression we used edgeR [201]. Specifically, we 
(1) built a counts table with all samples, using DGElist function, (2) normalized counts using the 
default TMM method, which accounts for compositional differences between the libraries, using 
calcNormFactors function (3) obtained a table with normalized count-per-million (CPM), using 
cpm function, which we used directly for data analysis, or converted CPM to RPKM by 
(cpm/gene length/1000). Gene length file was kindly provided to us by Xiaobin Zheng. For the 
differential expression analysis, an exact test was performed with an estimated Biological 
Coefficient of Variation (BCV) of 0.1, and topTags function was applied. A final table containing 
logFC (is log2FC), logCPM (is log2CPM), p-value and FDR value for each gene was obtained. 
See Appendix (scripts 8-10) for scripts used to process fastq files into the final file containing 
RNA read counts for transcriptome.  
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Gene Annotation and Differential Expression analysis. One widely used data annotation is 
NCBI’s RefSeq Refgene dataset (Pruitt et al, 2005). Illumina provides ready-to-use reference 
sequence annotation as part of its iGenomes collection 
(https://support.illumina.com/sequencing/sequencing_software/igenome.html) that is based on the 
RefSeq dataset, but is more conveniently organized. For example, the iGenomes annotation 
(GTF) file already contains gene names and other attributes such as transcription start site id 
(tss_id) and transcript_id, avoiding the need to cross-reference in order to get this information 
otherwise. Thus both, the alignment and differential expression (DE) analysis were performed 
using the most updated version of NCBI’s gene annotation.  
 
Analysis of transposable element RNA. The file containing mouse genome repetitive elements 
was obtained from RepeatMasker and downloaded as mm9.fa.out.gz file  
(http://www.repeatmasker.org). For the analysis of the transcriptional landscape of repetitive 
elements we used RepEnrich [184] according to the suggested protocol 
(https://github.com/nerettilab/RepEnrich). Briefly, we aligned RNA-seq data to the genome using 
bowtie1 parameters that allow only unique mapping (-m1) and outputted multimapping and 
uniquely mapping reads into separate files. We ran RepEnrich python script on the data and then 
used EdgeR for subsequent processing of fraction counts file, which contained 1444 repetitive 
element entries.  Specifically, we (1) built a counts table with all samples, using DGElist 
function, (2) normalized counts using the default TMM method, which accounts for 
compositional differences between the libraries, using calcNormFactors function (3) obtained a 
table with normalized count-per-million (CPM), using cpm function, which we used directly for 
data analysis. For the differential expression analysis, an exact test was performed with an 
estimated dispersion specific to each pairwise comparison (which varied between 0.06 and xxx), 
and topTags function was applied. A final table containing logFC (is log2FC), logCPM (is 
log2CPM), p-value and FDR value for each repetitive element entry (subfamily). 
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This document contains a pipeline for alignment of the 100-by-100 bp HiSeq 2000 paired 
end bisulfite sequencing reads using Bismark bisulfite mapper and methylation caller, 
and Bowtie2. Mouse mm9 build and the genome for lambda phage were used. The protocol 
uses only one sample, “SampleVG2”, for demonstration. Supplementary Tables 1-3 







Bismark version v0.13.0 was used 
Bismark_methylation_extractor experimental version (11 December 2014) by Felix Kruger 




1. Perform Quality Control on raw sequence data using fastqc on a subset of 
reads 
 
<fastqc> assesses an overall quality of the bisulfite-converted reads. Particularly 
informative are “Per Base Sequence Quality” and “Per Base Sequence Content” plots.  
 
fastqc VG2_NoIndex_L001_R1_001.fastq.gz VG2_NoIndex_L001_R2_001.fastq.gz 
 
* R1 refers to Read 1, R2 refers to Read 2 
 
 
2. Concatenate all reads of the same sample into one file, each paired end 
independently 
 
cat /Sample_VG2/VG2_NoIndex_L001_R1_0??.fastq.gz > VG2_IDX2WTSPG2_L001_R1ALL.fastq.gz 
cat /Sample_VG2/VG2_NoIndex_L001_R2_0??.fastq.gz > VG2_IDX2WTSPG2_L001_R2ALL.fastq.gz 
 
 
3. Prepare genome of interest for bisulfite alignments 
 
Bismark will create two folders within the specified directory, one for a C --> T 
converted genome, and another for the G--> A converted genome. Only one genome 
(genome.fa) should be in a folder specified. 
 
USAGE: bismark_genome_preparation [options] <path_to_genome_folder> 
 




#Prepare lambda phage genome 
/mnt/sequence/gaysinskaya/bin/bismark_genome_preparation --bowtie2  
/mnt/sequence/gaysinskaya/Bismark_bt2lambda 
 
4. Align bisulfite genome using Bowtie2 
 
USAGE: bismark [options] <genome_folder> -1 <mates1> -2 <mates2> 
 
# --bowtie2, Uses Bowtie 2 
# --bam, The output will be written out in BAM format 
# -p, Launch parallel search threads (default: 1) 
# --score_min, minimum alignment score needed for an alignment to be considered 
"valid" 
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# -1 <mates1>, Specify paired-end reads 1  
# -2 <mates1>, Specify paired-end reads 2   
# -o, indicates output folder name, otherwise, current folder 
 
Can first test the alignment using a subset of 10000 using  $bismark -u 10000 
 
#Align to mouse mm9 genome 
bismark --bowtie2 --bam -p 4 --score_min L,0,-0.4 




#Align to lambda phage genome 
bismark -q --bowtie2 --bam -p 4 --score_min L,0,-0.4 -o lambda 




5. Deduplicate reads 
 
<deduplicate_bismark> removes alignments to the same position in the genome which can 
arise by e.g. PCR amplification. Paired-end alignments are considered a duplicate if 
both partner readd start and end at the exact same position. Deduplication allows only 
1 read for each position in the genome. 
 




6. Examine M-bias table and plot to determine methylation bias 
 
Methylation state should not depend on read position. Methylation-bias (M-bias) plots 
shows methylation levels across the read positions and ought to show an overall flat 
(albeit with noise-like variation) horizontal line. See Kasper D Hansen et al, Genome 
Biology 2012 for detail.  
 
USAGE: bismark_methylation_extractor [options] <filenames>  




7. Extract methylation, while eliminating M-bias 
 
Based on M-bias analysis, we removed 6 nucleotides from the 5' end of read 1, 10 
nucleotides from the 5' end of read 2, and 1 nucleotide from 3' end of both reads 
 
USAGE: bismark_methylation_extractor [options] <filenames> 
 
# --multicore <int>, Sets the number of cores to be used for the process. 
# --gzip, Methylation files will be written out in a compressed GZIP form  
# --paired-end, Indicates that input files are paired-end 
# --no_overlap, For paired-end reads it is theoretically possible that Read 1 and Read 
2 overlap. This option avoids scoring overlapping methylation calls. 
# --report, Prints out a methylation summary and the parameters used  
# --ignore <int>, Ignore the first <int> bp from the 5’ end of Read 1 
# --ignore_r2 <int>, Ignore the first <int> bp from the 5' end of Read 2  
# --ignore_3prime <int>, Ignore the last <int> bp from the 3' end of Read 1  
# --ignore_3prime_r2 <int>, Ignore last <int> bp from the 3' end of Read 2 
# -o, Specifies name of the existing output folder  
# --comprehensive, Merge all strand-specific methylation info into 3 context-dependent 
output files: CpG-context, CHG-context and CHH-context 
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bismark_methylation_extractor --multicore 2 --gzip --paired-end --no_overlap --report  
--ignore 6  











The bismark_methylation_extractor output is tab-delimited in the following 
format (1-based coords):  
<seq-ID> <methylation state> <chromosome> <start position (= end position)> 
<methylation call>  
  
Bismark methylation extractor version v0.14.3_devel 
HWI-ST375:284:C5T2AACXX:1:1101:1132:1990_1:N:0: + chr8 117459180 Z 
HWI-ST375:284:C5T2AACXX:1:1101:1132:1990_1:N:0: + chr8 117459136 Z 
HWI-ST375:284:C5T2AACXX:1:1101:1132:1990_1:N:0: + chr8 117459111 Z 
HWI-ST375:284:C5T2AACXX:1:1101:1203:1989_1:N:0: + chr6 111824998 Z 
HWI-ST375:284:C5T2AACXX:1:1101:1203:1989_1:N:0: + chr6 111824917 Z 
 
* Methylated cytosines receive a '+' orientation, * Unmethylated cytosines receive a 
'-' orientation 
* z     unmethylated C in CpG context 
* Z     methylated C in CpG context 
 
 
8. Generate strand-specific coverage file 
 
<bismark2bedGraph> module will write out a coverage (.cov) file, and an optional 
bedGraph (.bedGraph) output. By default, only cytosines in CpG context are considered.  
 
USAGE: bismark2bedGraph [options] -o <output> [methylation extractor input files] 
 





The CpG coverage report is tab-delimited (1-based coords):  
<chromosome> <start position> <end position> <methylation percentage> <count 
methylated> <count unmethylated> 
 
chr8 3000264 3000264 100 1 0 
chr8 3001031 3001031 100 1 0 
chr8 3001165 3001165 0 0 1 
chr8 3001720 3001720 100 1 0 
 
* strand specific information per CpG is in separate line 
9. Generate final strand-merged coverage file  
 
<coverage2cytosine> module generates a cytosine methylation report for a genome of 
interest and a sorted methylation input file (.cov) produced by the script 
"bismark2bedGraph". By default, the output uses 1-based chromosome coordinates and 
reports CpG positions only (for both strands individually and not merged in any way).  
 
The option --merge_CpG will generate and post-process the genome-wide report to write 
out an additional coverage file which has the top and bottom strand methylation 
evidence pooled into a single CpG dinucleotide entity. This is the desirable input 
format for downstream processing with R-package bsseq (by K.D. Hansen).  
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 USAGE: coverage2cytosine [options] --genome_folder <path> -o <output> [input] 
 





The genome-wide cytosine report is tab-delimited (1-based coords):  
<chromosome> <position> <strand> <count methylated> <count unmethylated> <C-context> 
<trinucleotide context>  
chr8 3000264 + 1 0 CG CGT 
chr8 3000265 - 0 0 CG CGT 
chr8 3000685 + 0 0 CG CGT 
chr8 3000686 - 0 0 CG CGA 
 
The genome-wide cytosine report is tab-delimited in the following format (1-
based coords):  
<chromosome> <start position> <end position> <methylation percentage> <count 
methylated> <count unmethylated> 
 
head VG2d.merged_CpG_evidence.cov 
chr8 3000264 3000265 100.000000 1 0 
chr8 3001031 3001032 100.000000 1 0 
chr8 3001164 3001165 0.000000 0 1 
chr8 3001719 3001720 100.000000 1 0 
 
* strand specific information per CpG is merged into one line 
* The merged_CpG_evidence.cv is the final file used for all subsequent 
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Protocol 2: Analyzing WGBS with the bsseq package 
            —————————————————————————————————————— 
 
This document contains a pipeline for analyzing WGBS data with Bsseq package, 
pre-processed by Bismark.  The document focuses on analysis-related tasks and 
questions. The document does not deal with differential methylation, but uses 
bsseq package to perform basic, overall DNA methylation analysis. Supplementary 





R version 3.0.1 (2013-05-16) was used 
Bsseq version 0.10.0 was used 
 
Sample IDs: 
Group 1: VG1d (Spg1), VG3d (PL1), VG5d (L1), VG7d (Z1), VG911d (P1), VG12d 
(D1)m VG24d (Spz1) 
Group 2: VG2d (Spg2), VG4d (PL2), VG6d (L2), VG8d (Z2), VG10d (P2), VG13d (D2), 
VG14d (D3, excluded later), VG25d (Spz2) 
Group 3: VG15d (koSpg1), VG16d (koPL3), VG17d(koPL1), VG18d(koPL2), 
VG19d(koLZp1), VG21d(koLZp2) 
 
* Group 1 = WT biological replicate 1 
* Group 2 = WT biological replicate 2 





Import DNA methylation 
 
#Import group 1 
 
VG1d <- read.bismark(files = 
"/mnt/sequence/gaysinskaya/FACS_BSSEQ2014_Rep1/Sample_VG1/rawalign/methextract/
VG1d.merged_CpG_evidence.cov", sampleNames = "wtSpg1", rmZeroCov = T) 
#skip to last in the group 
VG24d <- read.bismark(files = 
"/mnt/sequence/gaysinskaya/methylation/map/VG24/methextract/VG24d.merged_CpG_ev
idence.cov", sampleNames = "wtSpz1", rmZeroCov = T) 
 
#Import group 2 
 
VG2d <- read.bismark(files = 
"/mnt/sequence/gaysinskaya/FACS_BSSEQ2014_Rep2/Sample_VG2/rawalign/methextract/
VG2d.merged_CpG_evidence.cov", sampleNames = "wtSpg2", rmZeroCov = T) 
#skip to 
VG25d <- read.bismark(files = 
"/mnt/sequence/gaysinskaya/methylation/map/VG25/methextract/VG25d.merged_CpG_ev
idence.cov", sampleNames = "wtSpz2", rmZeroCov = T) 
 
#Import group 3 
 
VG15d <- read.bismark(files = 
"/mnt/sequence/gaysinskaya/methylation/map/VG15/methextract/VG15d.merged_CpG_ev
idence.cov", sampleNames = "koSpg1", rmZeroCov = T) 
#skip to 
VG21d <- read.bismark(files = 
"/mnt/sequence/gaysinskaya/methylation/map/VG21/methextract/VG21d.merged_CpG_ev
idence.cov", sampleNames = "koLZP2", rmZeroCov = T) 
 
Obtain "raw" CpG coverage and methylation levels 
***Summary for all samples can be found in Supplementary Table 3 
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#Calculate mean "raw" methylation levels 
colMeans(getMeth(VG1d, type = "raw")) 
#[1] 0.810014 
 
#Repeat for all samples 
 
 
Extract "raw" DNA methylation and coverage for CpGs covered in common 
by all samples in a group (common CpGs).  
Note, common CpGs were calculated per group (see above) 
 
### Extract "raw" DNA methylation and coverage for common CpGs  
 
#Combine and save 
VG_WTrep1_full <- combineList(list(VG1d, VG3d, VG5d, VG7d, VG911d, VG12d, 
VG24d)) 
save(VG_WTrep1_full, file = "VG_WTrep1_full.rda") 
 
VG_WTrep1_full 
# An object of type 'BSseq' with 
#   21046103 methylation loci 
#   7 samples 
# has not been smoothed 
 
#Examine how many CpGs are covered in common between all samples 
sum(rowSums(getCoverage(VG_WTrep1_full) >=1) == 7) 
#[1] 13882854 
 
#Extract and export coverage file of all CpGs in a file 
VG_WTrep1_full.cov <- getCoverage(VG_WTrep1_full) 
save(VG_WTrep1_full.cov, file = "VG_WTrep1_full.cov") 
 
#Select and export coverage file of common CpGs 
VG_WTrep1_full_keepLoci <- which(rowSums(VG_WTrep1_full.cov[ , ] >=1) == 7) 
save(VG_WTrep1_full_keepLoci, file = "VG_WTrep1_full_keepLoci.rda") 
 
#subset raw methylation data for common CpGs 
VG_WTrep1_full_raw_fit_Loci <- VG_WTrep1_full[VG_WTrep1_full_keepLoci, ] 
save(VG_WTrep1_full_raw_fit_Loci, file = "VG_WTrep1_full_raw_fit_Loci.rda")  
 
#Check that number of CpGs matches the number of common CpGs 
VG_WTrep1_full_raw_fit_Loci 
# An object of type 'BSseq' with 
#   13882854 methylation loci 
#   7 samples 
# has not been smoothed 
 
#Repeat for other groups.   
 
 
Summarize raw Methylation and Plot "raw" CpG methylation across common 
CpGs 
***Summary for all samples can be found in Supplementary Table 5  
 
x <- getMeth(VG_WTrep1_full_raw_fit_Loci, type = "raw") 
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colnames(x) <- c("Spg1","PL1", "L1", "Z1", "P1", "D1", "Spz1") 
 
y <- getMeth(VG_WTrep2_full_raw_fit_Loci[, c(1:6,8)], type = "raw") 
colnames(y) <- c("Spg2","PL2", "L2", "Z2", "P2", "D2", "Spz2") 
 
head(x) 
# Spg1 PL1        L1        Z1 P1 D1 Spz1 
# [1,]    1 1.0 0.8000000 0.7500000  1  1    0 
# [2,]    1 1.0 0.2000000 0.8000000  1  1    1 
# [3,]    1 1.0 0.0000000 1.0000000  1  1    1 
# [4,]    1 1.0 0.6666667 1.0000000  1  1    1 
# [5,]    1 1.0 1.0000000 0.7142857  1  1    1 




#Combine biological replicates into one column and rename 
bind <- rbind(x,y) 
colnames(bind) <- c("Spg","PL", "L", "Z", "P", "D", "Spz") 
 
#Summarize methylation in bins 
binsbind <- rep( 1:(nrow(bind)/500), each=500 ) 
testbind <- as.matrix( aggregate( bind, list(binsbind[1:nrow(bind)]), 
na.rm=TRUE, mean ) ) 
 
summary(testbind) 
#     Group.1           Spg                PL                L           
#  Min.   :    1   Min.   :0.08282   Min.   :0.05611   Min.   :0.07197   
#  1st Qu.:14478   1st Qu.:0.78422   1st Qu.:0.65979   1st Qu.:0.71665   
#  Median :28954   Median :0.84827   Median :0.72189   Median :0.77411   
#  Mean   :28954   Mean   :0.82771   Mean   :0.70979   Mean   :0.76059   
#  3rd Qu.:43431   3rd Qu.:0.89472   3rd Qu.:0.77569   3rd Qu.:0.82345   
#  Max.   :57908   Max.   :0.97644   Max.   :0.92996   Max.   :0.94939   
#        Z                 P                 D                Spz         
#  Min.   :0.06248   Min.   :0.07493   Min.   :0.07474   Min.   :0.0774   
#  1st Qu.:0.74953   1st Qu.:0.79943   1st Qu.:0.80631   1st Qu.:0.8077   
#  Median :0.81008   Median :0.86528   Median :0.87270   Median :0.8744   
#  Mean   :0.79211   Mean   :0.84371   Mean   :0.85111   Mean   :0.8527   
#  3rd Qu.:0.85672   3rd Qu.:0.91486   3rd Qu.:0.92390   3rd Qu.:0.9248   
#  Max.   :0.95725   Max.   :0.97877   Max.   :0.97852   Max.   :0.9847   
 




Plot "raw" CpG methylation across common CpGs 
***Summary for all samples can be found in Figure 2A 
 
Reps = read.table("VG_WTreps_full_RawMeth_Bin500.txt") 
 
png(filename = "boxplot.WTReps_RawMeth_full_Bin500_colors2.png", width = 800, 
height = 500, units = "px") 
par(mar=c(4.1, 4.1, 4.1, 2), font.axis=2, font.lab=2, cex.lab = 1.8, cex.axis = 
2.2, las=0.5) 
boxplot(Reps[, c(2:8)], range =0, ylim=c(0,1), axes=T,  
col=c("blue","red", "green", "orange", "dark violet", "sky blue", "grey"), 
names= c("Spg", "PL", "L", "Z", "P", "D", "Spz"),  
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Protocol 3. Analysis of DMRs with bsseq package 
 
This Protocol was written and executed by Valeriya Gaysinskaya, with guidance 
from Kasper Daniel Hansen. 
The Protocol was adopted from “Analyzing WGBS with the bases package" by Kasper 
Daniel Hansen. 
 
This document contains a pipeline for extracing and analyzing Differentially 
Methylated Regions (DMRs) from WGBS data with Bsseq package, pre-processed by 





R version 3.0.1 (2013-05-16) was used 
Bsseq version 0.10.0 was used 
 
Sample IDs (here, samples were grouped based on their Illumina Sequencing 
date): 
Group 1: VG1d (Spg1), VG3d (PL1), VG5d (L1), VG7d (Z1), VG911d (P1), VG12d (D1) 
Group 2: VG2d (Spg2), VG4d (PL2), VG6d (L2), VG8d (Z2), VG10d (P2), VG13d (D2), 
VG14d (D3, excluded) 
Group 3: VG15d (koSpg1), VG16d (koPL3), VG17d(koPL1), VG18d(koPL2), 
VG19d(koLZp1), VG21d(koLZp2), VG24d (Spz1), VG25d (Spz2) 
 
* Group 1 = WT biological replicate 1 
* Group 2 = WT biological replicate 2 
* Group 3 = Mael-/- biological replicates 1 and 2 
 
 
PART I: IMPORT, COMBINE and SPLIT. 
 








#Import datasets  
 
#Import group 1 
 
VG1d <- read.bismark(files = 
"/mnt/sequence/gaysinskaya/FACS_BSSEQ2014_Rep1/Sample_VG1/rawalign/methextract/
VG1d.merged_CpG_evidence.cov", sampleNames = "wtSpg1", rmZeroCov = T) 
#skip to last in the group 
VG12d <- read.bismark(files = 
"/mnt/sequence/gaysinskaya/FACS_BSSEQ2014_Rep1/Sample_VG12/rawalign/methextract
/VG12d.merged_CpG_evidence.cov", sampleNames = "wtD1", rmZeroCov = T) 
 
# Combine and save 
VG_WTrep1 <- combineList(list(VG1d, VG3d, VG5d, VG7d, VG911d, VG12d)) 
save(VG_WTrep1, file = "VG_WTrep1.rda") 
 
 
#Import group 2 
 
VG2d <- read.bismark(files = 
"/mnt/sequence/gaysinskaya/FACS_BSSEQ2014_Rep2/Sample_VG2/rawalign/methextract/
VG2d.merged_CpG_evidence.cov", sampleNames = "wtSpg2", rmZeroCov = T) 
#skip to last in the group 
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VG14d <- read.bismark(files = 
"/mnt/sequence/gaysinskaya/methylation/map/VG14/methextract/VG14d.merged_CpG_ev
idence.cov", sampleNames = "wtD3", rmZeroCov = T) 
 
#Combine and save 
VG_WTrep2 <- combineList(list(VG2d, VG4d, VG6d, VG8d, VG10d, VG13d, VG14d)) 
save(VG_WTrep2, file = "VG_WTrep2.rda") 
 
#Import group 3 
 
VG15d <- read.bismark(files = 
"/mnt/sequence/gaysinskaya/methylation/map/VG15/methextract/VG15d.merged_CpG_ev
idence.cov", sampleNames = "koSpg1", rmZeroCov = T) 
#skip to last in the group 
VG25d <- read.bismark(files = 
"/mnt/sequence/gaysinskaya/methylation/map/VG25/methextract/VG25d.merged_CpG_ev
idence.cov", sampleNames = "wtSP2", rmZeroCov = T) 
 
###Note, that koSpg2 is actually a koPL3 sample!!!! 
 
#Combine and save 
VG_bsseq3 <- combineList(list(VG15d, VG16d, VG17d, VG18d, VG19d, VG21d, VG24d, 
VG25d)) 





Summarize CpG coverage, DNA methylation and total number of CpGs covered 
(mappable CpGs) 






# An object of type 'BSseq' with 
#   19255878 methylation loci 
#   1 samples 
# has not been smoothed 
 
#skip to last 
 
VG12d 
# An object of type 'BSseq' with 
#   20491322 methylation loci 
#   1 samples 




# Total # of CpGs 
#Average Meth 
 





colMeans(getMeth(VG1d, type = "raw")) 
#[1] 0.810014 
 
#skip to the last 
 









From the above evaluation, we can see that each sample was covered at a 
slightly different depth, covering a slightly different number of CpGs. By 
combining samples into one group above we accounted for more genomic CpGs. 
Where the CpG coverage is zero, combining samples resultit in the non-covered 





For DMR analysis it is important to account for most CpGs spatially. Thus, even 
if a particular CpG is not available for analysis and is 'NA', leaving that 
unavailable CpG is important for the Bsseq package to know that there is a CpG 
there. Thus, instead of using individual samples that were originally imported 
into Bsseq, it is recommended, instead, to split the combined file into 
individual samples (thus accounting for more CpG sites). 
 




#Split samples from Group 1 
 
VG1c <- VG_WTrep1[, 1] 
save(VG1c, file = "VG1c.rda") 
#skip to last 
VG12c <- VG_WTrep1[, 6] 
save(VG12c, file = "VG12c.rda") 
 
#Split samples from Group 2 
 
VG2c <- VG_WTrep2[, 1] 
save(VG2c, file = "VG2c.rda") 
#skip to last 
VG14c <- VG_WTrep2[, 7] 
save(VG14c, file = "VG14c.rda") 
 
#Split samples from Group 3 
 
VG15c <- VG_bsseq3[, 1] 
save(VG15c, file = "VG15c.rda") 
#skip to last 
VG25c <- VG_bsseq3[, 8] 




Part II. PREPARE SAMPLES FOR PAIRWISE DMR ANALYSIS.  
 
In Part II, biological replicates of a pairwise comparison are combined for a 
2x2 analysis. 
'Random' chromosomes are eliminated, because they are very short, and lead to 
false interpretations. 
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#Combine into one file 
WTSpgPL <- combineList(list(VG1c, VG3c, VG2c, VG4c)) 
save(WTSpgPL, file = "WTSpgPL.rda") 
 
WTSpgPL 
# An object of type 'BSseq' with 
#   21140248 methylation loci 
#   4 samples 




#      [,1] [,2] [,3] [,4] 
# [1,]    6    3    4    8 
# [2,]    3    3    1    4 
# [3,]    3    1    0    1 
# [4,]    4    0    2    7 
# [5,]    5    1    3    4 
# [6,]    6    1    2    4 
 
#Examine the number of CpG sites covered by all 4 samples at least once 
sum(rowSums(getCoverage(WTSpgPL) >=1) == 4) 
#[1] 16838779 
 
# Get a summary of CpG coverage 
summary(getCoverage(WTSpgPL)) 
#        V1                 V2                 V3                V4           
#  Min.   :    0.00   Min.   :    0.00   Min.   :    0.0   Min.   :    0.00   
#  1st Qu.:    2.00   1st Qu.:    1.00   1st Qu.:    2.0   1st Qu.:    3.00   
#  Median :    3.00   Median :    3.00   Median :    4.0   Median :    5.00   
#  Mean   :    3.35   Mean   :    3.07   Mean   :    4.4   Mean   :    5.02   
#  3rd Qu.:    4.00   3rd Qu.:    4.00   3rd Qu.:    6.0   3rd Qu.:    7.00   
#  Max.   :72672.00   Max.   :63392.00   Max.   :73959.0   Max.   :67439.00   
 
 
#Examine Random Chromosomes and decide which to eliminate 
 
seqnames(WTSpgPL) 
# factor-Rle of length 21140248 with 35 runs 
#   Lengths:      1452905      1090019      1154052 ...        13798       
186820 
#   Values :         chr1        chr10        chr11 ...         chrY  
chrY_random 
# Levels(35): chr1 chr10 chr11 chr12 chr13 ... chrX chrX_random chrY 
chrY_random 
 
#Examine chromosome names 
seqnames(WTSpgPL)@values 
#  [1] chr1         chr10        chr11        chr12        chr13        
#  [6] chr13_random chr14        chr15        chr16        chr16_random 
# [11] chr17        chr17_random chr18        chr19        chr1_random  
# [16] chr2         chr3         chr3_random  chr4         chr4_random  
# [21] chr5         chr5_random  chr6         chr7         chr7_random  
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# [26] chr8         chr8_random  chr9         chr9_random  chrM         
# [31] chrUn_random chrX         chrX_random  chrY         chrY_random  
# 35 Levels: chr1 chr10 chr11 chr12 chr13 chr13_random chr14 chr15 ... 
chrY_random 
 
#Examine lengths of chromosomes 
seqnames(WTSpgPL)@lengths 
# [1] 1452905 1090019 1154052  935939  963041     755  910348  860439  744977 
# [10]      19  835358     729  714134  552845    7768 1495101 1173611      22 
# [19] 1299246    1245 1329239     204 1147014 1187167     450 1111831    3337 
# [28] 1057470    2491     273   16770  888289    2542   13798  186820 
 
#Connect chr name with chr length for easy visualization and subsequent double 
checking of final length 
cbind( seqnames(WTSpgPL)@lengths, seqlevels(WTSpgPL)) 
#      [,1]      [,2]           
#  [1,] "1452905" "chr1"         
#  [2,] "1090019" "chr10"        
#  [3,] "1154052" "chr11"        
#  [4,] "935939"  "chr12"        
#  [5,] "963041"  "chr13"        
#  [6,] "755"     "chr13_random" 
#  [7,] "910348"  "chr14"        
#  [8,] "860439"  "chr15"        
#  [9,] "744977"  "chr16"        
# [10,] "19"      "chr16_random" 
# [11,] "835358"  "chr17"        
# [12,] "729"     "chr17_random" 
# [13,] "714134"  "chr18"        
# [14,] "552845"  "chr19"        
# [15,] "7768"    "chr1_random"  
# [16,] "1495101" "chr2"         
# [17,] "1173611" "chr3"         
# [18,] "22"      "chr3_random"  
# [19,] "1299246" "chr4"         
# [20,] "1245"    "chr4_random"  
# [21,] "1329239" "chr5"         
# [22,] "204"     "chr5_random"  
# [23,] "1147014" "chr6"         
# [24,] "1187167" "chr7"         
# [25,] "450"     "chr7_random"  
# [26,] "1111831" "chr8"         
# [27,] "3337"    "chr8_random"  
# [28,] "1057470" "chr9"         
# [29,] "2491"    "chr9_random"  
# [30,] "273"     "chrM"         
# [31,] "16770"   "chrUn_random" 
# [32,] "888289"  "chrX"         
# [33,] "2542"    "chrX_random"  
# [34,] "13798"   "chrY"         
# [35,] "186820"  "chrY_random"  
 
#Drop the chromosomes listed below and retain the rest: 
#Also Retain chr1_random only: largest chromosome in mouse genome, so even 
random contig presumably contains enough information 
#Also, retain "chrX_random" and "chrY_random" 
 
# [6,] "755"     "chr13_random" 
# [10,] "19"      "chr16_random" 
# [12,] "729"     "chr17_random" 
# [18,] "22"      "chr3_random" 
# [20,] "1245"    "chr4_random"  
# [22,] "204"     "chr5_random"  
# [25,] "450"     "chr7_random"  
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# [27,] "3337"    "chr8_random"  
# [29,] "2491"    "chr9_random"  
# [30,] "273"     "chrM"  
# [31,] "16770"   "chrUn_random" 
 
Eliminate unwanted random chromosomes 
 
#force - TRUE. Force dropping sequence levels currently in use. 
# seqlevels(WTSpgPL, force=TRUE) <- seqlevels(WTSpgPL)[seqlevels(WTSpgPL) != 
c("chr13_random")] 
# seqlevels(WTSpgPL, force=TRUE) <- seqlevels(WTSpgPL)[seqlevels(WTSpgPL) != 
c("chr16_random")] 
# seqlevels(WTSpgPL, force=TRUE) <- seqlevels(WTSpgPL)[seqlevels(WTSpgPL) != 
c("chr17_random")] 
# seqlevels(WTSpgPL, force=TRUE) <- seqlevels(WTSpgPL)[seqlevels(WTSpgPL) != 
c("chr3_random")] 
# seqlevels(WTSpgPL, force=TRUE) <- seqlevels(WTSpgPL)[seqlevels(WTSpgPL) != 
c("chr4_random")] 
# seqlevels(WTSpgPL, force=TRUE) <- seqlevels(WTSpgPL)[seqlevels(WTSpgPL) != 
c("chr5_random")] 
# seqlevels(WTSpgPL, force=TRUE) <- seqlevels(WTSpgPL)[seqlevels(WTSpgPL) != 
c("chr7_random")] 
# seqlevels(WTSpgPL, force=TRUE) <- seqlevels(WTSpgPL)[seqlevels(WTSpgPL) != 
c("chr8_random")] 
# seqlevels(WTSpgPL, force=TRUE) <- seqlevels(WTSpgPL)[seqlevels(WTSpgPL) != 
c("chr9_random")] 
# seqlevels(WTSpgPL, force=TRUE) <- seqlevels(WTSpgPL)[seqlevels(WTSpgPL) != 
c("chrM")] 
# seqlevels(WTSpgPL, force=TRUE) <- seqlevels(WTSpgPL)[seqlevels(WTSpgPL) != 
c("chrUn_random")] 
 
WTSpgPL_rm <- WTSpgPL 
save(WTSpgPL_rm, file = "WTSpgPL_rm.rda") 
rm WTSpgPL 
 
#Explore Bsseq object after removing unwanted chr 
WTSpgPL_rm 
# An object of type 'BSseq' with 
#   21113953 methylation loci 
#   4 samples 
# has not been smoothed 
 
summary(getCoverage(WTSpgPL_rm)) 
#        V1                 V2                 V3                 V4           
#  Min.   :    0.00   Min.   :    0.00   Min.   :    0.00   Min.   :    0.00   
#  1st Qu.:    2.00   1st Qu.:    1.00   1st Qu.:    2.00   1st Qu.:    3.00   
#  Median :    3.00   Median :    3.00   Median :    4.00   Median :    5.00   
#  Mean   :    3.34   Mean   :    3.07   Mean   :    4.39   Mean   :    5.02   
#  3rd Qu.:    4.00   3rd Qu.:    4.00   3rd Qu.:    6.00   3rd Qu.:    7.00   





Part III. SMOOTHING 
 
Previously we determined that there are zero coverage CpGs in every sample, and 
that they can be different for each sample.  In Part III, the DNA methylation 
level in a genomic regions is smoothed, using local likelihood estimation, for 
each sample. As a result, after smoothiing, every CpG in the objectect has an 
estimated methylation value, based on information from covered CpGs. 
 
Smoothing was done by chromosome using large DMR settings as outlined in Kasper 
D Hansen et al, Genome Biology 2012). 
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For smoothing in large blocks, a window size of 500 CpGs or 20,000 basepairs, 
whichever was larger, was used for smoothing. 




WTSpgPL_LGsmooth <- BSmooth(WTSpgPL_rm, parallelBy = c("chromosome"), ns = 500, 
h = 20000, maxGap = 10^8, mc.cores = 1, verbose = T) 
save(WTSpgPL_LGsmooth, file = "WTSpgPL_LGsmooth.rda") 
 
#[BSmooth] smoothing done in 3847.1 sec 
 
An object of type 'BSseq' with 
#   21113953 methylation loci 
#   4 samples 
# has been smoothed with 
#   BSmooth (ns = 500, h = 20000, maxGap = 100000000)  
 
#The coverage should not change 
summary(getCoverage(WTSpgPL_LGsmooth)) 
#        V1                 V2                 V3                 V4           
#  Min.   :    0.00   Min.   :    0.00   Min.   :    0.00   Min.   :    0.00   
#  1st Qu.:    2.00   1st Qu.:    1.00   1st Qu.:    2.00   1st Qu.:    3.00   
#  Median :    3.00   Median :    3.00   Median :    4.00   Median :    5.00   
#  Mean   :    3.34   Mean   :    3.07   Mean   :    4.39   Mean   :    5.02   
#  3rd Qu.:    4.00   3rd Qu.:    4.00   3rd Qu.:    6.00   3rd Qu.:    7.00   
#  Max.   :72672.00   Max.   :63392.00   Max.   :73959.00   Max.   :67439.00  
 
#The raw DNA methylation values have been smoothed  
summary(getMeth(WTSpgPL_LGsmooth, type = "smooth")) 
#    wtSpg1           wtPL1               wtSpg2              wtPL2         
#  Min.   :0.0000   Min.   :0.0000018   Min.   :0.0000895   Min.   :0.01287   
#  1st Qu.:0.7437   1st Qu.:0.6090292   1st Qu.:0.7305578   1st Qu.:0.65196   
#  Median :0.8737   Median :0.7081948   Median :0.8521176   Median :0.76311   
#  Mean   :0.8099   Mean   :0.6725245   Mean   :0.7906918   Mean   :0.71570   
#  3rd Qu.:0.9297   3rd Qu.:0.7636447   3rd Qu.:0.9024897   3rd Qu.:0.81378   
#  Max.   :1.0000   Max.   :1.0000000   Max.   :1.0000000   Max.   :1.00000   
 
#The raw DNA methylation profile, before smoothing, contains many NA values 
summary(getMeth(WTSpgPL_LGsmooth, type = "raw"))  
#        V1                V2                V3                V4          
#  Min.   :0.0       Min.   :0.0       Min.   :0.0       Min.   :0.0       
#  1st Qu.:0.8       1st Qu.:0.5       1st Qu.:0.7       1st Qu.:0.6       
#  Median :1.0       Median :0.8       Median :1.0       Median :0.8       
#  Mean   :0.8       Mean   :0.7       Mean   :0.8       Mean   :0.7       
#  3rd Qu.:1.0       3rd Qu.:1.0       3rd Qu.:1.0       3rd Qu.:1.0       
#  Max.   :1.0       Max.   :1.0       Max.   :1.0       Max.   :1.0       





Part IV. COMPUTING t-statistics 
 
A. Before computing t-statistics, CpGs with no coverage are removed, otherwise, 
most likely resulting in false positives. For this analysis we will only keep 





#Extract covrage into a separate matrix 
WTSpgPL_LGsmooth.cov <- getCoverage(WTSpgPL_LGsmooth) 
save(WTSpgPL_LGsmooth.cov, file = "WTSpgPL_LGsmooth.cov") 
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#Check the number of CpGs covered by all four samples at least once (common 
CpGs) 
sum(rowSums(getCoverage(WTSpgPL_LGsmooth[ , ]) >=1) == 4) 
#[1] 16825193 
 
#Select for coverage of common CpGs  
WTSpgPL_keepLociLG <- which(rowSums(WTSpgPL_LGsmooth.cov[ , ] >=1) == 4) 
save(WTSpgPL_keepLociLG, file = "WTSpgPL_keepLociLG.rda") 
 
#Subset smoothed data with select common loci  
WTSpgPL_fit_lociLG <- WTSpgPL_LGsmooth[WTSpgPL_keepLociLG, ] 
save(WTSpgPL_fit_lociLG, file = "WTSpgPL_fit_lociLG.rda") 
WTSpgPL_fit_lociLG 
# An object of type 'BSseq' with 
#   16825193 methylation loci 
#   4 samples 
# has been smoothed with 
#   BSmooth (ns = 500, h = 20000, maxGap = 100000000)  
 
summary(getCoverage(WTSpgPL_fit_lociLG)) 
#       V1                 V2                 V3                V4          
#  Min.   :    1.00   Min.   :    1.00   Min.   :    1.0   Min.   :    1.0   
#  1st Qu.:    2.00   1st Qu.:    2.00   1st Qu.:    3.0   1st Qu.:    3.0   
#  Median :    3.00   Median :    3.00   Median :    4.0   Median :    5.0   
#  Mean   :    3.83   Mean   :    3.56   Mean   :    4.9   Mean   :    5.6   
#  3rd Qu.:    5.00   3rd Qu.:    4.00   3rd Qu.:    6.0   3rd Qu.:    7.0   
#  Max.   :72672.00   Max.   :63392.00   Max.   :73959.0   Max.   :67439.0   
 
summary(getMeth(WTSpgPL_fit_lociLG)) 
#      wtSpg1            wtPL1            wtSpg2            wtPL2         
#  Min.   :0.01288   Min.   :0.0243   Min.   :0.01679   Min.   :0.02175   
#  1st Qu.:0.76614   1st Qu.:0.6217   1st Qu.:0.75067   1st Qu.:0.66745   
#  Median :0.88229   Median :0.7120   Median :0.85893   Median :0.76765   
#  Mean   :0.82250   Mean   :0.6791   Mean   :0.80209   Mean   :0.72377   
#  3rd Qu.:0.93245   3rd Qu.:0.7649   3rd Qu.:0.90475   3rd Qu.:0.81513   




B. T-statistics are formed as the difference in means between group 1 and group 
2 (group1 -  group2) divided by an estimate of the standard deviation, assuming 
that the variance in the two groups is paired samples (paired). The standard 
deviation estimates are then smoothed (using a running mean with a width of k) 
and thresholded (using qSd which sets the minimum standard deviation to be the 
qSd-quantile). The parameters used are as described in Kasper D Hansen et al, 
Genome Biology 2012, where the standard errors were smoothed using a running 
mean with a window size of 101 observations, and the threshold for the standard 
deviation of its 75th percentile was applied. 
 
```{r} 
WTSpgPL_fit_lociLG.tstat <- BSmooth.tstat(WTSpgPL_fit_lociLG, 
                                       group1 = c(1, 3), 
                                        group2 = c(2, 4), 
                                        maxGap = 100000000,  
                                        local.correct = FALSE, 
                                        estimate.var = "paired", 
                                        qSd = 0.75, 
                                        k = 101, 
                                        mc.cores = 1, 
                                        verbose = TRUE) 
 
save(WTSpgPL_fit_lociLG.tstat, file = "WTSpgPL_fit_lociLG.tstat.rda") 
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WTSpgPL_fit_lociLG.tstat 
# An object of type 'BSseqTstat' with 
#   16825193 methylation loci 
# based on smoothed data: 
#   BSmooth (ns = 500, h = 20000, maxGap = 100000000)  
# with parameters 
#   BSmooth.tstat (local.correct = FALSE, maxGap = 100000000)  
 
summary(WTSpgPL_fit_lociLG.tstat@stats) 
#     rawSds           tstat.sd        group2.means      group1.means     
#  Min.   :0.00000   Min.   :0.01041   Min.   :0.02519   Min.   :0.01483   
#  1st Qu.:0.02917   1st Qu.:0.05028   1st Qu.:0.64527   1st Qu.:0.75853   
#  Median :0.05044   Median :0.05153   Median :0.74099   Median :0.87046   
#  Mean   :0.05258   Mean   :0.05475   Mean   :0.70145   Mean   :0.81230   
#  3rd Qu.:0.07202   3rd Qu.:0.05469   3rd Qu.:0.78849   3rd Qu.:0.91830   
#  Max.   :0.37692   Max.   :0.24981   Max.   :0.99736   Max.   :0.99996   
#      tstat        
#  Min.   :-5.648   
#  1st Qu.: 1.403   
#  Median : 2.169   
#  Mean   : 2.046   
#  3rd Qu.: 2.807   





Part V. FINDING DMRs 
 
Once t-statistics have been computed, we can compute differentially methylated 
regions (DMRs) by thresholding the t-statistics. Here we use a quintile-based 





#Define ALL LG (LARGE) DMRs  
 
WTSpgPL_LGdmr0 <- dmrFinder(WTSpgPL_fit_lociLG.tstat, maxGap = 10000, stat = 
"tstat", cutoff = c(-2, 2), verbose = TRUE) 
save(WTSpgPL_LGdmr0 , file = "WTSpgPL_LGdmr0.rda") 
 
# To detect large DMR blocks, specify that a block needs to be at least 5kb in 
size 
WTSpgPL_LGdmrs <- WTSpgPL_LGdmr0[WTSpgPL_LGdmr0$width >= 5000, ] 





#     idxEnd            cluster             n               width         
#  Min.   :    6566   Min.   :   1.0   Min.   :    2.0   Min.   :   5000   
#  1st Qu.: 4274762   1st Qu.:  70.0   1st Qu.:  129.0   1st Qu.:  16786   
#  Median : 8497647   Median : 182.0   Median :  257.0   Median :  35223   
#  Mean   : 8587683   Mean   : 223.1   Mean   :  495.9   Mean   :  72252   
#  3rd Qu.:12941212   3rd Qu.: 343.0   3rd Qu.:  563.0   3rd Qu.:  80898   
#  Max.   :16825186   Max.   :1631.0   Max.   :12215.0   Max.   :1972045   
#                                                                          
#    invdensity        areaStat          maxStat          meanDiff       
#  Min.   :  39.3   Min.   : -495.6   Min.   :-2.894   Min.   :-0.2498   
#  1st Qu.: 101.4   1st Qu.:  299.5   1st Qu.: 2.414   1st Qu.: 0.1176   
#  Median : 129.2   Median :  653.2   Median : 2.883   Median : 0.1342   
#  Mean   : 161.2   Mean   : 1374.0   Mean   : 2.961   Mean   : 0.1356   
#  3rd Qu.: 182.8   3rd Qu.: 1526.5   3rd Qu.: 3.447   3rd Qu.: 0.1535   
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#  Max.   :4821.5   Max.   :39755.2   Max.   : 9.569   Max.   : 0.3337   
#                                                                        
#   group1.mean      group2.mean        tstat.sd        direction         
#  Min.   :0.2043   Min.   :0.1818   Min.   :0.01244   Length:19019       
#  1st Qu.:0.8175   1st Qu.:0.6760   1st Qu.:0.05078   Class :character   
#  Median :0.8708   Median :0.7284   Median :0.05263   Mode  :character   
#  Mean   :0.8484   Mean   :0.7128   Mean   :0.05384                      
#  3rd Qu.:0.9041   3rd Qu.:0.7679   3rd Qu.:0.05545                      
#  Max.   :0.9644   Max.   :0.8640   Max.   :0.10565          
 






#[1]  1374153075 
 
 
#Total # of CpG loci 
x <- WTSpgPL_LGdmrs[WTSpgPL_LGdmrs$direction == "hyper", ] 
y <- WTSpgPL_LGdmrs[WTSpgPL_LGdmrs$direction == "hypo", ] 
 
#Summarize, e.g., Hypermethylated DMRs (hyper in Spg, hypo in PL)  
summary(x) 
#    idxEnd            cluster           n               width         
#  Min.   :    6566   Min.   :   1   Min.   :    2.0   Min.   :   5000   
#  1st Qu.: 4269070   1st Qu.:  70   1st Qu.:  130.0   1st Qu.:  16926   
#  Median : 8494976   Median : 182   Median :  258.0   Median :  35440   
#  Mean   : 8583517   Mean   : 223   Mean   :  497.4   Mean   :  72479   
#  3rd Qu.:12935981   3rd Qu.: 343   3rd Qu.:  565.0   3rd Qu.:  81170   
#  Max.   :16825186   Max.   :1631   Max.   :12215.0   Max.   :1972045   
#                                                                        
#    invdensity         areaStat           maxStat         meanDiff       
#  Min.   :  40.08   Min.   :    4.18   Min.   :2.003   Min.   :0.02971   
#  1st Qu.: 101.52   1st Qu.:  302.26   1st Qu.:2.419   1st Qu.:0.11778   
#  Median : 129.28   Median :  655.91   Median :2.886   Median :0.13429   
#  Mean   : 161.06   Mean   : 1379.81   Mean   :2.979   Mean   :0.13662   
#  3rd Qu.: 182.89   3rd Qu.: 1530.16   3rd Qu.:3.449   3rd Qu.:0.15355   
#  Max.   :4821.50   Max.   :39755.16   Max.   :9.569   Max.   :0.33366   
#                                                                         
#   group1.mean      group2.mean        tstat.sd        direction         
#  Min.   :0.3310   Min.   :0.1818   Min.   :0.01244   Length:18951       
#  1st Qu.:0.8184   1st Qu.:0.6768   1st Qu.:0.05078   Class :character   
#  Median :0.8712   Median :0.7287   Median :0.05263   Mode  :character   
#  Mean   :0.8500   Mean   :0.7134   Mean   :0.05384                      
#  3rd Qu.:0.9043   3rd Qu.:0.7680   3rd Qu.:0.05546                      
#  Max.   :0.9644   Max.   :0.8640   Max.   :0.10565  
 
 








#Write out final dmr.txt file 
write.table(x=WTSpgPL_LGdmrs, file="WTSpgPL_LGdmrs.txt", sep="\t", row.names= 
FALSE, quote=FALSE) 
write.table(x=x, file="WTSpgPL_LGdmrs_hyper.txt", sep="\t", row.names= FALSE, 
quote=FALSE) 
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write.table(x=y, file="WTSpgPL_LGdmrs_hypo.txt", sep="\t", row.names= FALSE, 
quote=FALSE) 
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COMPUTATIONAL SCRIPTS 1-7: Processing of Illumina Bisulfite-seq reads 
 
# This pipeline is for the processing of Illumina Bisulfite-Sequencing reads, 
sequenced on HiSeq2000. The goal is to obtain a file containing CpG methylation 
evidence (methylation values and coverage data). 
## The pipeline uses a subset of samples from sequencing run 1 for 
demonstration, and includes samples 1,3,5,7,9 and 12 corresponding to wild-type 




### Script1: Concatenate all fastq.gz files and run FASTQ analysis 
      
#!/bin/bash 
 
# This script is "doGenerateFastq-WT-Rep1.sh" 
# This file concatenates all fastq.gz files for a particular sample and runs 
FASTQ analysis for wild-type (WT) samples of sequencing run 1 (sequenced on 
HiSeq2000) 
 
# view FASTQ directory and examine sample folders 





#SAMPLE="1 3 5 7 9 12" 
 
mkdir -p rawdata 
cd rawdata 
 
###For all samples 
for i in $SAMPLE 
do 
echo "Concatenating VG$i (Read 1)" 
  cat $FASTQ_DIR/Sample_VG$i/*_R1_*.fastq.gz > VG$i\_R1.fastq.gz 
  echo "Concatenating VG$i (Read 2)" 
  cat $FASTQ_DIR/Sample_VG$i/*_R2_*.fastq.gz > VG$i\_R2.fastq.gz 
  fastqc VG$i\_R1.fastq.gz & 
  fastqc VG$i\_R2.fastq.gz & 
done 




### Script2: Concatenate different samples, if necessary (e.g., to increase 
coverage) 






#mkdir -p rawdata 
#cd rawdata 
 
 # echo "Concatenating Sample VG9 with Sample VG11 (Read 1)" 
 # cat $FASTQ_DIR/VG9_R1.fastq.gz $FASTQ_DIR/VG11_R1.fastq.gz > 
VG911\_R1.fastq.gz 
 # echo "Concatenating Sample VG9 with Sample VG11 (Read 2)" 
 # cat $FASTQ_DIR/VG9_R2.fastq.gz $FASTQ_DIR/VG11_R2.fastq.gz > 
VG911\_R2.fastq.gz 
 # fastqc VG911_R1.fastq.gz & 
 # fastqc VG911_R2.fastq.gz & 
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mkdir -p rawdata 
cd rawdata 
 
  echo "Concatenating Sample VG19 with Sample VG20 (Read 1)" 
  cat $FASTQ_DIR/VG19_R1.fastq.gz $FASTQ_DIR/VG20_R1.fastq.gz > 
VG1920\_R1.fastq.gz 
  echo "Concatenating Sample VG19 with Sample VG20 (Read 2)" 
  cat $FASTQ_DIR/VG19_R2.fastq.gz $FASTQ_DIR/VG20_R2.fastq.gz > 
VG1920\_R2.fastq.gz 
     
        ************* 
             
             
             
### Script3: Align bisulfite-sequencing samples to mouse mm9 genome using 




# This script is "doBismarkMap_Rep1.sh" 
# This file aligns reads to mouse mm9 genome using Bismark, for samples of 
sequencing run 1. Note, prior Bismark genome preparation step is required (see 
Bismark documentation).  





SAMPLE="1 3 5 7 9 12 20" 
 
Bismark align all samples 
for i in $SAMPLE 
do 
  mkdir -p map 
  cd map 
  mkdir -p VG$i 
  cd VG$i 
  echo "Running Bismark on VG$i" 
 bismark -q -p 4 --bowtie2 --bam --score_min L,0,-0.4 $BISMARK_GENOME -1 
$FASTQ_DIR/VG$i\_R1.fastq.gz -2 $FASTQ_DIR/VG$i\_R 
 
done 
     ************* 
          
 
 
### Script4: De-duplicate bisulfite-sequencing reads using Bismark program 
       
#!/bin/bash 
 
#This script is "dedup_Rep1.sh" and is used to deduplicate reads in the .bam 
file 




SAMPLE="1 3 5 7 9 12 " 
 
# Deduplicate all samples 
#If want to deduplicate one sample only (e.g., sample 1), replace "for i in 
$SAMPLE" with "for i in 1".  
 
for i in $SAMPLE 
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do 
  cd $BAM_DIR 
  echo "Deduplicating  subset VG$i"   
  nohup deduplicate_bismark --paired --bam $BAM_DIR/VG$i/VG$i\_*.bam > 
nohupdedup_VG$i& 
done 
    ************* 
             
             
             
### Script5: Perform M-bias on deduplicated .bam files    
         
#!/bin/bash 
 
#This script is to perform M-bias (perform only on deduplicated .bam files) 
#The output allows for determination of methylation-bias (M-bias) and 
subsequent trimming of biased reads. 
 
#M-bias was performed using Bismark Extractor Version: v0.14.3_devel (last 
modified on 22 April 2015.) 
 
DEDUP_DIR=/mnt/sequence/gaysinskaya/methylation/map 
SAMPLE="1 3 5 7 9 12 20" 
 
#Run M-bias on all samples in SAMPLE 
 
for i in SAMPLE 
do 
  cd $DEDUP_DIR/VG$i 
  echo "Running M-bias only on VG$i" 
  nohup  bismark_methylation_extractorV14_3.pl --multicore 2 --mbias_only --
paired-end $DEDUP_DIR/VG$i/VG$i\_*.deduplicated.bam > nohupMbias_VG$i 
done 
    ************* 
          
             
             
             
### Script6: Perform methylation extraction and elimination of M-bias  
               
#!/bin/bash 
 
#This script is "dodoMethylExtract.sh" and it performs methylation extraction 
and elimination of M-bias, simultaneously.  
#Specifically, after examination of M-bias in previous step, this script 
extracts methylation information ignoring biased CpGs. The biased CpGs included 
6 nt at 5' of read 1, 10 nt at 5' of read 2, 1 nt at 3' of read 1 and read 2. 
 
DEDUP_DIR=/mnt/sequence/gaysinskaya/methylation/map 
SAMPLE1="1 3 5 7 9 12 20" 
 
for i in $SAMPLE1 
 do 
   cd $DEDUP_DIR/VG$i 
   mkdir -p methextract 
 
  echo "Extracting methylation from VG$i" 
  nohup  bismark_methylation_extractorV14_3.pl --multicore 2 --gzip --paired-
end --no_overlap --report --ignore 6 --ignore_r2 10 --ignore_3prime 1 --
ignore_3prime_r2 1 -o methextract --comprehensive 
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#Results file containing methylation information for C in CpG context will be 
written to 
methextract/CpG_context_VG1_R1.fastq.gz_bismark_bt2_pe.deduplicated.txt.gz 
#Results files containing methylation information for C in CHG context and C in 
CHH context will also be written out. 
 
 
# view CpG methylation file 
#head 
CpG_context_VG1_IDX5WTSPG1_L001_R1ALL.fastq.gz_bismark_bt2_pe.deduplicated.txt, 
where Z stands for methylated and z for unmethylated 
 
#HWI-ST375:277:C5LM0ACXX:1:1101:1407:2118_1:N:0: + chr1 92624580
 Z 
#HWI-ST375:277:C5LM0ACXX:1:1101:1407:2118_1:N:0: + chr1 92624623
 Z 
#HWI-ST375:277:C5LM0ACXX:1:1101:1407:2118_1:N:0: + chr1 92624767
 Z 
#HWI-ST375:277:C5LM0ACXX:1:1101:1326:2236_1:N:0: + chr10 30281603
 Z 
#HWI-ST375:277:C5LM0ACXX:1:1101:1631:2039_1:N:0: + chr4 73920485
 Z 
#HWI-ST375:277:C5LM0ACXX:1:1101:1631:2039_1:N:0: + chr4 73920346
 Z 
#HWI-ST375:277:C5LM0ACXX:1:1101:1620:2081_1:N:0: - chrX 104373998
 z 
 
     ************* 
          
 
### Script7: Merge CpG methylation for both strands  
# The output file is a final file used for DNA methylation analysis.  




# This script is "CpG_ExtractMerge.sh" 
# This script extracts strand-specific coverage (using bismark2bedgGraph 
script) followed by strand-merging (using coverage2cytosine script) 





SAMPLE1="1 3 5 7 9 12" 
 
for i in $SAMPLE1  
 do 
    cd $CpG_context/VG$i/methextract 
    echo "Extracting strand-specific CpG coverage from Sample VG$i" 
    nohup time bismark2bedGraph -o VG$i CpG_context_VG$i*.deduplicated.txt.gz > 
nohupcov 
    echo "Merging strand-specific CpG coverage from Sample VG$i" 
    nohup time coverage2cytosine -o VG$i\d --merge_CpG --genome_folder 
$mm9Genome VG$i\.bismark.cov > nohupcov2 
done 
    
 # view FINAL CpG methylation file   
 ## head VG1d.merged_CpG_evidence.cov 
 ### column ids: chr/CpG start/CpG end/% methyllation/# CpG evidence for 
methylated CpG/# CpG evidence for unmethylated CpG 
  
#chr1 3000574 3000575 100.000000 6 0 
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#chr1 3000726 3000727 100.000000 3 0 
#chr1 3000901 3000902 100.000000 3 0 
#chr1 3001346 3001347 100.000000 4 0 
#chr1 3001394 3001395 100.000000 5 0 
#chr1 3001631 3001632 100.000000 6 0 
#chr1 3002177 3002178 100.000000 1 0 
#chr1 3002338 3002339 100.000000 1 0 
#chr1 3002386 3002387 75.000000 3 1 
#chr1 3002599 3002600 100.000000 4 0 
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COMPUTATIONAL SCRIPTS 8-10: processing of Illumina RNA-seq reads 
 
# This pipeline is for processing Illumina RNA-Sequencing reads (50bp SE 
reads), sequenced on HiSeq2000. The goal is to obtain read counts for the 
transcriptome. 
## The pipeline uses a subset of samples from sequencing run 1, for 
demonstration, and includes samples 3,8,17,22,26 and 29 corresponding to wild-
type samples Spg1, PL1, L1, Z1, P1 and D1, respectively. 
 




# This script is used to generate concatenated fastq.gz files from original RNA 
seq files 




SAMPLE="3 8 17 22 26 29" 
 
mkdir -p rawdata 
cd rawdata 
 
###For all samples 
for i in $SAMPLE 
do 
  echo "Concatenating Sample_$i " 
  cat $FASTQ_DIR/Sample_$i/*.fastq.gz > Sample_$i\.fastq.gz 
  fastqc Sample_$i\.fastq.gz & 
done 
 




### Script2: Align RNA-sequencing samples to mouse mm9 genome and iGenomes 
transcriptome using Tophat program 
           
#!/bin/bash 
 
# This script is used to perform tophat on fastq.gz files  
# working directory = /mnt/sequence/gaysinskaya/FACS_RNAseq1 







#Note, the annotation was downloaded from Illumina website, iGenomes collection 
and dates to July,2015  
 
#Sequencing run 1 
SAMPLE="3 8 17 22 26 29" 
 
mkdir -p tophat_iGenomes 
cd tophat_iGenomes 
 
###For all samples 
for i in $SAMPLE 
do 
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 nohup tophat -p 5 -o tophat$i -G $TRANSCRIPTOME $GENOME 
$RAW_DIR/Sample_$i.fastq > itophat$i\_mm9.out  
done 









# This script "doHtseq-count.sh"is used to perform htseq-count on sam files 
# working directory = /mnt/sequence/gaysinskaya/FACS_RNAseq1 
 
# Make sure the sam file is in the directory from which htseq-count is executed 






#Sequencing run 1 
SAMPLE="3 8 17 22 26 29 31 32" 
 
for i in $SAMPLE 
do 
 cd $DIR/tophat$i  




#the option -s <no> signifies that the data are not from a stranded protocol 
and the -a option specifies a minimum score for the alignment quality. 
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A. Personal Statement 
Prior to my graduate work, I did research in three major areas of biology: (1) 
developmental biology, studying aspects of polar body formation in a non-model organism, clam 
Spisula solidissima, (2) neurobiology, focusing on the effects of maternal high-fat diet on brain 
development of the offspring in rat and (3) virology, working on developing mouse model for 
hepatitis C. In my graduate studies I investigated the developmental biology and DNA 
epigenetics of mouse germ cells and explored the biology of the transposable elements - the 
highly abundant remnants of ancient infections, in mouse germline. My thesis research focused 
on characterizing and understanding a unique aspect of meiosis, namely, transient relaxation of 
DNA methylation at meiotic onset. My work highlights a period in spermatogenesis when 
genome-wide DNA methylation, including DNA methylation-dependent control of potentially 
dangerous transposable elements, is relaxed. My work has an important implication for 
understanding sensitivity of meiotic germ cells to retrotransposon expression, implicating the 
epigenetically relaxed state of meiotic onset in this sensitivity. My thesis research enhances our 
understanding of the epigenetic dynamics and plasticity of mouse male germ cells during meiotic 
prophase I. My expertise covers unique skills, like fluorescence activating cell sorting of 
spermatocytes, bioinformatics skills, including analysis of genome-wide DNA methylation and 
transcription post deep sequencing and common methods in cell and molecular biology, such as 
immunohistochemistry and microscopy.    
 
B. Positions and Honors 
 
Positions and Employment 
2009-  Predoc fellow. Johns Hopkins University/Carnegie Institution. Lab of Dr. 
Alex Bortvin.  
2007-2009 Lab technician. The Rockefeller University. Lab of Dr. Charles Rice.  
2004-2007 Volunteer/Research Assistant. The Rockefeller University. Lab of Dr. Sarah 
Leibowitz.                           




2013 The J. Brien Key Graduate Travel Award  
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2003 Howard Hughes Medical Institute (HHMI) Undergraduate Research Scholarship  
 
C. Contribution to Science 
 
1. My earliest work contributed to our understanding of the formation and function of a polar 
body. A polar body is a byproduct of oocyte meiosis and it is a fundamental feature of sexual 
reproduction. This work describes the sequence, spatial organization and mechanism of major 
cytoskeletal events contributing to unequal cytokinesis and polar body formation in clam 
Spisula solidissima.  
 
a. Pielak RM, Gaysinskaya VA, Cohen WD. Formation and function of the polar body 
contractile ring in Spisula. Developmental Biology. 2004;269(2):421-32 
b. R.M.Pielak, V.A. Gaysinskaya, and W.D.Cohen. “Cytoskeletal events preceding polar 
body formation in activated Spisula eggs”. Biological Bulletin. 2003;205(2):192-3. 
 
2. In the field of neurobiology I worked on describing the effects of overeating and obesity on 
rat brain, particularly, the hypothalamic region. I was involved in efforts showing that 
maternal high-fat diet affects fetal brain development.  
 
a. Chang GQ, Gaysinskaya V, Karatayev O, Leibowitz SF. Maternal high-fat diet and fetal 
programming: increased proliferation of hypothalamic peptide-producing neurons that 
increase risk for overeating and obesity. J Neurosci. 2008;28(46):12107-19. 
b. Gaysinskaya VA, Karatayev O, Chang GQ,  Leibowitz SF. Increased caloric intake after 
a high-fat preload: relation to circulating triglycerides and orexigenic peptides. 
Physiology and Behavior. 2007;91(1):142-53.   
c. G.-Q. Chang, O. Karatayev, R. Ahsan, V. Gaysinskaya, Z. Marwil, and S.F. Leibowitz. 
“Dietary fat stimulates endogenous enkephalin and dynorphin in the paraventricular 
nucleus: role of circulating triglycerides. American Journal of Physiology- Endocrinology 
and Metabolism 2007;292(2):E561-70. 
 
3. Interest in disease-causing pathogens led me to work in the field of infections dieseases. 
Among a team of viologists and molecular biologists, I worked on developing humanized 
mice model for hepatitis C.  This work enabled modeling of human hepatitis C in mice and 
elucidation of the mechanism and the pathology of this worldwide viral infection.   
 
a. Ploss A, Khetani SR, Jones CT, Syder AJ, Trehan K, Gaysinskaya VA, Mu K, Ritola K, 
Rice CM, Bhatia SN. Persistent hepatitis C virus infection in microscale primary human 
hepatocyte cultures. Proc Natl Acad Sci U S A. 2010;107(7):3141-5. 
b. Ploss A, Evans MJ, Gaysinskaya VA, Panis M, You H, de Jong YP, Rice CM. Human 
occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature. 
2009;457(7231):882-6. 
 
4. In my graduate research, I focused on understanding epigenetic changes in meiosis. I describe 
previously uncharacterized transient relaxation in DNA methylation at the onset of meiosis in 
mouse male germ cells. These studies demonstrate that relaxation in DNA methylation is 
linked to pre-meiotic DNA replication and results in transient relaxation of transposable 
element silencing in meiosis. My work identifies an additional step in epigenetic 
programming of the male germline that may be important for gamete quality control. 
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a. Valeriya Gaysinskaya, Godfried van der Heijden, Brendan Miller, Kasper D. Hansen, 
Alex Bortvin. Transient relaxation of DNA methylation at the onset of meiosis in male 
mice. Submitted. 
b. Gaysinskaya V and Bortvin A. Flow cytometry of murine spermatocytes. Curr Protoc 
Cytom. 2015;72(7):7.44.1-24. 
c. Gaysinskaya V, Soh IY, van der Heijden GW, Bortvin A. Optimized flow cytometry 
isolation of murine spermatocytes. Cytometry A. 2014;85(6):556-65. 
 
5. During my graduate training I became interested in issues related to bioethics and the politics 
of public health. I explored a particularly pertinent issue of mitorchondrial replacement 
therapy in the context of three-parent in vitro fertilization (IVF). 
 
a. Valeriya Gaysinskaya. “The many names of mitochondrial transfer IVF.” March 13, 
2015. Johns Hopkins Berman Institute of Bioethics, bioethicsbulletin.org. 
b. Valeriya Gaysinskaya. “Replacing faulty mitochondria”. February 3, 2015. Johns 
Hopkins Berman Institute of Bioethics, bioethicsbulletin.org. 
 
